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THE REGULATION OF TONB-DEPENDENT TRANSPORTERS IN NEISSERIA
GONORRHOEAE
By Aimee M Hollander
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2011
Major Director: Cynthia Nau Cornelissen, Ph.D.
Professor, Department of Microbiology and Immunology

Neisseria gonorrhoeae is an obligate human pathogen that causes the common sexuallytransmitted infection, gonorrhea. Gonococcal infections cause significant morbidity,
particularly among women, as the organism ascends to the upper reproductive tract,
resulting in pelvic inflammatory disease, ectopic pregnancy and infertility. Antibiotic
resistance rates have risen dramatically, leading to severe restriction of treatment options
for gonococcal disease. Gonococcal infections do not elicit protective immunity nor is
there an effective vaccine to prevent the disease. Thus, further characterization of
expression, function and regulation of surface antigens could lead to better treatment and
prevention modalities in the future. N. gonorrhoeae express a repertoire of TonBdependent transporters for the acquisition of iron. All of these transporters are under the
transcriptional regulation of Fur. We investigated putative intracellular iron sources
utilized by gonococci and the role that the TonB-dependent transporter, TdfF, played in
this acquisition. We determined that ascorbate which could prevent ferritin degradation
or withhold iron from gonococci, inhibited intracellular survival. The utilization of iron

xviii
from the iron binding moiety 2, 5-DHBA of the putative mammalian siderophore was
also examined. In this study we continued to investigate the regulation of TdfF and
further investigate potential host-specific inducing molecules for TdfF expression. We
investigated the regulation of tdfF expression and the role of MpeR, an AraC-like
regulator, in tdfF expression. We determined that MpeR, interacted specifically with the
DNA sequence upstream of fetA and activated FetA expression. We confirmed that the
outer membrane transporter, FetA, allows gonococcal strain FA1090 to utilize the
xenosiderophore, ferric-enterobactin, as an iron source. However, we further
demonstrated that FetA has an extended range of substrates that encompasses other
catecholate xenosiderophores, including ferric-salmochelin and the dimers and trimers of
dihydroxybenzoylserine. We demonstrated that fetA is encoded as part of an ironrepressed, MpeR-activated operon, which putatively encodes other iron transport
proteins. These iron transport proteins also play a role in xenosiderophore acquisition.
We also identified genetic differences that may explain why some gonococcal strains are
capable of xenosiderophore internalization in a TonB-dependent pathway and other
strains are restricted to TonB-independent pathways.
Interestingly, the chromosomal locus that codes for mpeR and tdfF is pathogen
specific. Thus understanding more about the TonB-dependent transporter and AraC-like
regulator may further elucidate the pathogenicity of N gonorrhoeae.
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CHAPTER 1 INTRODUCTION
I. Neisseria
The family Neisseriaceae contains the genera Neisseria, Moraxella,
Acinetobacter, and Kingella which differ from each other by cell morphology (155). The
members of the genus Neisseria are Gram-negative diplococci with adjacent flattened
sides.
Neisseria species are both pathogens and normal flora in humans. They are
differentiated based on their varying abilities to produce acid, as well as their DNase and
catalase activities. Species are also differentiated based on their ability produce acids
from carbohydrates through oxidation (not through fermentation) and their ability to
reduce nitrate and nitrite as well as oxidize fatty acids (133) (Table 1).
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Table 1. Biochemical Tests for the Identification of N. gonorrhoeae and Related Species
Acid Production

Species

G M

N. gonorrhoeae

S

F

L

Nitrate
Reduction

Polysacc haride
from Sucrose

S uperoxide

+ - - - -

-

-

++++

N. meningitidis

++ - - -

-

-

+++

N. lac tam ica

++ - - +

-

-

++

N. polysac charea

++ - - -

+

+

+

N. mucosa

++ + + -

+

+

+

Table adapted from Center of Disease Control and Prevention website.
Abbreviations: G, glucose; M, maltose; S, sucrose; F, fructose; L, lactose; (+) most
strains positive; (-) most strains negative. ++++ indicates strong positive; ++/+ indicates
weak positive.
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II. Pathogenic Neisseria Species
Of all Neisseria species, only N. gonorrhoeae strains are always pathogenic
whereas N. meningitidis are carried as normal flora of the nasopharynx. Under some
circumstances N. meningitidis can become invasive, causing sporadic cases of meningitis
and meningococcemia (155). These microorganisms are closely related yet highly
adapted to their respective host niches and cause entirely different clinical diseases.

III. Neisseria meningitidis
A. Epidemiology
N. meningitidis colonizes the nasopharnyx mainly as a commensal and is carried
by 5-10% of the healthy population in non-endemic times (269). Meningococci cause
symptomatic disease if they disseminate from the nasopharnyx and cause
meningococcemia or meningitis. Acquisition of N. meningitidis requires person-to-person
transmission via direct contact or through dispersion of respiratory droplets from an
infected individual to a susceptible individual. The frequency of meningococcal disease
varies according to the demographic and geographical location of the population. The
rate of nasopharyngeal carriage of N. meningitidis is lowest in young children, and
highest among adolescents and young adults (269). Meningococcal disease in Europe
and North America usually occurs as sporadic cases and the highest incidence rates are
seen in children less than 5 years of age (46). In North America, meningococcal disease
occurs at a rate of 1 case per 100,000 persons per year in the USA. The majority of these
cases occur in the winter season and in young children (223), with a case fatality rate of
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approximately 10% (223). Cases can also occur as clusters and localized outbreaks. N.
meningitidis is a major public health concern in areas where the bacteria are responsible
for pandemics and country-wide epidemics. Country-wide epidemics frequently occur in
the Sub-Saharan Africa, which is known as the “meningitis belt” (46).
B. Infection
Meningococcal meningitis starts with the colonization of the nasopharnyx,
followed by invasion and survival of bacteria in the bloodstream causing
meningococcemia. Then the bacteria can cross the blood–brain barrier, causing infection
in the central nervous system. Symptomatic meningococcemia may present as fever
lethargy, shock, coma, intravascular coagulation and skin rash (40, 140). Symptoms of
meningococcal meningitis include high fever, headache and stiff neck, which occur
several hours to two days after infection.
C. Treatment
The Centers for Disease Control and Prevention recommends that meningitis
treatment begin as early as possible in the course of the disease. An initial treatment with
antibiotics is recommend if bacterial meningitis is diagnosed (47). Appropriate antibiotic
treatment for bacterial meningitis reduces the risk of mortality to below 15%, although
the risk is higher among the elderly (47). About 11–19% of survivors have complications
due to infection which include neurologic disability, limb loss, and hearing loss (250).
There are two kinds of vaccines that protect against Neisseria meningitidis available in
the United States: meningococcal polysaccharide vaccine (Menomune®), and
meningococcal conjugate vaccine (Menactra® and Menveo®). These vaccines protect
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against meningococcal serogroups A, C, W135 and Y. There is currently no vaccine
against meningococcal serogroup B.

IV. Neisseria gonorrhoeae
A. Epidemiology
N. gonorrhoeae primarily infects the urogenital and anorectal mucosa following
intimate contact. Ejaculation does not have to occur for N. gonorrhoeae to be transmitted
or acquired and it can be spread from mother to baby during delivery. N. gonorrhoeae
causes the sexually transmitted infection gonorrhea which is responsible for an estimated
62.3 million infections worldwide (306). Over 300,000 infections are reported in the
United States per year and it is the second most common reportable infectious disease in
the US (49).
B. Infection
In men, gonorrhea can cause a symptomatic or asymptomatic infection. In
symptomatic infections, symptoms arise 1-14 days after contact with an infected partner
and include acute urethritis with purulent discharge and dysuria. Acute epdidymitis is the
most common complication of untreated gonococcal infection in males; however, very
rarely, disseminated gonococcal infection can occur.
It is estimated that up to 80% of women infected with N. gonorrhoeae are
asymptomatic or present with minor symptoms (190). The primary site of infection is the
endocervix and symptoms occur within the first 10 days of contact with an infected
partner. Symptoms can include urethritis with increased vaginal discharge, or vaginal
bleeding between periods. The spread of the microorganism into the upper genital tract
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can result in the development of complications from infection (99). The ascending
infection can lead to pelvic inflammatory disease which may cause ectopic pregnancy or
infertility (203, 267). Symptoms of rectal infection in both men and women can present
as asymptomatic or symptomatic infections. Symptoms may include discharge, anal
itching, soreness, bleeding, or painful bowel movements.
Other areas that may be infected by N. gonorrhoeae include the throat and eye.
Infections in the throat may cause a sore throat, but usually there are no symptoms.
Gonococcal conjunctivitis in adults is a localized infection that can lead to corneal
scarring and perforations leading to vision loss (165, 200, 287). In 0.5-3% of those
infected, disseminated gonococcal infections (DGI) can develop. Classic symptoms
include dermatitis, tenosynovitis, and fever. Besides serious secondary complications of
DGI, gonococcal infections have also been correlated with increased transmission of HIV
(60, 188).
C. Treatment
A variety of antimicrobial agents have been used for the treatment of gonorrhea
over the years. However, the introduction of new drugs to treat gonorrhea has repeatedly
led to the emergence and spread of N. gonorrhoeae with resistance to these new drugs
(308). In 1935, sulphamides were recommended for the treatment of gonorrhea;
however, by 1944 there was widespread resistance against this therapy (146, 167).
Penicillin was then prescribed for treatment until 1976. The gonococcus became resistant
to penicillin due to the plasmid-mediated resistance as well as other genetic mutations,
which led to the end of penicillin being recommended as a therapeutic agent for
gonorrhea in many areas of the world (216). Fluoroquinolones, such as Ciprofloxacin
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were widely used to treat gonorrhea from the mid-1980s until 2007 when the Centers for
Disease Control and Prevention no longer recommended this antibiotic for treatment of
infection (50, 279, 308). Consequently, only one class of antimicrobials, the extended
spectrum cephalosporins, is recommended and available for the treatment of gonorrhea in
the United States; however, resistance against this particular therapy is on the rise (299).
Most recently a gonococcal strain has been identified that is resistant to all known
antibiotic therapies (30).
In contrast to N. meningitidis, there is no vaccine to prevent infection with N.
gonorrhoeae. Gonococcal infections do not elicit protective immunity and individuals
can be infected by the same strain over and over again because the gonococcal cell
surface is extremely variable. Given the major morbidity from untreated gonococcal
infections, along with the rise of antibiotic resistance and lack of vaccine, it is important
to understand the genetic regulation of outer membrane proteins as well as the nutrient
acquisition systems employed by the bacteria. These proteins could serve as vaccine
antigens as well as targets of alternative treatments for the sexually transmitted infection
caused by N. gonorrhoeae.

V. N. gonorrhoeae Virulence Factors
N. gonorrhoeae expresses a wide range of virulence factors that contribute to
successful infection of the human host. These virulence factors include those that
contribute to mucosal adherence, cellular invasion, and immune evasion.
A. Pilus
Gonococcal pili play an important role in colonization of host tissue and piliated
gonococci have been recovered from primary cultures (150, 151). Pili are long (<6µm)
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filamentous structures that extend from the bacterial surface. The pili allow the
gonococcus to overcome the electrostatic barrier between the bacterium and the
eukaryotic host cell (125). Gonococcal pili are not only associated with colonization but
are important virulence factors because they play a role in the uptake of DNA. Piliated
gonococci are 1000-fold more competent for transformation by DNA than non-piliated
bacteria (24, 95, 268). Pili also play a role in twitching motility in which the pilus fibers
retract causing the bacteria to move along most surfaces (35).
The pilus fiber is primarily composed of a single pilin protein subunit, PilE,
which is assembled in a helical arrangement into a filament with a diameter of 6nm (214).
Located on the tip of the pilus fiber is the PilC protein (247) which has also been
identified as a surface component of N. gonorrhoeae (236, 246). Neisserial pili interact
with many cell types including epithelial cells, endothelial cells, granulocytes,
macrophages, and erythrocytes (248, 262, 294, 295). There are at least two different host
cell binding epitopes on the pilus. One epitope is the PilE subunit along the pilus fiber
and the other epitope is on the tip of the pilus mediated by PilC (257). Very little is
known about the receptors that are recognized by the two binding functions of the pilus
or about the cellular response to pilus-mediated adherence. Biochemical studies
performed to elucidate the cellular receptors for pilin dependent adhesion were
inconclusive with different studies concluding that receptors were either carbohydrate or
proteinaceous in composition (110, 153).
Since pili are surface exposed and are major virulence factors of the gonococcus;
attempts to produce an anti-gonococcal vaccine was focused on this surface antigen (33,
187, 285). However, pilus expression is phase variable due to the poly-cytosine tract in
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pilE (156). This phase variation leads to reversible on and off switching of pilin. Along
with phase variable expression, pili also undergo antigenic variation. Antigenic variation
results from a nonreciprocal transfer of DNA sequences from one of many silent pilS
cassettes into the expressed pilE locus (18, 112, 195, 276). As the pilS locus remains
unchanged during the recombination reaction, the process resembles a classic gene
conversion event (314). In addition to phase and antigenic variation, pilin also undergo
post-translational modifications. These modifications include phosphorylation as well as
glycosylation (126, 272). The high degree of PilE antigenic variation, phase variation
and post-translational modifications likely contribute to both the failure of gonococcal
infection to elicit protective immunity in the human host and the lack of efficacy
associated with N. gonorrhoeae pili vaccines (33, 261).
B. Opas
Neisserial Opa proteins were originally identified because changes in their expression
led to altered colony opacity and color due to changes in bacterial aggregation (29, 274).
The Opa proteins constitute a family of closely related but size-variable integral outer
membrane proteins that are predicted to span the membrane eight times with four surface
exposed loops (124, 182). A single gonococcal strain can possess up to 11 unlinked
chromosomal alleles that encode distinct Opa variants. It is thought that Opa expression
is important for gonococcal infection because gonococci recovered after urogenital,
cervical or rectal infection are typically Opa+, as are bacteria recovered after the
inoculation of human volunteers with transparent (Opa−) bacteria (143, 275). The only
exception to this Opa dependence is that Opa- bacteria predominate in the cervix early in
the menstrual cycle (274). Opas are thought to play a role in intimate interactions with the
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host cell that leads to trancytosis into sub-epithelial tissues. It has been demonstrated that
a subset of Opa protein variants bind to host cell surface-associated heparin sulfate
proteoglycans (HSPG). Many groups have also determined that Opas specifically bind to
CEACAM receptors that are differentially expressed on multiple tissues in the human
host (55, 292). Most Opa proteins bind to either CEACAM or HSPG glycoproteins
however some interact with both cellular receptors. The Opa variants that do bind to both
cellular receptors are only able to mediate cellular invasion by CEACAM (157). It has
been demonstrated by Wang et al, that gonococci expressing CEACAM-specific Opa
proteins are capable of passing from apical to the basolateral surface of polarized
epithelial cell line monolayer (298). Opas have also been shown to down regulate the
host immune response through the induction of B cell apoptosis, suppression of T-cell
activation (34), and inhibition of an antibody response (213). Similar to pilin, the
expression of each Opa allele is phase variable making it a poor vaccine antigen. Opa
phase variation is due to slipped strand mispairing in which a change in the number of
CTCTT repeats in the structural gene resulting in differential expression of Opas (204).
Additionally, gonococcal strains can express zero or multiple Opas at one time (270).
C. Porin
Porin is the predominant outer membrane protein of N. gonorrhoeae. It is encoded by the
porB gene. Gonococci possess one of two porB alleles, porB1a or porB1b, which encode
the PIA or the PIB protein, respectively (74, 106) Gonococcal strains are separated into
two serotypes based on the two different porin proteins. PorB assembles in the
membrane as a trimeric complex in which each PIA or PIB monomer forms a β barrel
structure with eight predicted surface-exposed loops (68, 142). PorB serves as an ion
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channel and is essential for cell survival. Porin has several functions associated with
gonococcal pathogenesis including effects on host cell apoptosis (201). Porin has been
shown to either induce or inhibit apoptosis depending on the cell line that is infected (91,
201). Porin can aid in cell invasion (103) and can also translocate from bacterial
membranes into the membranes of target cells. Porin has been identified in cytoplasmic
and phagosomal membranes of host cells (300). In addition, PorB has been associated
with antibiotic resistance (100). PorB aids in immune evasion in multiple ways as well.
Purified gonococcal porins can inhibit phagocytosis and degranulation by PMNs (26,
114). The gonococcal porin PorB1A is critical in modulating stable serum resistance by
binding to factor H (239). Porin can also down regulate the classical complement
pathway by binding to the C4b binding protein (238). Unlike the majority of gonococcal
surface structures, PorB is antigenically stable during infection. Porin diversity does exist
among strains but primarily within the surface-exposed loops. Porin diversity as well as
its ability to modulate immune responses makes it a poor vaccine candidate. However the
diversity of porin is exploited by the conventional N. gonorrhoeae serotyping method,
which uses a panel of monoclonal antibodies to type strains (277). Sequence-based
methods, such as multiple antigen sequence typing, porB sequencing (288), and porB
variable region (188) typing (282) are also used for serotyping strains.
D. Lipooligosaccharide
Lipopolysaccharide (LPS) is a component of the gram-negative outer membrane.
It is the main component of the outer leaflet of the outer membrane, being anchored to
the membrane by the lipid A moiety which is endotoxic. Extended outward from the
membrane is a core oligosaccharide followed by the O antigen which is a polymer of
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short oligosaccharide repeats. N. gonorrhoeae produce a short type of LPS known as
lipooligosaccharide (LOS) because the core oligosaccharide structure is highly branched
and it lacks repetitive O-antigen side chains. It has recently been observed that LOS may
play a role in the resistance to antimicrobial peptides (173). LOS also induces the
production of pro-inflammatory cytokines and binds to the TREM-2 receptor, which is
expressed on genitourinary epithelial cells and by the fallopian tube epithelium in the
host (231, 233).
LOS varies amongst gonococcal strains and this variation is due to phase-variable
expression of the glycosyl transferases, which are responsible for the biosynthesis of
variable α-chain carbohydrates of LOS. The phase variable expression is from slipped
strand mispairing due to poly-guanosine tract within the coding sequence of the gene
(70). LOS can also undergo post-translational modification in which a terminal galactose
residue is modified by the membrane-associated bacterial sialyltransferase using hostderived cytidine 5’-mono-phospho-N-acetylneuraminic acid (CMP-NANA) as the sialyl
donor (183). The sialylation of LOS prevents complement dependent killing of
gonococci. (9, 305).
E. Reduction-modifiable protein
Reduction-modifiable protein (RMP) is a gonococcal outer membrane protein
whose name refers to the observation that its molecular weight shifts following SDSPAGE in reducing conditions (181). RMP is conserved amongst gonococcal strains and is
thought to be a homolog of OmpA in Enterobacteria (104, 105). Antibodies produced
during gonococcal infection are specific to RMP (191, 242). When these RMP specific
antibodies are depleted from human sera, gonococci are then susceptible to serum-
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dependent killing. It has been demonstrated that RMP specific antibodies block the
binding of IgG, resulting in protection of the bacteria from the host immune response
(242). It is also thought that RMP antibodies increase host susceptibility to infection
(222).
F. IgA1 protease
Cleavage of IgA antibodies by the gonococcal protease leads to the separation of
the F(ab) fragment, which is involved in the antigen binding, from the FC domain, which is
involved in effector function (221). This results in the pathogen becoming decorated in
F(ab) fragments, masking gonococcal epitopes from the host immune system. It has also
been demonstrated that IgA1 protease cleaves human lysosomal/late endosome
associated membrane protein 1 (h-lamp-1) which may lead to survival during infection
(123, 177). Additionally, it has been demonstrated that IgA protease plays a role in the
transcytosis of gonococci across polarized cells (134). There are serologically distinct
IgA1 proteases of N. gonorrhoeae and this is due to the horizontal exchange of iga (116).
Thus IgA protease not only plays a role in immune evasion but may also play a role in
gonococcal intracellular survival of epithelial cells.

VI. Host Iron Sources
Iron is an essential element for all living organisms and plays a crucial role in a
variety of cellular functions in metabolism, cellular growth and differentiation as well as
oxygen transport, DNA synthesis and energy production (37). However, excess free iron
is toxic and donates electrons to produce hydroxyl radicals via the Fenton reaction:
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Fe2+ + H202ÆFe3+ + OH- +OH. These free hydroxyl radicals cause oxidative stressinduced damage of DNA, lipids and proteins leading to cell damage and death. Thus
99.9% of host iron is held in intracellular storage proteins or bound to host iron binding
proteins for extracellular transport (189). The following are iron sources that are
available within the human host and could provide this necessary nutrient to gonococci.
A. Ferritin
Ferritin is an iron-binding protein that is ubiquitous within the human host.
Ferritin is a 24-mer globular protein with an iron core. Ferritin is made up of heavy and
light chain proteins with molecular masses of 21 kDa and 19 kDa respectively (12, 93,
280). Naturally-occurring ferritin does not contain more than 3000 iron atoms/molecule,
although in principle it can accommodate up to 4500 (120, 280). The sequestration of
iron by ferritin serves two purposes. First, ferritin sequesters iron and segregates the iron
in a non-toxic form. Second, ferritin serves as a cellular iron storage unit. In normal
human sera, ferritin circulates at a relatively low concentration of 1µM therefore ferritin
serves as an intracellular iron source to the host (1).
B. Transferrin
Transferrin is a single-chain glycoprotein with the molecular weight of about 80
kDa and has two structurally similar but functionally distinct lobes. Each lobe consists of
two dissimilar domains enclosing a deep hydrophilic cleft bearing an iron binding site.
Normally, all non-heme iron in circulation is bound to transferrin in human sera and only
30% of transferrin binding sites are occupied with iron. Transferrin has one of the highest
metal binding affinities recorded, with a binding constant for ferric iron of 10–23 M (160)
and can retain iron at a pH as low as 5 (185). The principal physiological role of serum
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transferrin is to transport iron through the circulatory system and release the iron to irondepleted cells in a receptor mediated endocytosis-dependent manner (4).
C. Lactoferrin
Similar to transferrin, lactoferrin is an 80 kDa glycosylated protein that is
comprised of a polypeptide chain folded into two symmetrical lobes. Lactoferrin is
secreted by mucosal epithelial cells and found in mucosal secretions including tears,
saliva, vaginal fluids, semen, nasal, bronchial secretions, bile, gastrointestinal fluids, milk
and urine (85). Lactoferrin has a binding constant for ferric iron of about 10–20 M and can
retain iron at a pH as low as 3 (14). Lactoferrin is a multifunctional protein that is
involved in the absorption of iron, but also in immune responses (168, 169), antimicrobial
activities (310) and has both anticarcinogenic (21) and anti-inflammatory properties (61).
D. Heme
Heme is a porphyrin containing an iron atom in its center. Heme is produced in
virtually all mammalian tissues. Its synthesis is most pronounced in the bone marrow and
liver because of the requirements for incorporation into hemoglobin and cellular
cytochromes (218, 271). Isolate heme is very toxic is toxic to cells but required for
hemoproteins such as hemoglobin and hemopexin (271).
E. Hemoglobin
Hemoglobin, found in red blood cells, transports O2 in the circulatory system and
facilitates reactive oxygen and nitrogen species detoxification. It is tetrameric in structure
and each subunit contains a heme group (217).
F. Haptoglobin
Haptoglobin is a plasma hemoglobin scavenger that binds to hemoglobin with a
binding affinity of 10-12 M (148). Release of hemoglobin into plasma is the result of
senescent erythrocytes being degraded. In plasma, stable hemoglobin-haptoglobin
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complexes are formed and are delivered to the reticulo-endothelial system by receptormediated endocytosis (148).
G. Siderophores
Free iron concentrations in the human host are reduced to about 10-24M in human
serum due to host iron binding proteins such as transferrin, and hemoglobin (240). To
overcome the lack of free iron availability in the human host, commensal and pathogenic
bacteria produce siderophores. Siderophores are low molecular weight iron chelators that
can strip iron from host iron binding proteins. They are also produced and secreted by
yeast, fungi and many plants and have dissociation constants in the range of 10-20M (57).
Most siderophores are biosynthetically produced by large multienzyme synthases that
resemble the eukaryotic fatty acid synthases (15, 69). They often have a peptide
backbone, with modified amino acid side chains creating the iron-coordinating ligands.
Siderophores are classified by the iron coordinating ligands into three groups including
the catecholate, hydroxamate and hydroxycarboxylate groups (130). Once released into
the environment or human host, the siderophore will sequester iron from iron binding
proteins such as transferrin or will chelate free iron in the environment. The ferrated
siderophore will then return to the bacteria and deliver the sequestered iron.
H. Neutrophil gelatinase-associated lipocalin
Neutrophil gelatinase-associated lipocalin (NGAL) also known as lcn2 or
siderocalin is constitutively expressed in myelocytes and stored in specific granules of
neutrophils as well as expressed in epithelial cells during inflammation. NGAL which is
part of the lipocalin family, has a tertiary structure determined by highly conserved
segments of the individual lipocalin proteins, termed the lipocalin folds. These folds form
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eight anti-parallel β-sheets that surround a hydrophobic pocket. Lipocalins in general act
as transport or carrier proteins (90) by binding substrates to the hydrophobic pocket.
NGAL functions as a siderophore binding protein. Therefore, NGAL is like a
counterstrike of the host against the bacteria scavenging for iron. Interestingly, certain
bacteria are able to glucosylate the catecholate siderophore enterobactin to form
salmochelin. Salmochelin, is not recognized by NGAL and can continue to strip host iron
binding proteins of their iron (88).
I. 2,5 DHBA
It has been recently determined that mammalian cells may secrete a siderophorelike molecule. When distinguishing if NGAL binds to human derived iron coordinating
molecules, 2,5 Dihydroxybenozic acid (DHBA) was identified. 2,5-DHBA is related to
2,3-DHBA which is the iron-binding moiety of the bacterial siderophore enterobactin
(75). A mammalian homolog to entA was identified. EntA plays a critical role in
synthesis of the bacterial siderophore enterobactin but was identified in murine cells to
play a role in the synthesis of the siderophore with the 2,5 DHBA moiety (75). When this
entA homolog was knocked down with RNA interference, there was a deregulation of
cellular iron homeostasis within the murine cells. The composition and structure of the
intact mammalian siderophore remain unknown (75).

VII. Iron Acquisition Systems of N. gonorrhoeae
Because N. gonorrhoeae is an obligate human pathogen it must rely on human
iron sources for its nutritional needs. Unlike most bacteria, N. gonorrhoeae do not
produce siderophores (304). Rather, gonococci employ 1- and 2- component systems to
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acquire iron from host iron binding proteins. Gonococci acquire iron from multiple host
iron binding proteins (Figure 1).
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Figure 1. Iron Acquisition Systems of N. gonorrhoeae
The outer membrane receptors for each iron source are depicted as barrels traversing the
outer membrane (OM). In the 2-component iron acquisition systems, the associated
lipidated proteins are shown tethered to the outer membrane. The periplasmic ironbinding protein (PBP) for each system is depicted as a brown semi-circle. The PBP is
responsible for shuttling the iron across the periplasmic space. Transferrin and
Lactoferrin acquisition systems utilize the PBP FbpA, the Fet system utilizes the protein
FetB and it is hypothesized that FetB2 is associated with TdfF. TonB, ExbB, and ExbD
are responsible for supplying energy to the iron acquisition systems and are light blue,
attached to or imbedded within the cytoplasmic membrane (CM). The ABC transport
system which is responsible for transporting iron across the cytoplasmic membrane is
depicted in bright green and traversing the cytoplasmic membrane. The transferrin and
lactoferrin transport system utilize FbpBC for transport of iron across the CM. It is
hypothesized that the Fet system utilizes an ABC transport system encoded by genes
ng2091-2089. There has not been a PBP or ABC transport system identified for
hemoglobin transport. An ABC transport system has not been identified for TdfFdependent intracellular iron acquisition system.

OM

20

Trasferrin
Acquisition
TbpB

Lactoferrin
Acquisition
LbpB

TbpA

Hemoglobin
Acquisition

Xenosiderophore
Acquisition

Intracellular Iron
Acquisition

HpuA

LbpA

HpuB

FetA

FetB

FbpA

TdfF

FetB2

CM
TonB/Exb
B/ExbD

FbpB/C

TonB/ExbB
/ExbD

TonB/ExbB/
ExbD

NG20912088

TonB/ExbB
/ExbD

21
A. Transferrin iron acquisition system
The gonococcal transferrin-iron uptake system is a TonB-dependent system
composed of two transferrin binding proteins, TbpA and TbpB (Figure 1). TbpA is an
outer membrane barrel made up of 22 transmembrane β-strands (62, 64). It has 11
surface exposed loops and an amino terminal plug domain (62). TbpA is necessary for
the internalization of iron from transferrin. TbpB is a surface-tethered lipoprotein that is
important for increased efficiency of iron acquisition (6). The precise mechanism of iron
removal and transport into the bacteria’s periplasm on ferrated transferring has bound to
TbpA/TbpB has not been completely elucidated. However, it has been proposed that once
iron is extracted from transferrin it interacts with the plug domain of TbpA (207, 312)
and once the plug domain interacts with energized TonB the plug unfolds resulting in the
presentation of the iron to the periplasm (111). In the periplasm, FbpA binds to the iron
(54) and shuttles it to the ABC transport system which is composed of FbpB and FbpC
(Figure 1). The ABC transport system transports the iron across the bacterial cytoplasmic
membrane.
B. Lactoferrin iron acquisition system
Similar to the transferrin acquisition system, the lactoferrin iron acquisition system is
made up of two components and is TonB-dependent (22, 25). LbpA is similar to TbpA in
that it is a TonB-dependent outer membrane transporter; LbpB is an outer membrane
lipoprotein. Interestingly about 50% of gonococcal isolates have lost the ability to
express the Lbps due to a deletion removing the lbpB gene and a portion of the lbpA gene
(5). Also, lbpB, when present, is subject to phase variation due to a poly-cytosine tract
within the gene’s coding region. Details of how the Lbps bind lactoferrin, extract iron,
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and are energized by TonB have not been elucidated. However, it has been determined
that the Fbp system used by the Tbp system also transports the iron extracted by the Lbp
system across the periplasm and into the cytoplasm (54) (Figure 1).
C. Hemoglobin iron acquisition system
Gonococci are capable of utilizing both free heme and heme bound to hemoglobin
as an iron source (52, 53). There has not been a specific receptor identified for heme
acquisition but hemoglobin acquisition is employed by a TonB-dependent 2-component
system consisting of HpuA and HpuB (Figure 1). HpuB is the outer membrane β-barrel
whereas HpuA is the associated lipoprotein. Both proteins must be present for iron
acquisition from hemoglobin to occur. It is hypothesized that the HpuA/B proteins form a
heteromultimer in order to constitute the obligate hemoglobin binding pocket (52).
Similar to Lbp, the HpuA/B system is phase variable due to a poly-guanosine tract within
the hpuA gene (52). Interestingly, HpuA and HupB do not exclusively interact with
human hemoglobin and can recognize hemoglobin from non-human sources. The
subsequent transport of iron from the HpuA/B system is presumed to involve a
periplasmic binding protein and ABC transport system; however neither has been defined
for this iron acquisition system (Figure1) .
D. Siderophore iron acquisition
As stated previously N. gonorrhoeae does not produce siderophores. However the
bacteria can utilize iron from siderophores produced by other bacteria, or
xenosiderophores. N. gonorrhoeae can acquire iron from the catecholate
xenosiderophores aerobactin, enterobactin, salmochelin, and dihydroxybenzoylserine (43,
273, 303). The fetA gene formerly named frpB (20) encodes the TonB-dependent ferric
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enterobactin transporter, FetA. It was demonstrated that FetA is an important component
for the binding and acquisition of the xenosiderophore ferric enterobactin (43), which is a
catecholate-type siderophore produced by enterics. Distinct from the Lbps, Tbps, and
Hpu, FetA is a single component transporter (Figure 1). Downstream of fetA are genes
that encode a putative periplasmic binding protein, fetB, and ABC transport system,
which is thought to be involved in the transport of iron from FetA into the gonococcal
cytoplasm (Figure 1). Similar to the majority of surface exposed proteins, fetA is phase
variable due to a poly-cytosine track in the promoter of the gene (44). Our laboratory has
also determined that gonococcal strain FA19 acquires enterobactin, salmochelin, and
dihydroxybenzoylserine in a TonB-independent manner (273). Strain FA19 requires the
FbpABC transport system for utilization of these xenosiderophores (273) rather than the
Fet system. These findings indicate that there are Ton-dependent and independent
pathways for the utilization of iron from xenosiderophores.
E. Intracellular iron acquisition
Another single component transporter, the TonB-dependent transporter, TdfF has
been identified to be important for intracellular survival in gonococcal strain FA1090
(113). The tdfF mutant was defective in intracellular survival; however, excess iron
overcame this survival defect indicating that TdfF is important for intracellular iron
acquisition (113). Interestingly, tdfF expression only occurs in the presence of epithelial
cells or cell culture media and not in the presence of bacterial growth media. This finding
indicates that a cell or serum specific molecule is involved in inducing tdfF expression
(113). Additionally, tdfF has only been identified in pathogenic Neisseria and not in
commensals. Upstream of tdfF is a gene that codes for a putative periplasmic binding
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protein that has homology to the periplasmic binding protein FetB and is annotated as
FetB2. It is hypothesized that FetB2 is part of the intracellular iron acquisition system;
however, the rest of the transport system remains unidentified (Figure 1). The ligand
involved in TdfF-dependent iron acquisition has not been identified.
It has also been determined that TonB-dependent intracellular iron acquisition is
strain specific. Gonococcal strains FA19 and MS11 do not depend upon the expression
of TonB or TdfF for survival (317). Both of these strains differ from gonococcal strain
FA1090 in that they both posses a gonococcal genetic island (178) which encodes a type
IV secretion system (117). It is hypothesized that this GGI is involved in a TonB bypass
mechanism (317).

Neisseria meningitidis can trigger rapid redistribution and

degradation of cytosolic ferritin within infected epithelial cells suggesting that N.
meningitidis can tap into ferritin as an iron source (162). Both gonococci and
meningococci can interfere with transferrin uptake by infected epithelial cells (31)
implying the microorganisms affect iron transport within the host cell. Ferritin
acquisition by N. gonorrhoeae has not been investigated.
F. TonB-dependent transport
The presence of an outer membrane in Gram negative bacteria limits access to
many nutrients. Any molecules below the threshold size of about 600 kDa can cross the
outer membrane by diffusion through porin channels (205). In contrast most nutrients
and iron sources are either too big or too scarce to be acquired by diffusion through
porins. Thus, high affinity receptors are employed and the energy necessary for the
delivery of substrates to the periplasm is derived from a complex of proteins that include
TonB, ExbB and ExbD. Almost all iron sources utilized by gonococci are taken up in a
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high affinity, receptor-mediated, TonB-dependent manner. The exceptions are ferric
citrate, heme, and some xenosiderophores, which are taken in a TonB-independent
manner by gonococci (23, 273). TonB interacts with components in both the cytoplasmic
and outer membranes whereas ExbB and ExbD are anchored in the cytoplasmic
membrane. ExbB and ExbD harness energy from the proton motive force of the
cytoplasmic membrane and transfer this energy to TonB (128). Once TonB is energized,
it takes on a different conformation compared to when it is in an energy-deficient state.
TonB then transfers its energy to the outer membrane transporters. There are currently
two models for how TonB transduces energy from the cytoplasmic membrane to the
outer membrane. In the shuttle model, TonB which dimerizes, transfers energy from the
cytoplasmic membrane to the TonB-dependent transporter in four steps. In step one, the
potential energy of the cytoplasmic membrane proton gradient is harnessed by the
ExbB/D energy-harvesting complex. In step two, the energy is stored via a
conformational change in the associated TonB dimer. In the third step, TonB shuttles
through the periplasm, where the stored potential energy is transferred to a ligand bearing
TonB-dependent transporter. The energization of the transporter leads to ligand release
into the periplasmic space. In step four the de-energized TonB is then returned to the
cytoplasmic membrane (225, 226). Another model of TonB-dependent energization is
the propeller model. In the propeller model, TonB remains associated with the
cytoplasmic membrane at all times. Once energized by the proton motive force through
ExbB/D the C-terminal ‘propeller’ of TonB becomes associated with the plug portion of
the outer membrane transport and causes the release of the bound ligand into the
periplasm (45).
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VIII. Genetic regulation of iron acquisition
Excess iron is toxic due to its ability to catalyze Fenton reactions which leads to
the formation of reactive oxygen species. Iron uptake has to be well regulated to maintain
the optimum concentration of intracellular iron and prevent intracellular iron overload.
A. Fur regulation
The Fur protein of E. coli is a 17 kDa polypeptide (253) which acts as a
transcriptional regulator of iron-regulated promoters by virtue of its Fe2+-dependent DNA
binding activity (13, 73). Regardless of the presence or absence of Fe2+ the Fur protein
has been isolated as a dimer (197). Under iron-replete conditions, Fur binds to the iron
and acquires a conformation the enables it to bind to a target DNA sequence called a Fur
box. When Fur is bound to the Fur box, transcription is inhibited and the genes are
repressed. (Figure 2) When iron is scarce, Fur cannot complex with Fe2+ or bind to the
Fur box, allowing the RNA polymerase to access the iron regulated genes (109, 154)
(Figure 2). A Fur homolog has been identified in N. gonorrhoeae (19). Using DNA
footprinting, it was established, that in E. coli , the strongest natural Fur binding site
comprises two hexameric GATAAT direct repeats followed by a 6 base pair inverted
repeat, ATTATC (82). The gonococcal Fur binding sequence is similar to that of E. coli
with two hexameric direct repeats consisting of ATAAT followed by ATTAT (139).
Early studies of N. gonorrhoeae using a missense mutant confirmed that Fur regulated not
only known iron acquisition genes but also a broad range of other genes (78, 281). It was
recently determined that roughly 10% of the genes in the N. gonorrhoeae genome are
responsive to iron, with 30% of those open reading frames (ORFs) regulated directly by
Fur (139).
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Figure 2. Fur Regulation
Fur is a dimeric protein depicted in purple. Under iron-replete conditions, Fur binds to
iron (red circles) and acquires a confirmation the enables it to bind to a target DNA
sequence called a Fur box, usually located within the promoter of an iron regulated gene.
The Fur box sequence, as depicted in the yellow rectangle is comprised of two hexameric
GATAAT direct repeats followed by a 6 base pair inverted repeat, ATTATC. When Fur
is bound to the Fur box, transcription (green arrow) is inhibited (red “X”) and the gene is
repressed. When iron is scarce, Fur cannot complex with Fe2+ or bind to the Fur box,
allowing the RNA polymerase to access the promoter and the gene is transcribed (green
arrow).
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B. AraC-like regulation
The AraC family of transcriptional regulators constitutes one of the largest groups
of regulatory proteins in bacteria (311). These regulators are involved in the
transcriptional regulation of a variety of cellular processes in Gram-negative and Grampositive bacteria, including carbon metabolism, stress responses and virulence (97).
AraC, the regulator of the L-arabinose operon in Escherichia coli, was the first member
to be identified, purified, and characterized biochemically (108, 258-260). In general,
these regulators are between 200 and 300 amino acids in length arranged in two domains:
a conserved helix-turn-helix DNA-binding domain at the C-terminus and variable Nterminal domain. In many cases the variable N-terminal domain is responsible for both
protein dimerization and ligand binding. In the context of iron acquisition, AraC-like
transcriptional regulators have been employed by a variety of bacteria including
Pseudomonas aeruginosa, Bordetella species, and Yersenia pestis (16, 87, 127). In all
three of these organisms the AraC-like transcriptional regulator is involved in the
regulation of siderophore biosynthesis and acquisition.
The mechanism of AraC-like regulation of siderophore genes involves the
cognate siderophore functioning as a co-inducer binding to the N-terminal domain of the
AraC-like regulator. Generally, both the AraC-like regulator, and the siderophore
biosynthesis/acquisition genes are repressed by Fur under iron-replete conditions (Figure
3). Once the Fur repression is relieved under iron-deplete conditions, the AraC-like
regulator is expressed, as well as very low levels of siderophore biosynthesis/acquisition
genes (Figure 3). Once the AraC-like regulator binds to its inducing agent, usually the
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siderophore, it will then activate the transcription of the siderophore/biosynthesis genes
(Figure 3). The gonococcal genome does encode AraC-like regulators and it has been
recently demonstrated that one of these regulators, MpeR, (92) is Fur regulated (139).
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Figure 3. AraC-like Regulation
The AraC-like regulator and siderophore biosynthesis/acquisition genes are repressed by
Fur (purple) under iron-replete conditions. Once Fur repression is relieved under irondeplete conditions, the AraC-like regulator gene is expressed (large green arrow), as well
as very low levels of siderophore biosynthesis/acquisition genes (small green arrow). The
AraC-like regulator protein (large orange half moon) then binds to an inducing molecule
(blue circles). This inducing agent is usually a siderophore. After the AraC-like protein
binds to its specific inducer, it positively regulates the transcription of the
siderophore/biosynthesis genes (large green arrows).
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C. Slipped-strand mispairing
Slipped-strand mispairing occurs during DNA replication, when DNA polymerase
‘slips’ on a string of repeated nucleotides in the template DNA, either adding or deleting
one repeat unit in one of the daughter strands (171). The string of repeated nucleotides
can consist of a simple homopolymeric tracts or a single nucleotide (291). Slipped-strand
mispairing can result in phase variation due to repeated nucleotides located within the
open reading frame of a gene, which causes a frameshift mutation. This kind of phase
variation due to slipped strand mispairing occurs in gonococcal genes that encode
enzymes involved in LOS synthesis, as well as Opas, and HpuB (17, 52, 204). If the
repeated nucleotides exist in the promoter region of a gene, slipped strand mispairing can
result in differences in promoter-strength during transcription. Phase variation due to
changes in promoter strength occurs in gonococcal gene fetA which encodes the
xenosiderophore receptor, FetA (44).

IX. Objectives
The goal of the research described in this thesis was to characterize TonBdependent transporters involved in intracellular and extracellular iron acquisition and the
transcriptional regulation involved in the expression of these transport systems. This was
accomplished through three major objectives. The first involved the analysis of TdfF
expression in the presence of host derived inducing signals in vitro which could lead to
potential ligands for TdfF-specific iron acquisition. The second objective was to further
our understanding of potential intracellular iron sources acquired by Neisseria
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gonorrhoeae in a TonB-dependent manner. The third objective was to elucidate the iron
acquisition system responsible for xenosiderophore uptake and the regulation behind this
acquisition system. In this objective we also further characterized specific
xenosiderophores utilized by gonococci. These studies have not only elucidated the
mechanism of two different TonB-dependent iron acquisition systems but also identified
genetic differences between gonococcal strains responsible for variations in iron
acquisition. Understanding the mechanism of intracellular and extracellular iron
acquisition and the regulation behind these systems can lead to a better understanding of
the pathogenesis by the microorganism.
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Chapter 2 Material and Methods

I. Bacterial growth conditions
Gonococcal strains (Table 2) were maintained on GC medium base (GCB; Difco)
containing Kellogg’s supplement 1 (151) and 12 µM ferric nitrate. For mutant selection,
strains were grown on media supplemented with 50µg/ml kanamycin or 1 µg/ml
erythromycin. For iron-depleted growth conditions, gonococci were grown in a defined
medium that was treated with Chelex 100 (BioRad) to render it iron free (CDM) (304).
For iron-replete conditions, gonococcal strains were grown in CDM for one mass
doubling before the addition 12 µM ferric nitrate. For growth in the presence of
siderophores, gonococci were grown in liquid CDM for one mass doubling, and then
ferric siderophores were added at a concentration of 10 µM. All liquid cultures were
grown at 37°C with 5% CO2. For large scale preparation of gonococcal membrane
proteins, GCB broth containing Kellogg’s supplement 1 was inoculated with plate-grown,
non-piliated gonococci as described previously (64). For iron-deplete conditions, the iron
chelator Desferal (deferroxamine mesylate; Sigma Aldrich) was added to a final
concentration of 50 µM; for iron-replete conditions, 12 µM ferric nitrate was added. E.
coli strains were maintained on Luria Bertani agar plates and grown in Luria Bertani
media containing 200 µg/ml of carbenicllin at 37°C shaking at 225 rpm.
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Table 2. Strains and Plasmids used in this study
Strains and
Genotype a and/or relevant characteristics
plasmids
N. gonorrhoeae
FA1090
Wild type (ΔlbpA, HpuAB off)

Reference or
Source
(28)

MS11

Wild type strain

(196)

FA19

Wild type strain

(198)

UU108

Wild type strain

FA6959

FA1090 fetA::Ω (Strr Spcr)

FA7241

FA1090 ng2090:: Ω (Strr Spcr)

FA7029

FA1090 ng2088 :: Ω (Strr Spcr)

MCV656

FA1090 tonB::Ω (Strr Spcr)

Sparling Lab
(unpublished)
Sparling Lab
(unpublished)
(113)

MCV659

FA1090 tdfF::Ω (Strr Spcr)

(113)

MCV304

FA1090 mpeR::aphA-3 (Strr Spcr Kmr )

This study

MCV305

FA1090 mpeRC(Strr Spcr Kmr Ermr )

This study

fetA::Ω, mpeR::aphA-3 (Strr Spcr kmr )

This study

F- ompT hsdSB (rB-mB-) gal dcm (DE3)

Novagen

MCV306
E. coli
BL21 (DE3)
C41 (DE3)
Top10F’

Rosetta

F- ompT hsdSB (rB-mB-) gal dcm (DE3) derivative
F´{lacIq, Tn10(TetR)} mcrA Δ(mrr-hsdRMS-mcrBC)
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu) 7697
galU galK rpsL (StrR) endA1 nupG
F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE2
(CamR)

Plasmids
pCR2.1 TOPO

KanR AmpR

peT22b(+)

AmpR

(43)

Avidis
InVitrogen

Novagen
InVitrogen
Novagen
This study

pVCU353

PCR 2.1 TOPO containing tdfF full length amplified with
oVCU365 and oVCU367
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pVCU358

This study

pVCU354

PCR 2.1 TOPO containing tdfF plug amplified with
oVCU412 and oVCU413
PCR 2.1 TOPO containing tdfF loops 1-5 amplified with
oVCU414 and oVCU415
PCR 2.1 TOPO containing ng2090 amplified with oVCU
629 and oVCU630
pET22b(+) containing full length tdfF

pVCU355

pET22b(+)containing tdfF plug

This study

pVCU357

pET22b(+)containing tdfF loops 1-5

This study

pGCC3-mpeR

pGCC3 containing the full-length mpeR gene and 250 bp of
upstream sequence

This study

pVCU366

pCR 2.1 containing 800bp of fetA through fetB amplified by
oVCU498 and oVCU499

This study

pVCU359
pVCU364

This study
This study
This study
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II. Cell culture Media and incubation conditions
The ME180 endocervical epithelial cell line (HTB 33; American Type Culture
Collection) was maintained in McCoy’s 5A medium (Gibco) supplemented with 10%
heat inactivated fetal bovine serum (FBS; Gibco). Cells were maintained at 37°C in a 5%
CO2 atmosphere. Infection media was McCoy’s 5A supplemented with 10% FBS and
24µM Fe(NO3)3 and replication media consisted of McCoy’s 5A supplemented with 10%
FBS and no additional iron. For detection of tdfF, gonococci were incubated in the
following media: McCoy’s 5A with 10% FBS (replication media), replication media
supplemented with 50µM epinephrine (Sigma), replication media supplemented with
50µM norepinephrineenephrine (Sigma), replication media supplemented with 50µM
human liver ferritin (Calbiochem), or McCoy’s 5A media alone for 4 hours before RNA
isolation.
III. Construction of gonococcal mutants
All strains and plasmids used in this study are listed in Table 2. Gonococcal
strains FA1090, MS11, FA19 and UU1008 have been described previously (28, 196,
198). To create gonococcal strain MCV304, the mpeR gene was inactivated by the
insertion of a kanamycin resistance cassette (aphA-3) as previously described (92). All
oligonucleotide primers used in this study are described in Table 3. Primers 5'mpeR and
3'mpeR were used to PCR amplify chromosomal DNA from FA19 mpeR::aphA-3 strain
(92) . The amplicon was then used to transform gonococcal strain FA1090. To select for
allelic exchange, FA1090 transformants were plated on GCB agar containing kanamycin.
Strain FA6959 was previously constructed (43) by insertional inactivation of the FA1090
fetA gene with a polar Ω cassette (228). For the construction of the complemented strain,
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mpeRC (MCV305), the mpeR coding sequence from gonococcal strain FA19 was
amplified using primers 5’ pMpeR pac and 3’ GC4 MpeR (Table 3). The resulting
amplicon contains the mpeR gene and 250 bp upstream of the mpeR start codon. The
amplicon was inserted between the PacI and PmeI sites of pGCC3 (265). The resulting
plasmid, pGCC3-mpeR, was then digested with ClaI and the fragment containing mpeR,
lctP, aspC, and the erythromycin resistance cassette was purified and used to transform
MCV304. Transformants were selected on GCB agar supplemented with erythromycin.
The resulting complemented strain, MCV305, contains the original mpeR mutation and
an ectopically-inserted copy of the wild-type mpeR gene, preceded by 250 base pairs
including upstream regulatory signals. The fetA, mpeR double mutant strain, MCV306,
was constructed by transforming FA6959 with the mpeR::aphA-3 amplicon as described
in the construction of MCV304. GCB agar supplemented with kanamycin was used for
selection. Strains MCV656 was created by inserting a polar Ω cassette into tonB and
strain MCV659 was created by inserting a polar Ω cassette into tdfF as previously
described (113).
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TABLE 3. Oligonucleotides used in this study.
Oligonucleotide
Amplicon
Sequence (5’-3’)
5’mpeR
mpeR::aphA-3
ATGAACACCGCCGCCATCT
3’mpeR
mpeR::aphA-3
GCACTTTTTCACATCCGAAGG
GGTTAATTAACGAAACAACCTGCAGAAACC
5’pMpeR pac
mpeRC construct
3’ GC4 MpeR
mpeRC construct
GGTTTAAACTCAGCACTTTTTCACATCCGA
malEmpeRF
mpeR coding region
CACTGGGGATCCATGAATACCGCCGCCATCT
malEmpeRR
mpeR coding region
CACTGGCTGCAGTCAGCACTTTTTCACATCCGA
5’fetAup
500bp upstream fetA probe
GCCCGAACGGTTCGGACAAATT
3’fetAup
500bp upstream fetA probe
TTGTTCGTCCTTTTGAGTGT
3'fetAupint
fetA1 upstream probe
TCACTTGGTGCTTCAGCACC
5'fetAupint
fetA2 upstream probe
GGTGCTGAAGCACCAAGTGA
rnpB1F
CGGGACGGGCAGACAGTCGC
rnpB
GGACAGGCGGTAAGCCGGGTTC
rnpB1R
rnpB
CGCCGTATTTGTTGCTGGCGTATTTGTAGC
oVCU 332
tdfF RT-PCR Rev
TTTGGAATACGACATCGCACCGCAAACC
tdfF RT-PCR Fwd
oVCU333
CATATGACACGCTTCAAATACTCCCTGCTT
full length NdeI -tdfF Fwd
oVCU365
CTCGAGTTTAAACCGATAGGTAACGC
full length tdfF-xho1 Rev
oVCU374
CATATGCCGACCATCACCGTTACCGCC
NdeI-tdfF plug domain Fwd
oVCU412
CTCGAGCTTGCGGGTCGGGTGTTTGCG
tdfF-xho1 plug domain Rev
oVCU413
CATATGCCATTGTTTGAAGTCCGCGCC
tdfF-NdeI loops 1-5 Fwd
oVCU414
CTCGAGGAGTATCAGCGAAACGTTGTC
tdfF-xho1 loops 1-5 Rev
oVCU415
GCGTTTCCCACCGAAATCCACAAT
mpeR RT-PCR Fwd
oVCU484
AGCGTAATAATCGGGCGGAGAGTT
mpeR RT-PCR Rev
oVCU485
AAAGATTACGAAGCCGGCAAAGGC
fetA RT-PCR Fwd
oVCU486
TTCAACAGGGTTTGTTCGGCAAGG
fetA RT-PCR Rev
oVCU487
oVCU498
fetA-fetB Fwd
CCAACGCTGCACCAATACCCTGC
oVCU499
fetA-fetB Rev
CCTTCAGCTTGTCGGCTTCCGCCTG
oVCU500
fetB-NG2091 Fwd
CAGGCGGAAGCCGACAAGCTGAACG
oVCU501
fetB-NG2091 Rev
GCACAGGCTGACGGCAAACAATACC
oVCU513
NG2091-NG2090 Fwd
GGTATTGTTTGCCGTCAGCCTGTCG
oVCU516
NG2091-NG2090 Rev
GCTCGCTCGGGACGGTATTGAATC
oVCU515
NG2090-NG2089 Fwd
GACTTTGTCTTGCACCTGCGCCTG
oVCU518
NG2090-NG2089 Rev
CAGTTCGCGGACGATGACGAACTG
oVCU517
NG2089-NG2088 Fwd
CTGTGCGGACATTCCTGCCCGAC
oVCU553
NG2089-NG2088 Rev
TGCTTTGGCAGAACACCATCGCAA
oVCU110
16S rRNA Fwd
TATCGGAACGTACCGGGTAGC
oVCU111
16S rRNA Rev
GTATTACCGCGGCTGCTGGCA
oVCU529
fetA qRT-PCR Fwd
ATCCAACACCAATTTGGCGTA
oVCU530
fetA qRT-PCR Rev
CATCGGCGGAATAGCGTTT
oVCU461
mpeR qRT-PCR Fwd
TCTACCGCCAGTACCAAACC
oVCU462
mpeR qRT-PCR Rev
GGCTGAAATTGTGGATTTCG
oVCU457
rmpM qRT-PCR Fwd
GGAGCAGGCTCCTCAATATG
oVCU458
rmpM qRT-PCR Rev
TAAAGTCGGTATGGCCTTCG
oVCU576
NG2091 qRT-PCR Fwd
GTGAGCGTGAATTTGGGTTT
oVCU577
NG2091 qRT-PCR Rev
TATTGCCGACCGTTACAATG
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oVCU629
oVCU630
oVCU676

NG2090 sequencing Fwd
NG2090 sequencing Rev
fetB primer extension

AAACGCTGACCAACAACCCGATTC
GCTTAATACCGCCTTCATGCCCAA
CAG GGT CGG AAT TTT GCG GCG AAC AC
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IV. Construction of expression plasmids
The full length tdfF expression plasmid was constructed by PCR amplification of
the tdfF gene from gonococcal strain FA1090 genomic DNA. The forward primer
oVCU365 (CATATGACACGCTTCAAATACTCCCTGCTT) contained the NdeI site
(bold) (Table 3) and amplified the tdfF native signal sequence. The reverse primer,
oVCU357 (CTCGAGTTTAAACCGATAGGTAACGC) contained the XhoI restriction
site (bold) (Table 3) and encoded the terminal phenylalanine of tdfF from gonococcal
strain FA1090. The resultant PCR product was ligated into the TOPO pCR2.1 vector
(InVitrogen) and transformed into competent E. coli strain TOP10 (InVitrogen). The
transformants containing the correct plasmid, pVCU35,3 was screened for incorporation
of the tdfF gene by restriction digest followed by agarose gel electrophoresis. After
digestion with NdeI, and XhoI, the tdfF gene was purified from the agarose gel (Qiagen)
and ligated into the pET-22b(+) expression vector (Novagen). The resultant plasmid,
pVCU354, contained the full length tdfF gene under control of a T7 promoter, as well as
a region encoding a 6X histidine tag immediately 3’ of tdfF. For expression of
recombinant TdfF, the plasmids were transformed into the E. coli expression strain
BL21(DE3) (Novagen) which expresses T7 under the control of the lac promoter.
The tdfF plug expression plasmid, pVCU355, was constructed by PCR
amplification of the plug domain and excluded the signal sequence. Forward primer
oVCU412 (CATATGCCGACCATCACCGTTACCGCC) contained the NdeI site (bold)
(Table 3) and amplified the FA1090 tdfF gene from the sequence that encodes amino acid
P14 of the mature protein. The reverse primer oVCU413
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(CTCGAGCTTGCGGGTCGGGTGTTTGCG) contained an Xho1 site (bold) (Table 3)
and amplified the plug domain from the sequence that encodes R166 of the mature
sequence. The PCR product was ligated into the TOPO pCR2.1 vector (InVitrogen) and
transformed into competent E. coli strain TOP10 (InVitrogen). The transformants of the
resulting plasmid pVCU358 were screened for incorporation of the tdfF gene by
restriction digest followed by agarose gel electrophoresis. After digestion with NdeI and
XhoI, the plug encoding portion of the gene was purified from the agarose gel (Qiagen)
and ligated into the pET-22b(+) expression vector (Novagen). The resultant plasmid
pVCU355, encoded recombinant TdfF plug in which a C-terminal histidine tag was fused
to R166 of the mature protein.
Similarly, the tdfF loops expression plasmid was constructed by amplifying the sequence
that encodes the first half of the TdfF loop domain. The forward primer oVCU414
(CATATGCCATTGTTTGAAGTCCGCGCC) encodes the NdeI site (bold) (Table 3)
and amplified the FA1090 tdfF gene from the sequence that encodes P181 of the mature
sequence. The reverse primer oVCU415 (CTCGAGCTTGCGGGTCGGGTGTTTGCG)
encodes an Xho1 site (bold) (Table 3) and amplified the sequence that encodes L680 of the
mature sequence. This PCR product was ligated into pCR2.1 vector (InVitrogen) and
resulted in pVCU359. This plasmid was digested with Xho1 and NdeI, separated on an
agarose gel by electrophoresis and the tdfF loops gene was purified from the agarose gel
(Qiagen). The subsequent purified gene product was ligated into the pET22b(+)
expression vector (Novagen) and resulted in pVCU357 in which tdfF loops were
expressed with a 5’ histidine tag.
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Both pVCU355 and pVCU 357 were transformed into the E. coli expression strain C41
(DE3) (Avidis).
V. Recombinant protein expression
For small scale induction of pVCU354, pVCU355, and pVCU357, starter
cultures of E. coli (5 mls) were grown for approximately 6 hours at 37°C in Luria Bertani
broth (LB) containing 1% glucose and 200µg/ml of carbenicillin before being stored
overnight at 4°C. 1ml of the starter culture was used to inoculate 5 ml of LB broth
containing 1% glucose and 200µg/ml carbenicillin. Cultures were shaken at 225rmp at
37°C until they reached the OD600 .04-1.0, about 2 hours. For cultures that were induced,
0.5 mM IPTG (isopropyl-β-D-thiogalactopyranoside) was added to induce recombinant
protein expression. The induced and not induced cultures were grown for 4 hours.
Following the 4 hour growth, 1 ml of culture was pelleted and solubilized with 2x
laemelli solubilizing buffers for subsequent SDS-PAGE analysis.
For large scale recombinant protein induction from plasmids pVCU354,
pVCU355, and pVCU357 starter cultures of E. coli (5mls) were grown for approximately
6 hours at 37°C in LB medium containing 1% glucose and 200 µg/ml of carbenicllin and
stored at 4°C until used for large-scale growth and induction. Prior to the large scale
production, starter cultures were pelleted at 3200 X g for 5 minutes, and the supernants
were decanted. Fresh LB was added at original volume and the pellets were
resuspended. The resuspended starter cultures were inoculated into 1L of LB broth at pH
7.5 containing 1% glucose and 500 µg/ml carbenicillin. The cultures were placed at 37°C
with shaking at 225rpm until the OD600 reached 0.4-0.6. Cultures were then subjected to
centrifugation (4°C for 15 min at 6000 X g) to pellet the bacteria. Supernants were
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decanted and the pellet was resuspended in 1L of fresh LB containing 1% glucose and
500 µg/ml carbenicillin. 0.5 mM IPTG (isopropyl-B-D-thiogalactopyranoside) was
added to induce recombinant protein expression. Cultures were grown overnight at 27°C
(about 16hrs). Following inductions, cultures were pelleted at 6,000 X g for 15min and
stored at -80°C.
VI. Recombinant protein purification
For rTdfF plug and rTdfF loop domain purification, bacterial cell pellets were
thawed on ice and cells were lysed under denaturing conditions with 8 mM urea buffer
pH 6.3 ( 10mM NaH2PO4, 10 mM Tris-Cl, 8 mM urea). The solubalized rTdfF plug and
rTdfF loops domain extracts were bound with nickel-nitriloacetic affinity resin (Qiagen)
for at least 1 hour while shaking at room temperature. Following batch binding, the resin
was loaded onto a disposable column and washed with 8mM urea buffer pH 6.3 (10 mM
NaH2PO4, 10 mM Tris-Cl, 8 mM urea) and eluted 4 times with 8mM urea buffer pH 5.9
and 8 mM urea buffer pH4.5. The elutions were pooled together for each recombinant
protein and dialyzed 2 times, overnight at 4°C, in 6 mM urea at pH 4.5 (NaH2PO4, 10
mM Tris-Cl, 6 mM).
VII. Coomassie blue protein staining
SDS-PAGE gels were stained with Coomassie blue (0.25% Coomassie R-250,
50% methanol, 10% glacial acetic acid) following electrophoresis. Gel were incubated in
Coomassie blue stain overnight at room temperature and then destained in 20% methanol
and 5% glacial acetic acid at room temperature until background staining was minimized.
Gels were dried in gel drying buffer (40% methanol, 10% glycerol, and 7.5% glacial
acetic acid) over night.
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VIII. Production of TdfF specific polyclonal rabbit sera
Purified rTdfF plug and rTdfF loops as described above were used to immunize
rabbits. Each antigen was used to immunize two separate female New Zealand –SPF
rabbits. Two rabbits designated F2522 and F2523 were immunized with rTdfF plug and
two rabbits designated F2388 and F2389 were immunized with rTdfF loops domain. The
rabbit immunization and bleed schedule was as follows, Day 0 pre-immune sera was
collected and rabbits were initially immunized with rTdfF in Freund’s complete adjuvant.
Day 14 and 28 rabbits received rTdfF boost and on day 35 and day 40 the rabbits were
bled. Serum samples were screened by Western blot for specificity against rTdfF plug or
rTdfF loops domain. Immunizations and sera collections were done on a fee for serum
basis by New England peptide.
IX. Sequence Analysis
To determine the sequence of FA19 and FA1090 ng2090, chromosomal DNA from each
strain was used in a PCR amplification reaction in which the following primers were used
to amplify the full length gene, oVCU629 and oVCU630. The resultant PCR product was
ligated into the TOPO pCR2.1 vector (InVitrogen) competent E. coli strain TOP10
(InVitrogen) were transformed with this construct resulting in plasmid oVCU364. The
resultant plasmid was sequenced through the VCU Nucleic Acid Research Facilities
using commercially available primers specific to TOPO pCR2.1.
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X. Gentamicin protection assay
Epithelial cells were seeded into 12-well plates and grown to 70-80% confluence
in McCoy’s 5A media supplemented with 10% FBS. Prior to infection, gonococcal
strains were maintained on GC agar plates supplemented with Kellogg’s Supplement 1
(151) and 12 µM FeNO3 at 37°C in a 5% CO2 atmosphere. Piliated, gonococcal strains
were harvested from GC plates and suspended in CDM (304). The infection inocula were
prepared by diluting each strain in infection media containing McCoy’s 5A with 10%
FBS and 24 µM FeNO3. Supplemental iron in the media promotes efficient growth and
invasion. A multiplicity of infection (MOI) of 10 was maintained throughout the
experiments. Epithelial cell monolayers were infected for 4 hours followed by a
phosphate buffer saline (PBS) wash to remove any extracellular, non-adherent bacteria.
Infected cells were then incubated in McCoy’s 5A and 10% FBS supplemented with
25µg/ml gentamicin for 1 hour. Gonococci are susceptible to gentamicin but the drug
cannot be absorbed by the epithelial cells. After 1 hour incubation, gentamicin was
removed and cultures were washed twice with PBS. The time 0 cells were immediately
lysed by treatment with saponin mix (PBS, 2 mM EDTA, 0.5% saponin) for 1 minute and
then gonococci were diluted and plated for viable counts on GC agar plate. The 24 hour
time point cells were incubated in replication media which consists of McCoy’s 5A and
10% FBS. One hour prior to the 24 hour time point, cells were washed with PBS, and
treated a second time with gentamicin for 1 hour before being washed and plated as
described above. For assays in which the cells were serum starved, after the initial 4 hour
incubation and gentamicin treatment, the replication media added back for the subsequent
24 hour incubation contained McCoy’s 5A only. When we tested the addition of 40 uM
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apo-bovine transferrin, we added the apo-bovine transferrin to a replication media
consisting of either McCoy’s 5A alone or McCoy’s 5A and 10% FBS. When we
incubated infected cells in the presence of ferritin degradation inhibitors, we incubated
the cells in one of the following replication media: McCoy’s 5A and 10% FBS with 200
µM ascorbate (Sigma), McCoy’s 5A and 10% FBS with 10µM leupeptin (Sigma),
McCoy’s 5A and 200 µM ascorbate (Sigma), or McCoy’s 5A and 10 µM leupeptin
(Sigma). Each assay was conducted independently at least 3 times and data presented
are the mean of 3 separate experiments.
XI. Isolation of cell fractions containing membrane proteins
As described previously (64), gonococci were pelleted after large scale growth
under iron-replete or iron-deplete conditions. Gonococcal cells were then resuspended in
10 mM HEPES [4-(2-hydroxyethyl)-1-piper azine-ethanesulfonic acid] and passed
through a French pressure cell once at 20,000 lb/in2. Intact gonococcal cells were
removed by centrifugation at 8,500 X g and membrane proteins were pelleted by
centrifugation at 140,000 X g for 1h. Total membrane protein fractions were resuspended
in 10mM HEPES and protein concentrations were determined by bicinchoninic acid
assay (Pierce).
XII. Separation of total membrane protein fractions and mass spectrometry analysis
Membrane protein fractions, isolated as described above, were solubilized and
proteins were separated on a 7.5% polyacrylamide gel. Proteins were visualized by
Coomassie blue staining. One band of interest was extracted from the stained gel and
submitted to the VCU Mass Spectrometry Resource Center for identification. The sample
was digested overnight with trypsin and the resulting peptides were extracted. The
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peptides were analyzed on a LC-MS system that consisted of a Thermo Electron Deca XP
Plus mass spectrometer with a nanospray ion source interfaced with a reversed-phase
capillary column.
XIII. Immunodetection of FetA, TbpA and TdfF
For detection of FetA in total membrane protein preparations, aliquots containing
20µg of protein were resolved using SDS-PAGE. For detection of FetA in whole cell
lysates, gonococcal strains were grown in the presence of iron-containing catechols for 6
hours; every 2 hours, aliquots were removed and standardized to culture density. Cells
were pelleted and lysed with Laemmli solubilizing buffer (159) and stored at –20°C.
Before use, 5% β-mercaptoethanol was added to all preparations prior to heating at 95°C
for 3 minutes. After SDS-PAGE, proteins were electroblotted to nitrocellulose
membranes in 20 mM Tris base, 150 mM glycine, and 20% methanol (284) within a
submerged transfer apparatus (BioRad). For detection of FetA, membranes were blocked
with 5% skim milk in low-salt TBS (LS-TBS). FetA blots were then probed with a FetAspecific monoclonal antibody (44) and washed with LS-TBS, followed by a secondary
goat anti-mouse antibody conjugated to alkaline phosphatase (BioRad). Blots were
developed using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate (Sigma).
For detection of TbpA in whole cell lysates, proteins were separated by SDSPAGE as described above, followed by electroblotting to nitrocellulose. Membranes were
blocked with 5% bovine serum albumin (Roche) in high-salt Tris-buffered saline (TBS)
plus 0.05% Tween 20 (Sigma). TbpA blots were then probed with a polyclonal, TbpAspecific antiserum (67) and washed with high-salt TBS plus 0.05% Tween, followed by a
secondary goat anti-rabbit antibody conjugated to alkaline phosphatase (BioRad). Blots
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were developed using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate
(Sigma).
To evaluate TdfF expression during infection, ME180 cells were inoculated with
gonococcal strain FA1090 at an MOI 20. After 4 hours, supernants were collected and
pooled. Monolayers containing ME180 cells and gonococci were washed with PBS twice
and treated with Saponin (PBS, 2 mM EDTA, 0.5% saponin); lysates were pooled and
vortexted. Bacteria from the supernatant or cell-associated populations were pelleted by
centrifugation at 5,000 x g for 10min at 4°C. The pellets were solubalized with Laemmli
solubilizing buffer (159) and stored at –20°C. Before use, 5% β-mercaptoethanol was
added to all preparations prior to heating at 95°C for 3 minutes.
For gonococci incubated in different cell culture conditions, non-pilliated bacteria
were resuspended to 100 klett unit in 1XCDM and added to the following media
conditions: McCoy’s 5A with 10% FBS (replication media), replication media
supplemented with 50µM epinephrine (Sigma), replication media supplemented with 50
µM norepinephrineenephrine (Sigma), replication media supplemented with 50 µM
human liver ferritin (Calbiochem), or McCoy’s 5A media alone for 4 hours before
pelleted by centrifugation at 50000 X g. The pelleted bacteria were lysed with Laemmli
solubilizing buffer (159) and stored at –20°C. Before use, 5% β-mercaptoethanol was
added to all preparations prior to heating at 95°C for 3 minutes. For detection of TdfF in
whole cell lysates, proteins were separated by SDS-PAGE as described above, followed
by electroblotting on nitrocellulose. Membranes were blocked with 5% bovine serum
albumin (Roche) in high-salt Tris-buffered saline (TBS) plus 0.05% Tween 20 (Sigma).
TdfF blots were then probed with either polyclonal, TdfF plug or TdfF loop domain
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specific antiserum (this study) and washed with high-salt TBS plus 0.05% Tween,
followed by a secondary goat anti-rabbit antibody conjugated to alkaline phosphatase
(BioRad). Blots were developed using nitroblue tetrazolium and 5-bromo-4-chloro-3indolylphosphate (Sigma).
XIV. RNA isolation
For gonococcal strains grown in CDM under iron-deplete and iron-replete
conditions as described above in bacterial growth conditions, after one mass doubling,
12 μM FeNO3 (iron replete), or no additional iron (iron-deplete) was added and the
cultures were grown for an additional 2 h.
For gonococcal strains incubated in different cell culture media for tdfF detection,
gonococci were incubated in the following media conditions: McCoy’s 5A with 10%
FBS (replication media), replication media supplemented with 50 µM epinephrine
(Sigma), replication media supplemented with and 50 µM norepinephrineenephrine
(Sigma), replication media supplemented with 50µM human liver ferritin (Calbiochem),
or McCoy’s 5A media alone for 4 hours before pelleted by centrifugation at 50000 X g
Total RNA was isolated from cultures using the RNeasy mini kit as directed by
the manufacturer (Qiagen). Purified RNA was treated twice with RNase-free DNase as
directed by the manufacturer (Qiagen). SUPERase-In (Ambion) was added before storage
at −80°C.
XV. Qualitative reverse transcriptase PCR (RT-PCR)
Portions of 16S rRNA, tdfF, fetA, mpeR, and intergenic regions between the fet
genes were amplified using the Thermoscript RT-PCR system (InVitrogen) as described
previously (113). A portion of this reaction was used as template for PCR amplification
with Platinum Taq Polymerase (Invitogen) according to the manufacturer's protocol.
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Oligonucleotide sequences of the primers used in this analysis are listed in Table 3. After
an initial denaturation step at 94°C for 3 min, DNA was amplified for 30 cycles. Each
cycle consisted of 1 min at 94°C, 30 s at 60°C and 1.5 min at 72°C, followed by a final
extension step of 10 min at 72°C. To detect any DNA contamination of RNA
preparations, parallel RT-PCR reactions were conducted in the absence of reverse
transcriptase. Amplicons resulting from the RT-PCR reactions were detected by ethidium
bromide staining of agarose gels.
XVI. Real time RT-PCR
cDNA was generated by reverse transcription of 100 ng of total RNA using the
Accuscript High Fidelity 1st strand cDNA synthesis Kit (Stratagene) according to the
manufacturer’s protocol. Synthesized cDNA was used as PCR template. The SensiMix
SYBR No-ROX Kit (Bioline) and CFX96 Real Time System (BioRad) was employed for
the real time RT-PCR reactions. Oligonucleotide sequences of the primers used in this
analysis are listed in Table 2. The polar Ω insertion in fetA was located between the
binding sites for the primers used to detect fetA expression; the aphA-3 cassette was
located downstream of the primer binding sites for mpeR expression analysis. The
cDNA/SensiMix mixture was initially heated to 94°C for 10 min and subjected to 40
cycles conducted under the following conditions: 95°C for 15 s, 60°C for 30 s, and 72°C
for 30 s. Transcription of rmpM was employed as an internal control. For each
experimental condition, fetA, mpeR, and ng2091 transcripts were normalized to rmpM
levels. The relative CT method (179) was employed to compare normalized expression
levels under different conditions. Three biological replicates were analyzed, each
conducted in triplicate.
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XVII. Identification of fetB transcriptional start site by primer extension analysis
performed in the laboratory of Dr. William Shafer
In order to identify the fetB transcriptional start site, RNA was harvested from
FA1090 grown under iron-replete or iron-deplete conditions as described above. The
reverse primer, oVCU676 (Table 3), was radiolabeled with [ γ- 32P] using T4
polynucleotide kinase; 5μg of RNA was incubated with the radiolabeled primer and
reverse transcriptase to generate the primer extension product. In order to generate
reference sequence products, plasmid pVCU366 (Table 2) was sequenced using the
reverse primer, oVCU676, and the SequiTherm EXCEL II DNA Sequencing kit
(Epicenter) as described previously (245). The sequencing template plasmid, pVCU366,
was generated by amplification of wild-type FA1090 genomic DNA with the primers
oVCU498 and oVCU499 (Table 3). The resulting amplicon contained the fetB promoter
region and was cloned into pCR 2.1 (InVitrogen). Both the primer extension product and
the reference sequence were subjected to electrophoresis on a 6% acrylamide sequencing
gel, which was dried and subjected to autoradiography for visualization.
XVIII. Electrophoretic mobility shift assay (EMSA) performed in the laboratory of
Dr. William Shafer
MpeR was fused in-frame at its amino-terminus to the maltose-binding protein
(MBP) using the pMal-c2x fusion vector (New England Biolabs). For this purpose, the
mpeR coding region was PCR-amplified from FA19 chromosomal DNA, isolated as
described (186) using primers 5’ malEmpeRF and 3’ malEmpeRR (Table 3). The
resulting amplicon was purified using the QIAquick PCR purification kit (Qiagen). Both
the vector and PCR product were digested with PstI and BamHI (New England Biolabs)
and ligated using T4 DNA Ligase (New England Biolabs). E. coli transformants
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harboring the construct were selected on LB agar (Difco) plates containing 100μg/ml of
ampicillin. Both strands of the cloned insert were sequenced to ensure fidelity of the
PCR amplification reaction and in-frame fusion with malE. Growth of the E. coli
transformant bearing the plasmid construct, induction of expression and purification of
MBP-MpeR was performed as described previously for an MBP-MtrR fusion (164).
For the EMSA studies, the 500 bp, intergenic region immediately upstream of the
FetA start codon was PCR-amplified from FA1090 chromosomal DNA using primers
5’fetAup and 3’fetAup (Table 2). This upstream region was further divided into two
smaller products by PCR amplification. The 5’fetAup and 3'fetAupint primers (Table 3)
resulted in fetA1. The 5'fetAupint and 3'fetAup primers (Table 3) were used to amplify
fetA2 region. These three PCR products was purified using the QIAquick PCR
purification kit (Qiagen) and end-labeled with [ γ- 32P] (Perkin Elmer) and T4
polynucleotide kinase (New England Biolabs). The radiolabeled PCR products were
purified by excising the DNA from nondenaturing polyacrylamide gels, and recovered by
crush-soak elution overnight at 37°C into 750 µl of PB buffer from the QIAquick PCR
purification kit (Qiagen). The radiolabeled DNA/buffer mixture was centrifuged at
15,800 X g for 10min and the resulting supernatant was removed and added to a
QIAquick PCR purification kit (Qiagen) column, which was then washed with 750 µl PE
buffer. The DNA was eluted in 100 µl of nuclease-free water (Ambion). Five nanograms
of each radiolabeled probe was incubated with 10 μg of MBP-MpeR for 30 minutes at
room temperature.
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The specificity of the MpeR-fetA promoter interaction was evaluated by adding either
specific or non-specific, unlabeled competitor DNA to the binding reactions. The specific,
unlabeled competitor DNA was generated by PCR amplification of the fetA1 promoter region as
described above. The fetA2 sequence was also amplified as described above and used as an
unlabeled competitor. The non-specific competitor DNA was generated by PCR amplification of
a portion of the rnpB gene using the primers rnpB1F and rnpB1R (Table 3). All binding
reactions were incubated in DNA binding buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM DTT,
1 μg/ml Poly dIdC) for 30 min. at room temperature. All samples were subjected to
electrophoresis on a 5% (wt/vol) polyacrylamide gel at 4°C. After electrophoresis, the gel was
dried onto Whatman filter paper and exposed to X-ray film for autoradiography.
XIX. Preparation of ferric-siderophores
The siderophores used in this study were purchased from EMC Microcollections
(Tübingen, Germany). Siderophores were resuspended to a final concentration of
1mg/ml in sterile deionized water and ferrated to 80% saturation using FeCl3 (273). In
some experiments, the siderophores were purchased pre-ferrated and the lyophilized
ferric-siderophores were dissolved in methanol (enterobactin) or water prior to final
dilution in water. The results of the siderophore utilization assays were the same
regardless of whether the siderophores were purchased in the ferrated state or ferrated
immediately before use. The following is a list of the siderophores tested for growth
support of gonococcal strain FA1090: ornibactin, aerobactin, ferrichrysin, ferrirubin,
coprogen, neocoprogen, enterobactin, dihydroxybenzoylserine (DHBS) monomer, DHBS
dimer, DHBS trimer, salmochelin S4, and salmochelin S2. Both 2,3-DHBA (Sigma) and
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2,5-DHBA (Sigma) were resuspended to a final concentration of 1mg/ml in sterile
deionized water and ferrated to 80% saturation using FeCl3(273).
XX. Xenosiderophore utilization assays
Plate bioassays to evaluate xenosiderophore utilization were performed using
CDM plates supplemented with 2.5 µM apo-bovine transferrin to chelate excess iron. As
described previously (273) strains were inoculated onto plates using a sterile Dacron
swab (Puritan). A sterile pipette was used to bore a well into the agar. Subsequently,
10µl of the diluted ferric-siderophore solution (100 μg/ml) was added to each well. Ten
microliters of apo-bovine transferrin at a concentration of 10mg/ml was used as a
negative control and 10µl of ferric citrate (10µM) was used as a positive control. Plates
were incubated at 37°C in a 5% CO2 atmosphere for 24 hours and then evaluated for
ferric-siderophore dependent growth.
XXI. Statistical analyses
Statistical significance of xenosiderophore-dependent growth data was
determined by using a two-tailed, unpaired Student’s t test. P values for specific
comparisons are reported in the figure legend. For real time RT-PCR data (Table 4), the
relative CT method (179) was utilized to calculate the fold change for each comparison.
The range for each value is shown in parentheses. The average fold change values were
calculated from three independently-conducted RT-PCR reactions and are representative
of results generated from three independent RNA preparations (biological replicates).
Statistical significance of intracellular survival was assessed by a Student’s T-test in
which a P value < .01 and <.05 were considered significant.
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Chapter 3 DETECTION OF THE EXPRESSION OF TONB -DEPENDENT
TRANSPORTER, TdfF
I. Introduction
Neisseria gonorrhoeae is a Gram negative diplococcous and the causative agent
of the sexually transmitted infection, gonorrhea. To establish infection, gonococci need to
acquire iron from the human host. N. gonorrhoeae employs multiple TonB-dependent
acquisition systems for the utilization of various host iron sources. All gonococcal strains
express the transferrin iron acquisition system composed of TbpA/TbpB (6, 62, 64) and
50% of gonococcal isolates are capable of acquiring lactoferrin, a major iron source of
mucosal secretions, through components of the LbpA/B system (5). Gonococci acquire
iron from hemoglobin as well; however, expression of the hemoglobin transporter system
HpuA/B is subject to high frequency variation and most clinical and laboratory isolates
do not express the receptor (52). All of these iron sources are found outside the host
epithelial cell. Iron is necessary for N. gonorrhoeae to establish its intracellular
localization in vitro (113). TonB is also necessary for intracellular localization (113).
TonB-dependent iron acquisition systems are necessary for intracellular survival of other
microorganisms including Legionella pneumophila (102) and Shigella dysenteriae (241).
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Transport of iron into Gram negative microorganisms is initiated by the passage
of iron across the outer membrane and into the periplasmic space. Once in the periplasm,
the iron is translocated into the cytoplasm. TonB-dependent transporters are responsible
for the transport of iron across the outer membrane. These transporters have a high
affinity and specificity for their iron binding ligands. TonB-dependent transport requires
energy which is derived from the inner membrane proton motive force. TonB-dependent
transporters (TBDTs) interact with an inner membrane complex consisting of
TonB/ExbB/ExbD for energization (128). The exact energy transduction pathway from
TonB/ExbB/ExbD to the TBDT remains undefined (226). The first crystal structures of
two Escherichia coli TBDTs, the ferrichrome transporter (FhuA) (86, 180) and the ferric
enterobactin transporter (FepA) (39), revealed that these TDBTs consist of 2 structural
domains, a 22-stranded β-barrel that spans the outer membrane and a plug domain folded
into the barrel interior. The plug domain functions to occlude the barrel pore and to bind
ligand at the extracellular side of the membrane as well as interact with the
TonB/ExbB/ExbD complex at the periplasmic side of the outer membrane (290).
Since the sequencing of the gonococcal genome, multiple putative TonBdependent transporters have been identified. Three putative non-contiguous TonBdependent receptor genes tdfF, tdfG and tdfH were identified in strain FA1090 genome
database using BLAST programs comparing amino acid sequences from a panel of
characterized TonB-dependent receptors (286). Detailed comparisons of these putative
transporters to known TonB-dependent transporters revealed extensive areas of
homology within previously described conserved domains of TonB-dependent proteins
(64, 145). Such domains include the presence of a signal sequence which is necessary for
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the transporter to be exported out of the cytoplasm. Once the protein is exported to the
cytoplasm this signal sequence is cleaved. TonB-dependent transporters also contain a
terminal phenylalanine residue which is important for outer membrane localization. The
N-terminal region of TonB-dependent transporters makes up the plug domain and the Cterminus consists of membrane spanning domains which make up the β-barrel (64, 145,
286).
Previously, our laboratory investigated the role of the TonB system as well as
TonB-dependent transporters in survival within cervical epithelial cells. The Ton system
is necessary for intracellular survival of gonococci within epithelial cells and has been
demonstrated for N. meningitidis as well (161). None of the previously characterized
TonB-dependent transporters are necessary for intracellular survival; however, TdfF is
required for survival (113). The attenuated survival of the tdfF mutant is rescued with the
addition of iron indicating that tdfF is important for intracellular iron acquisition (113).
Additionally, tdfF expression is only detected when gonococci are incubated in the
presence of cervical epithelial cells or cell culture media (McCoy’s 5A and 10% heatinactivated fetal bovine serum (FBS)) and not in bacterial growth media (113).
Expression of tdfF is also detected during non-complicated infections of the female
urogenital tracts (2) implying that tdfF expression is host/intracellular niche- specific.
Understanding the regulation and inducing signal for tdfF expression could lead
to the identification of the iron source utilized by intracellular gonococci. In numerous
bacteria, gene expression for TBDTs involved in iron uptake, was regulated by the ferric
uptake regulator (Fur) (166). In the presence of iron, Fur binds to a DNA sequence called
the Fur box using Fe2+ as a cofactor and thereby represses expression of iron regulated
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genes (13). When iron is limiting, Fur cannot bind DNA, leading to derepression of
genes that encode iron transporters (13). tdfF contains a putative Fur box (113). Iron
levels may not be the only signal for tdfF expression as tdfF expression is not detected in
bacterial growth media under iron-deplete conditions and is only detected when
gonococci are incubated in epithelial cell culture conditions (113). These results indicate
that the inducing signal for tdfF expression could also be a ligand responsible for a
regulatory cascade that signaled that the bacteria were associated with or intracellular to
epithelial cells.
In this study we investigated potential proteins and molecules that could upregulate tdfF expression. We detected tdfF expression in the presence of heat-inactivated
fetal bovine serum (FBS) but did not determine the specific component of serum
responsible for induction of tdfF expression. We identified tdfF in all laboratory isolates
of N. gonorrhoeae and determined that the gene sequence was identical amongst all
gonococcal strains sequenced. Additionally, we expressed and purified rTdfF plug and
rTdfF loop domains from E. coli successfully. These recombinant proteins were used to
synthesize rabbit polyclonal anti-TdfF sera for detection assays.

II. Results
A. TdfF sequence is identical in gonococcal laboratory strains
Since TdfF is crucial for intracellular survival in wild type gonococcal strain
FA1090 we wanted to determine if other laboratory strains contained this gene. We were
also interested in the nucleotide sequence of this transporter because the gene may be
present in all strains but inactivated. For example, not all gonococcal strains express the
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genes that encode the TonB-dependent lactoferrin acquisition system LbpA/LbpB due to
a deletion removing the lbpB gene and a portion of the lbpA gene (5). To determine the
presence and nucleotide sequence of tdfF from multiple strains, we proceeded to
sequence the portion of tdfF that encodes the plug and half of the β-barrel domain that we
will proceed to call loop domain for the rest of this study from a variety of gonococcal
strains. Using FA1090-specific tdfF primers we amplified the plug and loop domains
from strains FA19, MS11, UU108 and compared these sequences to strain FA1090. We
aligned the nucleotide sequence from each gonococcal isolate and determined they were
identical in all of the gonococcal strains investigated. We also translated the nucleotide
sequence and observed identical amino acid sequences (Figure 4). Since this study, other
gonococcal and meningococcal strains have been sequenced, and tdfF has been identified
as pathogen-specific gene (184, 266) indicating it is important in pathogenicity. We have
since aligned TdfF from all sequenced gonococcal strains and observed that they shared
100% sequence identity. The identical sequences imply that the substrate acquired by
tdfF is only expressed in the intracellular environment away from any immune pressures
that would select for antigenic diversity.
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Figure 4. Sequence alignments of the plug and loop domain of TdfF
Panel A) Amino acid sequence alignment of loops 1-5 from FA1090, FA19, MS11, and
UU108.
Panel B) Amino acid sequence alignment of the plug domain of TdfF from FA1090,
FA19, MS11, and UU108. The MS11, FA19, and UU108 sequences, determined as part
of this study. Gray shading with black font indicates 100% identical sequence. Primer
sequence excluded from this analysis.
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A
FA1090
FA19
MS11
UU108

1
50
HFGLGADVSGSLNAEGTLRGRLVSTFGRGDSWRQLERSRDAELYGILEYD
HFGLGADVSGSLNAEGTLRGRLVSTFGRGDSWRQLERSRDAELYGILEYD
HFGLGADVSGSLNAEGTLRGRLVSTFGRGDSWRQLERSRDAELYGILEYD
HFGLGADVSGSLNAEGTLRGRLVSTFGRGDSWRQLERSRDAELYGILEYD

FA1090
FA19
MS11
UU108

51
100
IAPQTRVHAGMDYQQAKETADAPLSYAVYDSQGYATAFGPKDNPATNWSN
IAPQTRVHAGMDYQQAKETADAPLSYAVYDSQGYATAFGPKDNPATNWSN
IAPQTRVHAGMDYQQAKETADAPLSYAVYDSQGYATAFGPKDNPATNWSN
IAPQTRVHAGMDYQQAKETADAPLSYAVYDSQGYATAFGPKDNPATNWSN

FA1090
FA19
MS11
UU108

101
150
SRNRALNLFAGIEHRFNQDWKLKAEYDYTRSRFRQPYGVAGVLSIDHSTA
SRNRALNLFAGIEHRFNQDWKLKAEYDYTRSRFRQPYGVAGVLSIDHSTA
SRNRALNLFAGIEHRFNQDWKLKAEYDYTRSRFRQPYGVAGVLSIDHSTA
SRNRALNLFAGIEHRFNQDWKLKAEYDYTRSRFRQPYGVAGVLSIDHSTA

FA1090
FA19
MS11
UU108

151
200
ATDLIPGYWHADPRTHSASMSLTGKYRLFGREHDLIAGINGYKYASNKYG
ATDLIPGYWHADPRTHSASMSLTGKYRLFGREHDLIAGINGYKYASNKYG
ATDLIPGYWHADPRTHSASMSLTGKYRLFGREHDLIAGINGYKYASNKYG
ATDLIPGYWHADPRTHSASMSLTGKYRLFGREHDLIAGINGYKYASNKYG

FA1090
FA19
MS11
UU108

201
246
ERSIIPNAIPNAYEFSRTGAYPQPSSFAQTIPQYDTRRQIGGYLAT
ERSIIPNAIPNAYEFSRTGAYPQPSSFAQTIPQYDTRRQIGGYLAT
ERSIIPNAIPNAYEFSRTGAYPQPSSFAQTIPQYDTRRQIGGYLAT
ERSIIPNAIPNAYEFSRTGAYPQPSSFAQTIPQYDTRRQIGGYLAT

B
1
50
FA1090 DGYTVSGTHTPFGLPMTLREIPQSVSVITSQQMRDQNIKTLDRALLQATG
FA19 DGYTVSGTHTPFGLPMTLREIPQSVSVITSQQMRDQNIKTLDRALLQATG
MS11 DGYTVSGTHTPFGLPMTLREIPQSVSVITSQQMRDQNIKTLDRALLQATG
UU108 DGYTVSGTHTPFGLPMTLREIPQSVSVITSQQMRDQNIKTLDRALLQATG
51
100
FA1090 TSRQIYGSDRAGYNYLFARGSRIANYQINGIPVADALADTGNANTAAYER
FA19 TSRQIYGSDRAGYNYLFARGSRIANYQINGIPVADALADTGNANTAAYER
MS11 TSRQIYGSDRAGYNYLFARGSRIANYQINGIPVADALADTGNANTAAYER
UU108 TSRQIYGSDRAGYNYLFARGSRIANYQINGIPVADALADTGNANTAAYER
101
116
FA1090 VEVVRGVAGLPDGTGE
FA19 VEVVRGVAGLPDGTGE
MS11 VEVVRGVAGLPDGTGE
UU108 VEVVRGVAGLPDGTGE
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B. TdfF topology model
Nearly all Gram-negative bacteria have TonB-dependent transporters involved in
the uptake of nutrients such as iron, vitamin B12, nickel, carbohydrates, and probably
other substrates (255). TonB-dependent transporters share a common topology based on
twelve different TonB-dependent transporters that have been crystallized to date (206).
They all share two characteristic domains: a β-barrel comprised of 22 amphipathic βstrands, and a globular plug domain that is folded up inside the barrel (56, 206). The
topology of TdfF was determined with the online protein homology analog recognition
engine (PHYRE) (149). We analyzed the TdfF amino acid sequence from gonococcal
strain FA1090. FpvA, was selected as the biological template structure for the TdfF
topology model by PHYRE. FpvA is the outer membrane transporter required for iron
acquisition via the siderophore pyoverdine in Pseudomonas aeruginosa. FpvA, like other
ferrisiderophore transporters, consisted of a membrane-spanning β-barrel occluded by a
plug domain (254). FpvA had 29.15% sequence identity to TdfF. The predicted structure
of TdfF was consistent with the structure of characterized TonB-dependent transporters
(Figure 5A). Consistent with the previously crystallized TonB-dependent transporters
(206) TdfF contained a β-barrel and plug domain (Figure 5A). It was predicted that 11
outer membrane loops extend from the β-barrel and could be surface exposed (Figure
5B).
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Figure 5. TdfF topology model
A) Ribbon diagram of TdfF generated using the online protein homology analog
recognition engine (PHYRE) (149). The three dimensional model was synthesized using
FpvA as the biological template structure and shows a lateral view in which the
characteristic β-barrel structure can be observed. A bird’s eye view from the top of TdfF
looking into the β-barrel shows the globular plug domain. The protein secondary
structures are indicated by color: yellow indicates β-sheets, magenta indicates α-helices,
and blue represents turns.
B) TdfF two-dimensional topology generated based on characteristic structures of
TonB-dependent transporters. TdfF has two distinct domains: the C-terminal β-barrel
domain which is shown in yellow with 22 putative β-strand transmembrane domains and
eleven putative extracellular loops. The loops are labeled 1-11. The N-terminal plug
domain is show in the periplasm but is predicted to fold up into the β-barrel. The plug
and loops 1-5 were sequenced from all available gonococcal laboratory strains. OM
indicates outer membrane.
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C. Fetal bovine serum induces tdfF expression
Gene regulation is essential for microorganisms as it increases versatility and
adaptability by allowing the cell to express proteins when appropriate. When initially
identified, tdfF expression was not detected from gonococci grown in bacterial growth
media (286). Our laboratory demonstrated that tdfF transcription is detected only when
gonococci are incubated in the presence of cervical epithelial cells (113). Bacteria that
are adhered to or within cervical epithelial cells have increased tdfF transcript levels
compared to gonococci isolated from the infection supernatant (113). Similar to previous
work we demonstrated that tdfF expression is not detected in the presence of bacterial
growth media (113). Additionally, microarray analysis of gonococci isolated from
women with uncomplicated infections indicated an increase in tdfF expression (2)
suggesting that the gene is expressed more highly within the host.
A putative Fur box has been identified in the hypothetical -10 region of the tdfF
promoter (113). When gonococci are incubated in bacterial growth media under irondeplete conditions, tdfF transcript is not detected (113) suggesting that tdfF expression
is not only regulated by Fur, but that another regulator and inducing signal from
eukaryotic cells and/or the cell culture media supplemented with FBS is necessary for
gene expression. To determine if the inducing signal for tdfF expression is derived from
epithelial cells or cell culture media we separated the components involved in cell culture
and investigated tdfF transcript levels when gonococci were incubated in these
components.
Cell culture media consists of McCoy’s 5A media and 10% heat-inactivated fetal
bovine serum. McCoy’s 5A media was originally synthesized to support the amino acid
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requirements for in vitro cell cultivation. Hsu and Kellogg employed this medium to
support the growth of primary cultures derived from multiple tissue samples (135) It was
purchased as a sterile liquid media and in addition to amino acids contained sodium
bicarbonate and L-glutamine. Fetal bovine serum (FBS) is the most widely used growth
supplement for cell culture media because of its high content of embryonic growth
promoting factors. When used at appropriate concentrations it supplies many defined and
undefined components that satisfy specific metabolic requirements for the culture of cells.
Some of the defined components of serum included albumin, alpha-, beta-, and gammaglobulins (210) as well as bovine transferrin, ferritin, hormones, lipids, and growth
factors.
We assessed tdfF expression through qualitative RT-PCR in which we incubated
gonococcal strain FA1090 in either McCoy’s 5A media alone or McCoy’s 5A and 10%
FBS for 4 hours. After the incubation, RNA was isolated from the bacteria and RT-PCR
was performed. We probed for tdfF expression and used 16S rRNA expression as a
control because it was constitutively expressed under all conditions tested. We detected
increased tdfF specific transcript when the bacteria were incubated in the presence of
McCoy’s 5A and 10% FBS compared to gonococci incubated McCoy’s 5A alone,
(Figure 6). There are two possible explanations for these results. One is that a serum
derived component was responsible for inducing tdfF expression. If a serum component
was responsible for the induction of tdfF expression then we should be able to define the
serum component responsible for increased transcript. We incubated gonococci in
different serum components such as the iron binding protein ferritin, and the hormones
norepinephrine and epinephrine which have been shown to induce the expression of a
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TonB-dependent transporter in B. pertsussis (7). After 4 hour incubation in McCoy’s 5A
supplemented with these different serum components tdfF expression was examined by
RT-PCR. We did not detect tdfF when gonococci were incubated in these conditions
(data not shown). We also isolated RNA from gonococci incubated in defined serum
(Hyclone) and performed RT-PCR. Defined serum is commercially available and all the
components in this serum have been identified. Transcript of tdfF was not detected using
qualitative RT-PCR when gonococci were incubated in the defined serum (data not
shown). These results indicate an undefined serum component is responsible for tdfF
expression.
Another possible explanation from these results is that the tdfF expression
observed was modulated by iron availability. The presence of FBS chelates any excess
iron in the McCoy’s 5A, and this iron chelation was derepressing tdfF transcript through
Fur. N. gonorrhoeae cannot utilize bovine transferrin, (263) which is the major iron
source in FBS and it is also demonstrated that gonococci cannot multiply in cell culture
media (McCoy’s 5A and 10% FBS) (113). McCoy’s 5A is not an iron chelated media
and any available iron would be utilized by gonococci and cause Fur to repress tdfF. In
the presence of FBS, the bovine transferrin would chelate any iron away from gonococci
making the media more iron deplete in which Fur would no longer repress tdfF. The
addition of norepinephrine or epinephrine in McCoy’s 5A alone would not decrease free
iron from the media hence the lack of tdfF transcript detected. It was previously
demonstrated that when gonococci are incubated in cell culture media supplemented with
iron, tdfF transcript is not detected; however, tdfF is expressed in cell culture media in
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the absence of the supplemented iron (113). Therefore tdfF expression could be
modulated by both iron availability and a serum specific molecule or molecules.
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Figure 6. tdfF transcript levels detected in the presence of fetal bovine serum
Wild type strain (FA1090) was incubated in the presence of McCoy’s 5A + 10% heatinactivated FBS (+) or in McCoy’s 5A alone. tdfF specific transcripts were assayed by
RT-PCR. 16S rRNA was used as a positive control because it was constitutively
expressed under all growth conditions. Expression of 16S rRNA in the absence of reverse
transcriptase, (16S rRNA-RT was used as a negative control.
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D. Expression and Isolation of rTdfF
TdfF is predicted to be a 78kDa outer membrane protein that is only expressed
when gonococci are incubated in cell culture conditions in the absence of additional iron
(Hagen, 2006 #143; Turner, 2001 #221). As another means for tdfF detection, we chose
to generate a polyclonal TdfF specific antisera, which necessitated purification of rTdfF
for subsequent immunoblot assays.
We utilized the pET vector (Novagen) which is a bacterial plasmid designed to
enable the production of a large quantity of any desired protein. The tdfF gene was
cloned into this vector and was expressed under the control of the IPTG inducible T7
promoter. We chose to clone full length tdfF into the pET vector pET-22b(+) (Novagen)
which encoded ampicillin resistance, a C-terminal histidine tag and a T7lac promoter. A
lac operator sequence was just downstream of the T7 promoter within the plasmid, and
this plasmid also carried the lac repressor (lacI) which repressed the expression of the T7
RNA polymerase in the host cell. The addition of isopropyl-β-D-thiogalactopyranoside
(IPTG) induced T7 RNA polymerase production within the host cell, which in turn
transcribed the target DNA in the pET plasmid.
pVCU354 (pET-22b(+)tdfF) was transformed into E. coli strain BL21(DE3)
because this strain was the most widely used host for target gene expression. A single
colony from the transformation was grown overnight and this culture was split and used
as a stock to grow two parallel cultures. Once the cultures grew to an OD600 of 2.5, IPTG
was added to one culture and nothing was added to the other culture which was used as a
control. The cultures were grown for an additional 4 hours. We observed an initial
increase and then decrease in OD600 readings in our induced culture throughout the 4 hour
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induction. Whereas, the uninduced culture continued to increase in optical density over
the 4 hour growth period. Protein production was monitored in the two cultures with the
use of Coomassie stained SDS-PAGE analysis, we expected that if rTdfF was produced
then a dark band around 80kDa would be observed in whole cell lysates from the induced
culture compared to the uninduced culture. There was no difference in protein banding
pattern between the two cultures. Western blot analysis was also performed on whole cell
lysates isolated from both cultures and the blots were probed with anti-histidine tag
antibody. If rTdfF was expressed we would expect the C-terminal histidine tag to interact
with the anti-histidine antibody. rTdfF was not detected from either culture on these
blots by the histidine specific antibody. All together, these data indicate that the
expression of full length tdfF in E. coli could be toxic to the bacteria or expression is not
occurring due to insufficient tRNA pools.
Most amino acids are encoded by more than one codon, and each organism carries
its own bias in the usage of the 61 available amino acid codons. When the mRNA of
heterologous target genes is over expressed in E. coli, differences in codon usage can
impede translation due to the demand for one tRNA that may be rare or lacking in the
population. Insufficient tRNA pools can lead to translational stalling, premature
translation termination or frame shifting (147, 158). The amino acid content of TdfF
consisted of 27 prolines encoded by the sequence CCC which was considered a rarely
used codon by E. coli. These codons were found in the N-terminus of TdfF and could
lead to premature termination of translation. To enhance rTdfF expression in E. coli we
transformed pVCU354 plasmid into Rosetta strain (Novagen) which expressed rare
codons. IPTG induction of TdfF in the Rosetta cultures resulted in a very slight increase
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in OD600 compared to the uninduced cultures over a 4 hour growth period. When proteins
from whole cell lysates isolated from the two cultures were separated by SDS-PAGE,
Coomassie staining of this gel indicated no difference in protein banding pattern between
the two cultures. Also, western blot analysis in which anti-histidine antibodies were used
to probe for rTdfF expression did not detect an 80kDa protein. The lack of growth and
rTdfF expression in this system indicated that full length TdfF was toxic to the E. coli.
Since it was difficult to express full length rTdfF in the pET expression system we
attempted to express portions of the transporter. The signal sequence was removed from
the N-terminal sequence of tdfF which would prevent transport of the protein out of the
cytoplasm and could improve protein yield and E. coli viability. The sequences encoding
the plug domain or portion of the β-barrel, now called loop domain, were cloned into
pET-22b(+) (Figure 4B) to generate the subsequent plasmids pVCU355 and pVCU357
respectively. The plasmid constructs were transformed into E. coli strain C41. The strain
C41 was derived from BL21 (DE3) and had at least one uncharacterized mutation, which
prevented cell death associated with the expression of toxic recombinant proteins (199).
This E. coli strain was effective in over expressing toxic proteins from all classes of
organisms, eubacteria, archaea, yeast, plant and mammals and therefore was expected to
successfully produce portions of TdfF (199). The E. coli strain C41 containing either
pVCU355 or pVCU357 were grown to an OD600 of 2.5 and then one culture was induced
with IPTG and the other remained uninduced for an additional 4 hours. Similar levels of
increased optical density were observed for the induced cultures, compared to the
uninduced strains indicating that the induced cultures were viable. Whole cell lysates
were isolated from the induced and non-induced E. coli strains and separated by SDS-
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PAGE. A protein of the predicted size of 15kDa was identified by Coomassie stained
SDS-PAGE from the IPTG induced plug expressing strain (Figure 7A). Additionally,
histidine tag specific antibodies detected a protein of 15kDa expressed by the IPTG
induced culture via Western blot analysis (Figure 7B). Similarly, the loop domain which
was predicted to be 27kDa was detected in the induced cultures through Coomassie
stained SDS-PAGE analysis (Figure 7A) and anti-histidine antibodies detected a 27 kDa
protein by Western blot analysis. A smaller species between 15kD and 20kD was
detected by the anti-histidine antibody in lysates expressing rTdfF loops. This could be a
break down product or smaller protein expressed by the E. coli (Figure 7B). Both
recombinant proteins were insoluble and purified using denaturing conditions and a
histidine column. A stepwise dialysis was conducted to increase the pH of the solution in
which the proteins were eluted.

77

Figure 7. Expression of rTdfFplug and rTdfF loops
A) Coomassie blue stained SDS-PAGE containing proteins from E. coli expressing
rTdfF protein. Lanes contain solubalized E. coli lysates that express either pVCU355 or
pVCU357 induced with IPTG (I) or uninduced (NI) for 4 hours. Proteins were separated
on a 15% acrylamide gel. The arrows on the left indicate the band of rTdfF expression.
The position of molecular weight markers is indicated on the left.
B) Western blot analysis of the solubalized E. coli lyates that express either rTdfF plug or
rTdfF loops grown in the presence of IPTG (I) or no IPTG (NI) for 4 hours. Proteins
were separated on a 15% acrylamide gel. Blots were probed with an anti-histidine
antibody.
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E. Anti-TdfF rabbit polyclonal serum detects rTdfF
Antibodies recognize their target with high specificity and generally bind with a
very high affinity, within the nano/picomolar range to their target (249). Polyclonal antiTdfF antibodies were generated in rabbits against the rTdfF plug and rTdfF loops for
analysis of TdfF expression. Recombinant proteins were sent to New England Peptide
antibody program where female New Zealand Rabbits were immunized with rTdfF plug
or rTdfF loops. Sera were collected 35 and 40 days after the primary boost. We
determined the specificity of rabbit sera against the recombinant proteins and optimal
dilutions for the sera for future detection assays. The anti-TdfF sera detected rTdfF from
whole cell lysates isolated from induced E. coli cultures (Figure 8). The anti-TdfF plug
sera detected rTdfF plug from induced E. coli cultures and anti-rTdfF loops detected
rTdfF loops from induced E. coli strains (Figure 8). As expected, the anti-TdfF plug and
anti-TdfF loops sera also detected their corresponding purified rTdfF proteins (Figure 9).
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Figure 8. Polyclonal α-TdfF detects rTdfF
Western blot analysis of the solubalized E. coli lyates that express rTdfF. Blot 1
expresses rTdfF plug and blot 2 expresses rTdfF loops induced with IPTG (I) or
uninduced (NI) for 4 hours. Proteins were separated on a 15% acrylamide gel. Blot 1 was
probed with rabbit polyclonal α-TdfF plug and blot 2 was probed with rabbit polyclonal
α-TdfF loops sera as indicated below each blot. An arrow designates detection rTdfF
protein by α-TdfF sera
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Both plug and loop specific anti-TdfF sera were utilized for analysis of TdfF
expression in gonococcal strain FA1090. We first performed assays in which tdfF
expression was observed, in which gonococci were incubated in the presence of cervical
epithelial cells. We used gonococcal strain FA1090 and tdfF mutant strain (MCV659) as
our negative control in these TdfF detection assays. Gonococci were incubated with
cervical epithelial cells for 4 hours. After the 4 hour incubation the cell associated
bacteria and supernant associated bacteria were separated and solubilized. Gonococcal
protein expression was analyzed by immunoblotting and the blots were probed with antiTdfF sera. TdfF expression was not detected in the wild type strain (FA1090) (Figure 9)
under these incubation conditions. As expected, TdfF was not detected in proteins
isolated from the tdfF mutant strain (MCV659). We also incubated wild type gonococcal
strain FA1090 and tdfF mutant strain (MCV659) in various serum components for 4
hours. After the 4 hour incubation gonococci were solubilized and immunoblot analysis
was used to determine TdfF expression. Ferritin, a potential intracellular iron source, and
hormones such as norepinephrineeniphrine and epinephrine were added to the McCoy’s
5A media individually. None of these components induced detectable TdfF expression
(data not shown). In all our assays the anti-TdfF sera detected purified rTdfF loop
domain, rTdfF plug domain (Figure 9) or whole cell lysates from C41 expressing the
rTdfF proteins which were employed as positive controls (Figure 8). There could be
many reasons why we do not detect TdfF expression from these assays. One possible
explanation for the lack of TdfF detection by α-TdfF sera was that proteins from cell
culture media or epithelial cell were blocking antibody detection. TdfF detection was
expected to be between 70 kDa and 100 kDa based on the predicted molecular weight.
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There was a lack of protein detection in this area and that could be due to steric hindrance
of antibody binding by the serum specific protein (Figure 9). One such protein could be
bovine albumin which is abundant in bovine serum and has a molecular weight around 70
kDa. This phenomenon occurred in both the wild type and tdfF mutant strain (MCV659)
indicating we were observing a non-specific interaction.
The lack of TdfF detection could also be due to a lack of TdfF expression by
gonococci. Based on our previous observations TdfF expression is greatest in the
presence of cell culture media in the absence of additional iron (113). We observed very
low levels of TdfF transcript when gonococci were incubated in cell culture media alone.
The FBS may not be chelating all the iron in McCoy’s 5 media making it iron-replete.
Then gonococci would be able to obtain this iron and tdfF expression would be repressed
by Fur. Also, lots of FBS vary, and the particular lot used for these experiments could
lack a co-inducing signal necessary for TdfF expression hence the lack of TdfF detected
in these assays.
Finally, western blot analysis is not as sensitive as qualitative RT-PCR. TdfF
could be expressed but in very low levels under these conditions. We attempted to detect
TdfF from solubilized whole cell lysates which contain proteins from the outer
membrane, inner membrane, and cytoplasm. With all these proteins separated by SDSPAGE other TonB-dependent transporters as well as other proteins with a similar
molecular weight to TdfF could migrate to the same part of the gel as TdfF and prevent
TdfF detection. One way to enrich for TdfF would be to isolate outer membrane proteins
from gonococci incubated under cell culture conditions.
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Figure 9. Western blot analysis of TdfF expression
Western blot analysis of whole cell lysates probed with α-TdfF plug or α-TdfF loops as
indicated above each blot. Lane 1 contains whole cell lysates isolated from gonococcal
wild type strain (FA1090) adherent/intracellular with ME180 cells. Lane 2 contains
whole cell lysates isolated from tdfF mutant strain (MCV659) adherent/intracellular with
ME180 cells. Lane 3 contains purified rTdfF protein that corresponds with the α-rTdfF
sera that was used to probe the blot. Poncceau stain below each blot indicates equal
loading of protein for each lane.
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III. Discussion
Gonococcal infections require that the bacteria circumvent the innate ironwithholding mechanisms employed by the human host. Epithelial cells obtain iron from
ferrated transferrin from the serum via receptor-mediated endocytosis (224). The low pH
of transferrin-containing endosomes facilitates the release of iron from transferrin and is
then transported out of the endosome to the cytosol (224). Epithelial cells respond to
Neisseria infection by reducing transferrin receptor gene expression and transferrin
receptor cycling thus further limiting host iron availability (32). It was hypothesized that
gonococcal strain FA1090 utilized iron sources within the epithelial cell through the
TonB-dependent transporter TdfF (113). Understanding how tdfF gene expression is
induced may lead to the identification of the specific ligand for TdfF as well as elucidate
new mechanisms of intracellular pathogenesis.
We first wanted to determine if other gonococcal genomes contained the tdfF
gene. This TonB-dependent transporter is crucial for intracellular survival in gonococcal
strain FA1090 (113); however, other gonococcal strains have exhibited Ton-independent
survival in the presence of a strain specific gonococcal genetic island (317). Gonococcal
strain FA1090 does not possess this gonococcal genetic island indicating that TdfFdependent survival could be FA1090 specific and other strains may not encode for this
TonB-dependent transporter. We analyzed common gonococcal laboratory strains for
tdfF through PCR and sequence analysis. Using FA1090 specific tdfF primers, we
amplified the plug and loop domains from strains FA19, MS11 and UU108 and compared
these sequences to strain FA1090. Gonococcal strains FA1090 and FA19 were isolated
from patients with disseminated gonococcal infections (DGI) as well as localized
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infection. Strain MS11 was isolated from a localized infection and both FA19 and MS11
posses the before mentioned genetic island. All four laboratory isolates contain full
length tdfF. Since our investigation the Broad Institute has sequenced many more
gonococcal isolates and recently, tdfF was identified as a pathogen specific gene (184,
266).
All gonococcal strains sequenced to date have tdfF sequences that are 100%
identical. Since strains that contain a GGI also contain full length tdfF, then perhaps in
the presence of a functional Ton system TdfF is employed for intracellular survival and
the GGI is employed only if the Ton system is no longer functional. Also, the lack of
sequence diversity between the eleven putative outer membrane loops may indicate a lack
of immune pressure and support data that tdfF expression only occurs in the intracellular
environment. The transferrin receptor, TbpA isresponsible for acquisition of iron from
the serum, human iron binding protein, transferrin (63). In TonB-dependent transporters
that acquire iron from the extracellular environment it is common to observe sequence
diversity amongst surface exposed loops. When comparing TbpA sequence amongst
gonococcal isolates, both antigenic and sequence diversity was identified in
hypervariable regions (62). These regions are surface exposed loops on the TonBdependent transporter (312). It is possible that the intracellular niche would protect
gonococci from the immune system and thus sequence diversity of the loops domain
would be unnecessary. The lack of sequence diversity could also indicate a lack of
immunogenicity by TdfF. This could explain the difficulty in detecting TdfF by
immunoblot.
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We attempted to express full length rTdfF in E. coli for purification and
subsequent immunization to generate rTdfF anti-sera. We could not express full length
rTdfF due to multiple complications. It seems that full length TdfF was toxic to the E.
coli induced to express this protein as we observed a lack of growth in these cultures.
Even after addressing the possibility that TdfF employed a rarely used codon to encode
27 proline residues we still could not express full length rTdfF. This was not the first
report in which expression of a Neisserial outer membrane protein (OMP) was found to
be lethal to E. coli (106).
OMPs are synthesized with a signal sequence and are translocated through the
inner membrane by the SecA/Y/E/G export machinery in an unfolded form and in a
process that requires energy in the form of ATP (96, 278). Once the protein has arrived in
the periplasmic space, the signal sequence is removed by a signal peptidase (96, 278).
The later stages in OMP biogenesis such as transport through the periplasm and assembly
into the OM, are much less well understood. It has been demonstrated that the acquisition
of tertiary structure proceeds, at least partially, the insertion of the proteins into the OM
(81). Recent studies have led to the identification of Omp85 in Neisseria which is
involved in the insertion and assembly of OMPs. Omp85 homolog has been identified in
all Gram-negative bacteria studied (297) and the E. coli homolog, which is encoded by
the yaeT gene, was demonstrated to be essential and required for OMP biogenesis (77,
302). Interestingly, the outer membrane porin, PorA, from N. meningitidis does not
stimulate the assembly or transport activity of E. coli Omp85 indicating that, even though
the process of OMP assembly and transport by Omp85- related machinery is
evolutionarily conserved, species-specific adaptations appear to have occurred (243).
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Furthermore, in E. coli, Omp85 was recently renamed BamA, and is associated with at
least 4 lipoproteins: BamB, BamC, and BamD to make up the beta-barrel assembly
machinery necessary for the transport of beta-barrels to the outer membrane (309) like
that of TdfF (Figure 4). Neisseria have homologs to all components of the Bam system
in E. coli except BamB (296). Mutations in the Bam system that are tolerated by E. coli
are not in Neisseria (296). Thus, there are fundamental differences between Neisseria
and E. coli in outer membrane beta-barrel biogenesis that could prevent expression and
export inhibit high levels of full length TdfF protein from being expressed and could
explain why we could express plug and loop domains of TdfF.
We also observed two loop species when expressing and purifying rTdfF loops
(Figure 7). One species was assumed to be full length due to its size of 27 kDa whereas
the other species was smaller and identified at a molecular weight between 15 kDa and
20 kDa. It was unclear if the truncated species resulted from premature translational
termination or from proteolytic cleavage, both of which were artifacts of over expression
in E. coli.
The polyclonal rabbit anti-rTdfF sera produced from rTdfF plug and rTdfF loops
detected heterologous TdfF plug and TdfF loop domains from E. coli, but we were not
able to detect full length TdfF from N. gonorrhoeae. A possible explanation for this
phenomenon was that gonococci were not expressing tdfF under the conditions we tested.
Expression of tdfF has only been observed in the presence of or adhered/within epithelial
cells or cell culture media in the absence of additional iron (113). In this study tdfF
expression was only detected with the use of qualitative RT-PCR when gonococci were
incubated in cell culture media containing 10% heat-inactivated fetal bovine serum
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(Figure 6). We concluded that this expression could be due to increased iron stress by the
FBS as well as a serum specific inducing molecule. When we investigated TdfF
expression under these same conditions using western blot analysis the detection of TdfF
was not possible. We hypothesized that a serum derived protein of similar molecular
weight of TdfF was blocking anti-TdfF sera. This was a non-specific TdfF interaction
because TdfF was not detectable in either the wild type (FA1090) or tdfF mutant strain
(MCV659) under the same incubation conditions. We also concluded that the lack of
TdfF detection could be due to lack of sensitivity by Western blot analysis. The
qualitative RT-PCR assay showed low levels of tdfF specific transcript and thus low
levels of TdfF could be expressed on the surface of gonococci. To detect low levels of
TdfF, we suggested western blot analysis of outer membrane proteins only. Finally,
TdfF may not have been expressed in these assays. Due to differences in cell culture
media based on FBS lots, the FBS used in these assays could contain excess iron that
repressed tdfF expression or contain a decreased amount of a co-inducing molecule
required to produce TdfF.
In numerous bacteria, gene expression for TonB-dependent transporters involved
in iron uptake was regulated by Fur. Since TdfF played a role in intracellular iron
acquisition and contained a putative Fur box it was assumed to be regulated by Fur.
However when gonococci are incubated in bacterial growth media under iron-deplete
conditions, tdfF expression is not detected and additional iron in cell culture media
diminished expression (113) indicating that tdfF may be under a more complex
regulatory circuit involving iron. Within close proximity of tdfF on the gonococcal
chromosome was a gene that encoded an AraC-like regulator, mpeR (see chapter 4).

91
MpeR was first identified due to its role in regulating hydrophobic efflux pump activity
(92). MpeR was also iron regulated and had a Fur box in its putative promoter (78, 139).
Since MpeR was iron regulated and within close proximity of tdfF we hypothesized that
it could be regulating gene expression. AraC-like regulators are characterized by an Nterminal ligand binding domain and a C-terminal DNA binding domain. When an AraClike regulator binds to it ligand, it regulates the gene that corresponds to its DNA binding
domain. AraC-like regulators have been involved in invasion by other bacteria (144).
Since MpeR also regulated efflux pumps in gonococci it was conceivable that it was a
global regulator and could also regulate tdfF expression in the presence of a host inducing
signal. MpeR could also be regulated by other global regulators. Some genes that encode
TonB-dependent transporters rely on a signal transduction cascade to lead to the
subsequent transcription of the receptor. For example, the TonB-dependent transporter
FecE, in E. coli relies on sigma factors for expression. Other TonB-dependent
transporters are under the control of Fur as well as global regulators such as Crp (cAMP
receptor protein) (315) or regulatory small RNAs (sRNAs). sRNAs are short RNA
molecules that are synthesized as discrete transcripts and act by base-pairing with target
mRNAs over short regions of complementarity. Base-pairing between an sRNA and an
mRNA can lead to repression of mRNA translation (193, 289, Neisseria posses a Fur and
iron regulated sRNA, NrrF (Mellin, 2007 #283). sRNA-mediated regulation requires a
cofactor RNA-binding protein (Hfq) for proper gene regulation and stabilization which
was also identified in Neisseria (76). NrrF and Hfq have been shown to be involved in
Neisseria gene regulation in iron-depleted conditions (76, 193). Therefore the lack of tdfF
expression may be due to a missing inducing molecule that signals that gonococci are
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within or in contact with epithelial cells. This signal could be necessary for MpeR to
activate expression of tdfF or activate a complex regulatory cascade that may involve
MpeR, sigma factors and/or small RNAs.
We attempted to induce tdfF expression with the use of hormones and iron
sources identified in serum. We tested the hormones norepinephrineinephrine and
epinephrine. These neurotransmitters induce the expression of the B. pertussis TonBdependent iron transporter BfeA in the presence of serum (7). We also tried an
intracellular iron binding protein, ferritin, which gonococci cannot utilize as an iron
source but may sense in the intracellular environment. Finally, we tried to detect tdfF
expression in the presence of defined serum which contains specific serum components
as a way to exclude potential inducing molecules. We were not successful in detecting
tdfF expression in these sera using either qualitative RT-PCR or western blot approaches.
The lack of induction may be due to excess iron in the McCoy’s 5A media causing a
repression of tdfF which would inhibit any induction from these molecules.
To conclude, we did determine that fetal bovine serum in the cell culture media
does induce tdfF expression and this could be due to iron availability and the presence of
an inducing signal. We also determined that tdfF was identical amongst all gonococcal
isolates sequenced to date indicating there was little immune pressure for sequence
variability. We successfully expressed rTdfF plug and loop domains and polyclonal
rabbit anti-TdfF sera from these recombinant proteins. The sera detected rTdfF by
western blot but could not be employed to detect TdfF in gonococcus whole cell lysates.
Elucidating the mechanism of tdfF expression may provide clues to the intracellular
pathogenesis of N. gonorrhoeae including the identity of the ligand required for TdfF-
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dependent intracellular survival.
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Chapter 4 INTRACELLULAR IRON ACQUISITION BY Neisseria gonorrhoeae
I. Introduction
Neisseria meningitidis and Neisseria gonorrhoeae are closely related obligate human
pathogens. Both microorganisms possess an array of virulence factors that contribute to
their ability to adhere and invade mucosal epithelial cells (for a review see (107, 194)).
The first stages of infection involve adherence and invasion of epithelial cells, mediated
by bacterial cell surface components such as pili, opacity-associated proteins (Opa) and
lipooligosaccharide (LOS). Several gonococcal-specific studies indicate that pili play a
major role in the initial adherence of N. gonorrhoeae (192) and that the Opa proteins are
involved in both adherence and invasion of epithelial cells (157). LOS aids in adherence
and uptake of gonococcal cells, in addition to evoking a strong pro-inflammatory
response in urethral epithelial cells (122).
Another important virulence determinant for the bacteria is the ability to acquire iron
from the human host. Free iron exists in extremely low concentrations within the human
body. This presents a nutritional barrier to invading microbes called nutritional immunity
(301). In order to colonize humans, bacteria must acquire iron from human iron binding
proteins. Meningococci and gonococci employ multiple TonB-dependent transport
systems for the acquisition of iron from extracellular human iron binding proteins
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including, transferrin, lactoferrin and hemoglobin (22, 25, 53, 64, 174, 175, 212, 220,
307). Iron is necessary for intracellular survival and this survival is TonB-dependent for
both N. meningitidis and gonococcal strain FA1090 (113, 161). Furthermore, the TonBdependent transporter TdfF is important for gonococcal survival in an iron-dependent
manner, (113) however its intracellular iron source remains undefined. TdfF is pathogen
specific and has been identified in both N. meningitidis and N. gonorrhoeae (184, 266). It
is important to note that TonB-independent intracellular survival has been observed in
gonococcal strain MS11 (317). MS11 possesses the gonococcal genetic island (178)
(178) and TonB-independent intracellular survival is directly linked to type IV secretion
system structural components encoded by the GGI (317).
Iron is also essential for basic physiological processes within the epithelial cell.
Epithelial cells take up ferrated transferrin from the serum via receptor-mediated
endocytosis. The low pH of transferrin-containing endosomes facilitates the release of
iron from transferrin and the apo-transferrin is recycled to the cell surface (224). Iron is
then transported out of the endosome to the cytosol. Biochemical data suggests that
additional iron uptake mechanisms may exist through putative receptors for serum ironbinding proteins and molecules but these have not been characterized at a molecular level
or in vivo (129). One such molecule could be the recently identified mammalian
siderophore. Siderophores are low molecular weight iron binding compounds secreted by
many microorganisms. Mammalian cells express a homolog of entA from E. coli, which
encodes a bacterial protein that has a critical role in synthesis of the bacterial siderophore
enterobactin (75). The iron binding moiety of the mammalian siderophore consists of 2,5-
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DHBA, however the composition and structure of the intact siderophore remains to be
determined (75).
Once iron has been acquired by the epithelial cell, any excess iron is stored in the
cytosolic iron storage protein ferritin. Ferritin is a 24-mer proteinacious cage made up of
two subunits, H-ferritin and L-ferritin (280). Iron is taken up by the two subunits
cooperatively and H-ferritin possesses ferroxidase activity that converts soluble ferrous
ions into ferric hydroxides (170). L-ferritin lacks ferroxidase activity but is more efficient
in inducing iron nucleation and mineralization within the protein cage (12, 251). When
the cell needs to utilize iron from the ferritin, the ferritin monomers within the cytoplasm
of the cell form clusters, by an as yet-undefined mechanism, that are preferentially taken
up by lysosomes (234). Once the lysosome acidifies, ferritin releases the iron atoms
which can then be transported and utilized by the cell in a yet to be determined manner.
The degradation of ferritin can be blocked in vitro with the addition of leupeptin or
ascorbate. Leupeptin is a lysosomal protease inhibitor that has been used to prevent
ferritin degradation in multiple cell lines (244). Ascorbate prevents autophagy of ferritin
and its subsequent degradation within epithelial cells (38, 131, 211).
Host-pathogen interactions have been investigated in the context of Neisseria
induced alteration of epithelial cell iron homeostasis. During gonococcal and
meningococcal infections epithelial cells experience an alteration in transferrin receptor
expression and iron metabolism (31). Neisseria-infected human epithelial cells have
reduced levels of transferrin receptor messenger RNA and exhibit a reduction in
transferrin receptor cycling (31), which could promote the host cells to deplete
intracellular iron stores. Microarray data also establishes that cells infected with
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meningococci demonstrate an iron starvation gene expression profile (32). It was
hypothesized that depleting intracellular iron stores would prevent the proliferation of
pathogenic bacteria that were generally more invasive than commensal species. It was
demonstrated that during meningococcal infections, ferritin is redistributed from the host
cell cytosol into aggregates that associated closely with the intracellular bacteria (162)
and induced a rapid degradation of host cell ferritin. Thus meningococcal infection of
epithelial cells causes a reduction of transferrin uptake, which triggers an iron starvation
response (162). As a consequence, the host cell degrades cytosolic ferritin, releasing iron
in order to meet its own metabolic needs. The meningococci, in turn, hijack the ferritinderived iron in order to replicate within the epithelial cells (31, 32, 162).
Iron is required for enzymatic functions; however, excess free iron can be
detrimental by increasing oxidative damage. Therefore, iron homeostasis within the
bacterial cell must be tightly regulated (37). The ferric uptake regulator (Fur) acts as a
transcriptional regulator for iron acquisition genes in N. gonorrhoeae. Under iron-replete
conditions, Fur binds to a specific DNA sequence called the Fur box in the promoter of
iron regulated genes and blocks transcription (13). Under iron-deplete conditions Fur
disassociates from the Fur box and allows the RNA polymerase to bind to the promoter
and transcribe the iron regulated gene (13). Fur may not be the only transcriptional
regulator of iron acquisition genes in N. gonorrhoeae. An AraC-like regulator, MpeR,
was first identified as a regulator of a hydrophobic agent efflux pump (92). AraC-like
regulators have been shown to regulate the acquisition of iron in multiple microorganisms
including Yersenia pestis and Bordetella pertussis (16, 87). Interestingly, mpeR is iron
regulated (78, 139) indicating it could in turn regulate iron acquisition systems and it was
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within close proximity to tdfF on the gonococcal chromosome (Figure 10). In other
microorganisms in which AraC-like regulation occurs on iron transport genes, the AraClike regulator is encoded within close proximity of the transport system that it regulates
(16, 87). Therefore we hypothesize that MpeR may play a regulatory role in the
expression of tdfF.
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Figure 10. Chromosomal locus of tdfF
The gene, tdfF is shaded in yellow and encodes a TonB-dependent transporter important
for intracellular survival. Upstream of tdfF is a gene that encodes a conserved
hypothetical protein (CHP), a periplasmic binding protein (PBP) and another conserved
hypothetical protein where are all shaded in light blue. Encoded in the opposite direction
within close proximity to tdfF is mpeR, shaded in orange.
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In this study, we investigated the role of intracellular iron in the survival of N.
gonorrhoeae. We examined the role of MpeR during intracellular survival as a means to
determine if MpeR regulated TdfF. Utilizing gentamicin protection assays we determined
that MpeR did not play a regulatory role in intracellular survival under these in vitro
conditions. We explored gonococcal survival in ME180 epithelial cells incubated in
varying serum and iron conditions and demonstrated that similar to N. meningitidis,
gonococci have increased survival when epithelial cells were serum starved however, the
survival in the absence of serum was not due to increased intracellular ferritin
degradation but due to increased iron in the serum-deplete media. Additionally, we
investigated gonococcal utilization of 2,5- DHBA with plate bioassays and demonstrated
that gonococcal strain FA1090 utilized 2,5- DHBA at intermediate levels compared to
iron sources known to be utilized by gonococci and that iron acquisition by 2,5-DHBA
was TonB-independent.
II. Results
A. MpeR does not have an affect on intracellular survival
ME180 cervical epithelial cells support gonococcal invasion (137, 141) and
within 4 hours gonococci adhere to and invade the epithelial cells (113). Therefore, to
determine the number of bacteria that survive within the intracellular environment we
employed gentamicin protection assays with ME180 cells. In these assays, pilliated
gonococci were suspended in infection media and added to two separate epithelial cell
monolayer at an MOI of 10. This infection media consisted of McCoy’s 5A cell culture
media (Gibco), 10% heat-inactivated fetal bovine serum (FBS) (Gibco) and iron
supplementation to enhance invasion. Fetal bovine serum contains bovine transferrin
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which is not an iron source for gonococci because the transferrin binding proteins
(TbpA/TbpB) are species specific for human transferrin (63, 263). After the monolayers
were incubated with the infection media consisting of gonococci for 4 hours, the
monolayers were washed twice with PBS and gentamicin was added to kill any
extracellular bacteria. The extracellular gonococci were susceptible to gentamicin killing
but intracellular bacteria were protected because the drug was not able to penetrate
eukaryotic cells. Both monolayers were then washed again to remove any remaining
gentamicin. One monolayer was lysed and plated for intracellular bacteria enumeration.
This was time point 0. Replication media, consisting of McCoy’s 5A cell culture media
and 10% heat-inactivated FBS was added to the other monolayer. After 24 hours of
incubation, the monolayer was washed, treated with gentamicin, lysed and plated for the
enumeration of intracellular bacteria which was the 24 hour time point.
The mpeR gene was originally identified as encoding an AraC-like regulator that
plays a role in maximizing the function of hydrophobic agent efflux pumps (92).
Members of the AraC/XylS transcriptional regulator family have been characterized from
a wide variety of prokaryotes including both Gram-negative and Gram-positive bacteria.
The characteristic features used to identify MpeR as an AraC-like regulator are a
conserved stretch of approximately 100 amino acids at the C-terminal end that serves as
the DNA-binding domain and an N-terminal ligand binding domain (97). The main
regulatory roles of AraC-like regulators are in carbon metabolism, stress response, and
virulence and/or pathogenesis (97). In many microorganisms AraC-like transcriptional
regulators play a role in intracellular survival. For example, an AraC-like transcriptional
regulator PerA contributes to Enterococcus faecalis intracellular survival within
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macrophages (59). In Salmonella enterica, two AraC-like regulators play a role in
intracellular survival within epithelial cells (79, 237).
We initially determined that mpeR was iron regulated, (data not shown) which
was recently confirmed by microarray assays, FURTA assays, and the presence of a Fur
box in its promoter (78, 139). We hypothesized that since MpeR itself was iron
regulated, it could also regulate iron acquisition systems in gonococci, particularly the
one putatively encoded by the tdfF locus thus impacting intracellular survival. To
determine if MpeR played a role in intracellular survival, we performed a gentamicin
protection assay comparing the wild type strain to the mpeR mutant strain (MCV304) and
the mpeRC (MCV305) complemented strain. The mpeR mutant strain (MCV304)
consisted of the mpeR gene interrupted by a kanamycin resistance cassette. We used the
tonB (MCV656) and tdfF (MCV659) mutant strain as controls in these protection assays.
As expected both the tonB (MCV656) and tdfF (MCV659) had attenuated survival with
reduction in viable counts by 4 log and 1 log respectively, compared to the wild type
strain (FA1090) which had been previously observed (113) (Figure 11A). Both, the mpeR
(MCV304) and mpeRC (MCV305) strains survived similarly to the wild type strain
(FA1090) (Figure 11A). It appears that under these in vitro conditions, MpeR does not
have an effect on intracellular survival indicating it may not regulate tdfF expression
which has shown to be important for intracellular survival.
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Figure 11. Intracellular survival is not MpeR-dependent and increases in serum
starved epithelial cells
A) Intracellular survival in the presence of replication media containing McCoy’s5A and
10% heat-inactivated FBS. The bars represent intracellular survival in CFU/ml (log10)
for the following gonococcal strains: Wild type (FA109) (black), tonB mutant (MCV656)
(checkered), tdfF mutant (MCV659) (horizontal black lines) mpeR mutant (MCV304)
(vertical black lines) and mpeRC strain (MCV304) (93). Time points in hours indicated
along the x-axis. Intracellular survival assays were performed in triplicate and standard
deviation is indicated above each bar. A P value of < .01 was considered statistically
significant. An asterisk (*) denotes a significant decrease in intracellular bacteria counts
as compared to the wild type is indicated by an asterisk (*).
B) Intracellular survival in the presence of replication media containing McCoy’s 5A
alone. The bars represent intracellular survival in CFU/ml (log10) for the following
gonococcal strains: Wild type (FA1090) (black), tonB mutant (MCV 656) (checkered),
tdfF mutant (MCV659) (horizontal black lines) mpeR mutant (MCV304) (vertical black
lines) and mpeRC strain (MCV305) (93). Time points are indicated in hours along the xaxis. Intracellular survival assays were performed in triplicate and standard deviation is
indicated above each bar. A P value of < .01 was considered statistically significant. An
asterisk (*) denotes a significant decrease in intracellular bacteria counts as compared to
the wild type is indicated by an asterisk (*).
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B. Serum starvation increases gonococcal intracellular survival
In N. meningitidis, intracellular survival increases in serum starved epithelial cells
(162). Serum starvation increases the desferal-chelatable iron pool in cultured
hepatocytes and this increase in desferal-chelatable pools is derived from degraded
ferritin (211). Therefore, bacteria that survive in serum-starved epithelial cells could be
acquiring iron from degraded ferritin. We hypothesized that if N. gonorrhoeae were
utilizing iron from degraded ferritin then they would survive in serum starved epithelial
cells similar to N. meningitidis. Gentamicin protection assays were performed as
described above, but after the initial 4 hour incubation and gentamicin treatment, the cells
were incubated in McCoy’s 5A (Gibco) alone for 24 hours to induce serum starvation.
We investigated intracellular survival under serum-deplete conditions with the following
gonococcal strains: the wild type strain (FA1090), the tonB mutant strain (MCV659), the
tdfF mutant strain (MCV659) and the mpeR mutant strain (MCV305). The tonB
(MCV656) and tdfF (MCV659) mutant strains survived as well as the wild type strain
(FA1090) (Figure 11B) both mutant strains survived within 0.5 log of the wild type
strain. The mpeR (MCV304) and mpeRC (MCV305) strains survived as well as wild type
which was observed previously in the presence of serum (Figure 11A). These results
indicate that gonococci could be utilizing iron from degraded ferritin in a TdfF- and/or a
TonB-independent manner.
C. Intracellular survival is slightly attenuated in the presence of apo-bovine
transferrin
Replication media which consisted of McCoy’s 5A and 10% FBS contains bovine
specific iron binding proteins including bovine transferrin making the media iron-deplete
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for gonococci. Previous assays demonstrated that gonococci could not replicate in this
media (113). The attenuated survival of tonB and tdfF mutant strains could be rescued
with the addition of iron to the replication media (113) (Figure 12). McCoy’s 5A alone is
not iron free and could contain significant amounts of iron to rescue the mutants, similar
to what we observed when additional iron (FeNO3) was added to replication media
(Figure 12) (113).
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Figure 12. Gonococcal mutants are rescued with the addition of excess iron
Intracellular survival in the presence of McCoy’s 5A +10% heat-inactivated FBS
supplemented with additional iron. The bars represent gonococcal survival in CFU/ml
(log10) for the following gonococcal strains: Wild type (FA1090) (black), tonB mutant
(MCV656) (checkered), tdfF mutant (MCV659) (horizontal black lines) mpeR mutant
(MCV304) (vertical black lines). Time points in hours indicated along the x-axis.
Intracellular survival assays were performed in triplicate and standard deviation is
indicated above each bar.
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To ensure that the TonB- TdfF-independent survival phenomenon that was observed in
the absence of serum was not due to extracellular iron, we performed intracellular
survival assays in which the replication media was supplemented with 40 µg/ml of apobovine transferrin. After the 4 hour infection and initial gentamicin treatment, cells were
incubated with replication media consisting of McCoy’s 5A and apo-bovine transferrin or
McCoy’s 5A, 10% FBS, and additional apo-bovine transferrin for 24 hours. The bovine
transferrin would chelate any available iron away from gonococci. The following
gonococcal strains were tested for intracellular survival in the presence of excess apobovine transferrin: the wild type strain (FA1090), the tonB mutant strain (MCV656) and
the tdfF mutant strain (MCV659). In the presence of FBS and 40 µg/ml apo-bovine
transferrin we observed similar survival phenotypes as was observed in the presence of
McCoy’s 5A and FBS (Figure 13A). Both the tonB (MCV656) and tdfF (MCV659)
strains were significantly attenuated in survival compared to the wild type strain
(FA1090) with viable counts 4 log and 1 log lower, respectively (Figure 13A). When
McCoy’s 5A only replication media was supplemented with 40 µg/ml of apo-bovine
transferrin, the tonB mutant strain still survived but was slightly attenuated compared to
wild type. We also observed a slight attenuation in survival of the tdfF mutant strain
compared to the wild type in the absence of FBS. The decreased survival of the ton and
tdfF mutant strains was not significant in the McCoy’s 5A + apo-bovine transferrin
(Figure 13B) compared to the observed attenuation in the presence of FBS with
additional apo-bovine transferrin (Figure 13A). One possible explanation for this
phenomenon is that the addition of 40 µg/ml of apo-bovine transferrin was not enough to
chelate all the excess iron in the McCoy’s 5A replication media and therefore the mutants
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were being rescued by any remaining unbound iron. Another possible interpretation of
these results is that the bovine-transferrin was delivering any iron in McCoy’s 5A to the
ME180 epithelial cells. This would decrease ferritin degradation and increase
intracellular stores within the ferritin. Gonococci can not acquire iron directly from
ferritin (10, 41). If gonococci were tapping into iron from degraded ferritin then a
decrease in ferritin degradation could contribute to the lower level of survival in the
presence of apo-bovine transferrin in McCoy’s 5A alone.
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Figure 13. Intracellular survival in the presence of apo-bovine transferrin
A) Intracellular survival in the presence of McCoy’s 5A +10% heat-inactivated FBS with
an additional 40µg/ml apo-bovine transferrin. The bars represent gonococcal survival in
CFU/ml (log10) for the following gonococcal strains: wild type (FA1090) (black), tonB
mutant (MCV656) (checkered) and tdfF mutant (MCV659) (horizontal black lines). Time
points in hours indicated along the x-axis. Intracellular survival assays were performed in
triplicate and standard deviation is indicated above each bar. A P value of < .01 and <
.05 was considered statistically significant. A significant decrease in intracellular
bacteria compared to wild type by P<.01 is indicated by an asterisk (*) and a significant
decrease in survival compared to wild type at P<.05 is indicated by (@).
B) Intracellular survival in the presence of McCoy’s 5A with an additional 40µg/ml apobovine transferrin. The bars represent intracellular survival in CFU/ml (log10) for the
following gonococcal strains: FA1090 (black), tonB mutant (MCV656) (checkered) and
tdfF mutant (MCV659) (horizontal black lines). Time points in hours indicated along the
x-axis. Intracellular survival assays were performed in triplicate and standard deviation
is indicated above each bar. A P value of < .01 and < .05 was considered statistically
significant. A significant decrease in intracellular bacteria compared to wild type by
P<.01 is indicated by an asterisk (*) and a significant decrease in survival compared to
wild type at P<.05 is indicated by (@).
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D. Addition of ascorbate inhibits gonococcal intracellular survival in the presence of
FBS
Ferritin cannot be a direct iron source for Neisseria (10, 41) however if the ferritin
were degraded, the subsequently released iron could be acquired by the bacteria.
Meningococcal infections cause ferritin to cluster (162) within the cytoplasm similar to
what is observed when the epithelial cell needs to utilize iron from ferritin (234). N.
meningitidis also induce ferritin degradation within host epithelial cells (162). Ferritin
degradation can be pharmacologically blocked with the addition of ascorbate (vitamin C)
or leupeptin. The biosynthesis of ferritin and the rate of iron taken up by transferrin are
not affected by the presence of ascorbate. However, ascorbate does prevent autophagy of
ferritin and its subsequent degradation in several cell types (38, 131, 211). During N.
meningitidis infection, cells treated with ascorbate exhibit a decrease in intracellular
meningococci and increased levels of ferritin compared to untreated epithelial cells (162).
We hypothesized that if gonococci were accessing iron from degraded ferritin,
then survival would be attenuated in the presence of ascorbate similarly to what was
observed in N. meningitidis. We performed gentamicin protection assays in which the
replication media was supplemented with 200 µM ascorbate. This concentration of
ascorbate inhibited intracellular ferritin degradation (38, 131) but did not affect
gonococcal survival in the replication media alone (data not shown). Using the wild type
strain (FA1090) we performed parallel intracellular survival assays in which the
replication media was one of the following: McCoy’s 5A + 10% FBS, McCoy’s 5A +
10% FBS supplemented with 200 µM ascorbate or McCoy’s 5A + 10% FBS
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supplemented with 10 µM leupeptin. When ascorbate was added to replication media
containing McCoy’s 5A and FBS there was a significant decrease in gonococcal survival
with a decrease of 1.2 log in viable counts (Figure 14A) indicating that gonococcal
survival could be dependent on iron from ferritin degradation. We were also interested in
the intracellular survival of the wild type gonococci in the presence of leupeptin, a
lysosomal protease inhibitor. Interestingly there was only a slight decrease in
intracellular survival in the presence of 10µM leupeptin with a decrease by 0.2 logs
(Figure 14A). In N. meningitidis, intracellular survival was attenuated in the presence of
leupeptin, but leupeptin only partially prevented ferritin degradation (162). Therefore, in
our experiments, in the presence of leupeptin, ferritin could be partially degraded and still
acting as a potential iron source for the intracellular bacteria.
We also investigated the effect of ascorbate and leupeptin when gentamicin
protection assays were performed with replication media containing McCoy’s 5A in the
absence of FBS. We performed gentamicin protection assays using the wild type strain
(FA1090) under the following conditions: McCoy’s 5A + 10% FBS, McCoy’s 5A alone,
McCoy’s 5A supplemented with 200µM ascorbate, or McCoy’s 5A supplemented with
10µM leupeptin. We previously observed that gonococci survived in a Ton and TdfFindependent manner in the absence of FBS. We correlated increased survival phenotype
in these mutants with the rationale that serum starved cells had degraded their ferritin and
gonococci were utilizing the subsequent stored iron in a receptor and TonB-independent
manner. We expected a decrease in survival in the presence of both ascorbate and
leupeptin since both have been proven to decrease ferritin degradation in epithelial cells
(38, 244). Surprisingly, gonococci survived very well in the presence of both ferritin
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degradation inhibitors (Figure 14B). Neither ascorbate nor leupeptin decreased
gonococcal wild type (FA1090) intracellular survival indicating that the TonB and TdfFindependent survival we had previously observed was not due to acquisition of iron from
degraded ferritin.
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Figure 14. The effect of ascorbate and leupeptin on gonococcal strain FA1090
intracellular survival
A) Intracellular survival assay for gonococcal strain FA1090. The bars represent
intracellular survival in CFU/ml (log10) in which the replication media contains:
McCoy’s 5A+10% FBS (black bar with white hatch mark pattern) McCoy’s
5A+10%FBS + 200µM ascorbate (checkered pattern) or McCoy’s 5A+ 10% FBS +
10µM leupeptin (black and white horizontal stripes). Time points in hours indicated
along the x-axis. All intracellular survival assays were performed in triplicate and the
standard deviation is indicated above each bar. A P value of < .05was considered
statistically significant. A significant decrease in intracellular bacteria compared to wild
type in cell culture media alone by P<.05 is indicated by (@).
B) Intracellular survival assays for gonococcal strain FA1090.The bars represent
intracellular survival in CFU/ml (log10) in which the replication media contains:
McCoy’s 5A + 10% FBS (black bars with white hatch mark pattern), McCoy’s 5A alone
(solid black), McCoy’s 5A + 200uM ascorbate (checkered pattern) or McCoy’s 5A+
10µM leupeptin (black and white horizontal stripes). Time points in hours indicated
along the x-axis. All intracellular survival assays were performed in triplicate and the
standard deviation is indicated above each bar. A P value of < .05 was considered
statistically significant. A significant decrease in intracellular bacteria compared to wild
type in cell culture media alone by P<.05 is indicated by (@).
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E. Intermediate levels of Ton-independent growth in the presence of 2,5- and 2,3DHBA
TdfF was originally identified as a TonB-dependent transporter due to its
homology to FhuE (286) which is a TonB-dependent siderophore transporter in E. coli,
(252). FhuE is required for the uptake of iron from the hydroxamate siderophores
coprogen, ferrioxamine B and rhodotorulic acid by E. coli (119, 152). N. gonorrhoeae do
not secrete siderophores; however, the bacteria can utilize siderophores produced by
other bacteria, known as xenosiderphore utilization. Enterobactin, a catecholate
siderophore produced by E. coli is utilized by N. gonorrhoeae in a TonB-dependent
receptor mediated way (43). Based on the homology that TdfF shares with the
siderophore receptor of E. coli, we hypothesized that gonococci could utilize a host
derived siderophore-like molecule in a TonB- or TdfF-dependent manner. Recently a
gene encoding a protein important for mammalian siderophore biosynthesis was
identified (75). This siderophore-like molecule has a 2, 5-dihydroxybenzoic acid
(DHBA) binding moiety which is similar to the bacteria derived siderophore,
enterobactin which has a 2, 3-DHBA binding moiety (240). Therefore we investigated the
utilization of ferrated 2, 3- and 2, 5-DHBA with plate bioassays. In these assays,
gonococci were streaked out onto chemically defined, iron chelated growth media. Wells
were bored into the media and each iron source tested was added to these wells. Growth
in millimeters around each iron source was measured and an indication that gonococci
utilize the iron sources. Growth in the presence of ferrated 2, 3- and 2, 5-DHBA was
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analyzed in the following strains: the wild type strain (FA1090), the tonB mutant strain
(MCV656), the tdfF mutant strain (MCV659), the fetA mutant strain (FA6959), and
mpeR mutant strain (MCV304). FetA was identified as a TonB-dependent
xenosiderphore receptor important for enterobactin utilization (43). Ferric citrate was
used as a positive control since gonococci utilize it as an iron source in a Tonindependent manner. Bovine transferrin was used as a negative control because
gonococci do not use it as an iron source (63, 263). Dihydroxybenozic serine dimer (D2)
is an enterobactin derivative and was used as a TonB-dependent control since gonococci
could only utilize this xenosiderphore in a FetA, TonB-dependent manner (see chapter 4).
Figure 15 shows growth zones in millimeters detected around each iron source indicating
iron source utilization. As expected, D2 utilization was TonB and FetA dependent. When
comparing growth of the wild type in the presence of D2, a growth zone of 30 mm was
observed whereas growth zones of 19mm and 16mm were observed for 2,3-DHBA and
2,5-DHBA (Figure 15). There seems to be a slight increase in growth zones around 2,3DHBA compared to 2,5-between the gonococcal strains tested (Figure 15). The wild
type and mutant gonococcal strains exhibited similar intermediate growth in the presence
of ferrated 2, 3-DHBA and 2,5-DHBA compared to iron sources known to be utilized.
These results imply that N. gonorrhoeae could utilize iron from these compounds
however less efficiently compared to known iron sources and in a TonB- receptorindependent manner.
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Figure 15. Utilization of 2, 3-DHBA and 2, 5-DHBA by gonococcal strain FA1090
CDM plates were supplemented with apo-bovine transferrin to chelate any iron in the
growth media. Wells within the plates were inoculated with 10µl of the following iron
sources: D2: dimer form of dihydroxybenzoylserine, 2, 3-DHBA, Ferric citrate (+), 2, 5DHBA, apo-bovine transferrin. Each bar indicates growth in millimeters around each iron
source. Bars represent the growth zone of the following strains: wild type (FA1090)
(black), fetA mutant strain (FA6959) (checkered), tonB mutant strain (MCV656) (gray),
mpeR mutant strain (MCV304) (93) or tdfF mutant strain (MCV659) (horizontal stripes).
Horizontal dotted line indicates the limit of detection because it is the diameter of the
well containing each iron source. Plate bioassay was only performed once in triplicate.
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III. Discussion
N. gonorrhoeae, an obligate human pathogen, has a diverse array of iron
acquisition systems for utilization of host extracellular iron sources. For a review see
(65). Gonococci also possess a pathogen specific gene that codes for a TonB-dependent
transporter, TdfF (184, 266). Attenuated intracellular survival was demonstrated by the
tdfF mutant strain and was rescued with the addition of iron indicating this transporter
was important for intracellular iron acquisition (Figure 11) (113).
AraC-like regulators have been shown to be important for host cell invasion. In
Salmonella enterica serovar Typhimurium, which is a major cause of gastroenteritis,
multiple transcriptional regulators have been identified that activate the expression of
invasion genes in response to both environmental and genetic regulatory factors (144).
Two of these transcriptional regulators, HilC and HilD are predicted to be members of
the AraC/XylS family of transcriptional activators, based on homology within their Cterminal domains that contain a characteristic helix-turn-helix DNA binding motif (79,
237, 256). A mutation in hilD results in 53-fold decrease in invasion of cultured epithelial
cells and a mutation in hilC also results in attenuated invasion of host epithelial cells
(256). The host specific signals sensed by these AraC-like regulators have not been
identified (144). AraC-like regulators also play a role in iron acquisition in other
microorganisms including Y. pestis and B. pertussis (16, 87). In these systems the AraClike regulator is Fur regulated and once the inducing molecule is sensed under irondeplete conditions, the AraC-like regulator activates the iron acquisition system. Within
close proximity to tdfF on the gonococcal chromosome is the gene mpeR which encodes
an AraC-like transcriptional regulator (Figure 10). MpeR plays a role in the regulation of
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hydrophobic agent efflux pumps mediated by the Mtr system (92). MpeR is iron
regulated and contains a confirmed Fur box (78, 139). This suggests that MpeR could
modulate iron acquisition systems such as TdfF. If MpeR did regulate tdfF expression
we would expect a change in intracellular survival phenotype in the mpeR mutant strain
(MCV304). For example, if MpeR acted as an activator for tdfF expression then the
mpeR mutant strain (MCV304) should exhibit decreased intracellular survival. However,
if MpeR repressed tdfF expression then we would expect the opposite in which the mpeR
mutant strain (MCV304) would exhibit increased intracellular survival. During our in
vitro intracellular survival assays the mpeR mutant (MCV304) survived as well as the
wild type strain suggesting that it does not regulate tdfF (Figure 11). One possible
explanation for this outcome is that MpeR may be under the control of another regulator.
AraC-like regulators are often part of complex regulatory cascades involving hierarchal
induction of sequential regulators in response to multiple signals. Additionally, it has
been reported that the intergenic region between mpeR and tdfF contained two Fur boxes
and that this intergenic region could serve as two divergent promoters (84). If the bacteria
were under iron-replete conditions within the intracellular environment, then the
expression of mpeR would be repressed and thus the wild type (FA1090) would not
express MpeR similar to the mpeR mutant strain (MCV304). Recently, an in vitro study
using S1 nuclease protection assays showed no differential regulation of the genes cotranscribed with tdfF in meningococcal mutant strains either lacking or over expressing
mpeR (84). This study concluded that MpeR was not involved in the regulation of the
putative tdfF operon under in vitro conditions (84).

125
Since a ligand is expected bind to the N-terminal portion of an AraC-like
regulator before it can act as a regulator, the signal specific for MpeR regulation could be
missing in our in vitro assays as well. In the absence of this inducing ligand, MpeR would
not repress or activate tdfF expression and a change in intracellular survival between wild
type and mpeR mutant strains would not be observed.
TdfF was first identified in the N. gonorrhoeae FA1090 genome database by
comparing its amino acid sequence to a panel of characterized TonB-dependent receptors
(286). TdfF has an amino acid identity of 30% to the E. coli siderophore receptor FhuE
(252, 286). Since tdfF expression is host specific and encodes a receptor similar to a
siderophore receptor in E. coli, we hypothesized that the ligand for TdfF was host derived
and possibly a mammalian siderophore-like molecule. Mammalian cells have
homologous genes to those that encode siderophores in E. coli. A small molecule
identified in mammalian cells through gas chromatography-mass spectrometry contains a
2, 5-dihydroxybenzoic acid (DHBA) moiety (75). Dihydroxybenozic acid is incorporated
into various bacterial derived siderophores. 2,3-DHBA is the iron-binding moiety of
bacterial enterobactin (240) and similar to 2,3-DHBA, 2,5-DHBA can chelate iron (75).
As previously stated, DHBA is a binding moiety that contains a carboxylic acid group by
which the ring attaches to various scaffolds via amide linkages. Enterobactin consists of
three dihydroxybenzoic acid subunits (2,3-DHBA) linked together with serine backbone
(208). Gonococcal strain FA1090 utilized the xenosiderophore enterobactin through a
FetA, TonB-dependent mechanism (43). TonB-independent siderophore utilization has
also been observed for xenosiderophores in other gonococcal strains (273). Therefore we
investigated whether gonococcal strain FA1090 could utilize 2, 5-DHBA and if
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utilization was TonB- and/or TdfF-dependent, potentially identifying the ligand for TdfF.
Gonococci utilized both ferrated 2,5- and 2,3-DHBA in a Ton- FetA- and TdfFindependent manner (Figure 15). For wild type strain FA1090, DHBA derivatives were
utilized at intermediate levels in comparison to the positive control or DHBS dimer (D2)
(Figure 15). It is possible that the intermediate growth observed in the presence of DHBA
was because the TonB-dependent receptors did not recognize the iron binding moieties
alone. Perhaps, the xenosiderophore receptor recognized the amino acid side chains
associated with the DHBA binding moiety. In E. coli the TonB-dependent receptor for
enterobactin, FepA, is an outer membrane transporter with eleven surface exposed loops
at the entrance of the membrane channel. FepA transports the catecholate enterobactin,
but no other catecholates, nor any non-catecholate compounds (8, 42). Studies in which
the 11 surface loops are mutagenized indicate that the receptor's loops enwrap the ferric
siderophore at binding equilibrium and this interaction is specific to the siderophore
amino acid backbone (8, 42). The gonococcal TonB-dependent xenosiderophore
receptors may have a similar discrimination for specific catecholate iron sources and may
still recognize and utilize iron from the intact putative mammalian siderophore even if it
does not utilize iron from the binding moiety within the siderophore. The TonBindependent intermediate levels of growth observed through the plate bioassays may be
due to an alternative uptake pathway that involves the periplasmic ABC transport system,
FbpABC and porin acting as the outer membrane portal for the ferrated DHBA
derivatives as well as free iron. This Ton-independent pathway has been identified in
gonococcal strain FA19 (273) and we hypothesized that gonococcal strain FA1090 uses
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both a TonB-, receptor dependent pathway as well as a Ton-independent FbpABC
pathway for iron utilization from xenosiderophores.
Another potential iron source for intracellular gonococci could be degraded
ferritin. Ferritin cannot directly act as an iron source for Neisseria (10, 41). However,
iron from degraded ferritin could be utilized by gonococci when bound to a protein or
transport molecule that was involved in the trafficking from degraded ferritin to the
cellular cytosol. During meningococcal infections, ferritin is redistributed within the
epithelial cells to where the meningococci are located (162). Ferritin is also degraded
during meningococcal infections and iron previously contained within ferritin is released
as a low-molecular-weight species during infection (162). Preventing ferritin degradation
with the use of ascorbate or leupeptin reduces meningococcal intracellular replication
(162). Thus during infection, meningococci could possibly access the iron stored by
ferritin bound to a low molecular weight iron transporter. Epithelial cells infected with N.
gonorrhoeae exhibited an altered distribution of surface and cycling transferrin receptors
as well as reduced internalization of ferrated transferrin (31). A reduction in transferrin
cycling by the epithelial cells would lead to iron-deplete conditions for the cell and
ferritin degradation. Therefore we hypothesized that N. gonorrhoeae intracellular
survival was dependent on iron stored within the cytosolic ferritin. We first investigated
intracellular survival in serum starved cells.
Serum starvation increased desferal-chelatable pools derived from degraded
ferritin within the epithelial cell (211). We observed an increase in intracellular survival
in the absence of FBS amongst all gonococcal strains tested indicating that gonococci
could access iron from desferal-chelatable pools in a TonB- TdfF-independent manner
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(Figure 11B). Excess apo-bovine transferrin was added to the replication media to
chelate any excess iron in the McCoy’s 5A cell culture media and resulted in a TonBTdfF- independent survival (Figure 13B). We hypothesized that the bovine transferrin
was not chelating all the excess iron in the McCoy’s 5A media and we were observing an
iron induced invasion (Figure 12). An alternative hypothesis was that the excess bovine
transferrin was chelating any excess iron away from gonococci and delivering it to the
epithelial cells, preventing ferritin degradation due to the influx of iron. To elucidate the
mechanism of increased survival in the absence of FBS we performed intracellular
survival assays in the presence of the ferritin degradation inhibitors ascorbate and
leupeptin. Neither inhibitor affected intracellular survival indicating that the survival
observed in the presence of McCoy’s 5A was not dependent on iron originating from
ferritin (Figure 14B). We suspect that the TonB- TdfF- independent survival observed in
the presence of McCoy’s 5A alone is due to excess iron within the media. McCoy's 5A
medium was originally developed for the growth of Novikoff hepatoma cells. It is a
general purpose medium for both primary and established cell lines (293). McCoy’s 5A
contains inorganic salts, amino acids, vitamins, peptone, glutamine and glucose. Iron is
not a component of McCoy’s 5A; however, iron is not chelated and iron could be in any
of the media’s ingredients. The addition of fetal bovine serum to McCoy’s 5A chelated
any free iron due to bovine specific serum iron binding proteins. We concluded that
McCoy’s 5A media supplemented with 10% heat-inactivated FBS has the lowest amount
of free iron for gonococci to utilize, McCoy’s 5A media supplemented with 40ug/ml apobovine transferrin has an intermediate amount of free iron, and McCoy’s 5A media has
the freest iron when comparing all three media. Hence, the difference in intracellular
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survival phenotypes in the various media could be due to gonococci acquiring free iron
from these media.
When investigating intracellular survival in the presence of FBS, we confirmed
previous findings that survival is both TonB- and TdfF- dependent (113, 161) (Figure
10A) and it was dependent on iron acquisition (Figure 11). Interestingly, in the presence
of FBS we did observe attenuated gonococcal growth in the presence of ascorbate (Figure
14A). One conclusion we can draw from this result was that when intracellular iron was
the only source of iron available to gonococci, the host cell must first degrade ferritin
before gonococci could use the iron contained within the ferritin core. However, if
ascorbate prevented intracellular survival, then why did we not observe a difference in
survival in the presence of Leupeptin? Leupeptin inhibits lysomal protease and also
prevents ferritin degradation. We may have been observing an indirect effect by
ascorbate that did not involve ferritin degradation. Ascorbate can also complex with iron
and could be sequestering iron from the gonococci during the infection. Then the
observed effect that ascorbate had on gonococcal infection would not be due to lack of
iron from degraded ferritin but rather survival under iron deplete conditions.
If gonococci were acquiring iron originating from degraded ferritin then it would
still be assumed that ferritin degradation leads to the production of another iron-binding
protein that was used by the bacteria. As investigations into cellular iron metabolism
continue it will be important to determine if these iron transport protein/molecules could
be hijacked by N. gonorrhoeae.
In conclusion we determined that gonococci could utilize iron from iron binding
moieties commonly found in bacterial siderophores and a mammalian siderophore in a
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Ton and receptor-independent manner. We also determined that ascorbate inhibits
intracellular gonococcal survival which could be due to the inhibition of ferritin
degradation or iron sequestration by the ascorbate. Finally, MpeR did not play a role in
intracellular survival in these in vitro assays. Future studies on understanding gonococcal
intracellular iron acquisition would provide a clear picture of intracellular pathogenesis
caused by N. gonorrhoeae.
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Chapter 5 The IRON-REPRESSED, AraC-LIKE REGULATOR, MpeR,
ACTIVATES EXPRESSION OF fetA IN Neisseria gonorrhoeae

I. Introduction
Neisseria gonorrhoeae is an obligate human pathogen that primarily infects the
urogenital or anorectal mucosa following intimate contact. N. gonorrhoeae is the
etiological agent of gonorrhea, which is the second most commonly-reported, notifiable
infectious disease in the United States. In 2009, the Centers for Disease Control and
Prevention reported a total of 301,174 cases of gonorrhea in the United States(48);
however, this is thought to be a conservative estimate due to underreporting. In men, a
gonococcal infection is characterized by acute urethritis with symptoms that include
purulent discharge and dysuria. It is estimated that up to 80% of women infected with N.
gonorrhoeae are asymptomatic or present with very minor symptoms (190). Women
with symptomatic disease experience cervicitis and vaginal discharge. When left
untreated, due to the asymptomatic nature of the infection in women, the bacteria can
ascend to the upper female genital tract. This ascending infection can result in pelvic
inflammatory disease, which may lead to ectopic pregnancy or infertility (203, 267). The
Centers for Disease Control currently only recommends extended-spectrum
cephalosporins for treatment due to increased antimicrobial resistance to all previously-
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recommended therapies(50, 138, 172). Unfortunately, resistance to this class of
antimicrobial agent has already emerged (48). N. gonorrhoeae infections do not elicit
protective immunity and there is evidence that gonococcal infections increase the spread
of HIV(60, 188). Since gonococcal disease poses a significant public health challenge, it
is important to understand the pathogenesis of N. gonorrhoeae in order to identify new
therapies.
Iron is an essential macronutrient for most microorganisms including the
Neisseriae (37). Many microorganisms acquire iron from the human host by synthesizing
and secreting siderophores. Siderophores are low-molecular weight iron-chelating
molecules that scavenge iron from the environment or host iron binding proteins. N.
gonorrhoeae does not synthesize siderophores but instead obtains iron directly from
human iron binding proteins including transferrin, lactoferrin, and hemoglobin in a
receptor-mediated mechanism (25, 53, 64, 163). Expression of either the transferrin or
lactoferrin receptor by N. gonorrhoeae is necessary to establish infection in human male
volunteers (5, 66). Gonococci can also hijack siderophores produced by other bacteria,
which is known as xenosiderophore utilization. It has been previously demonstrated that
strains of gonococci can obtain iron from the xenosiderophores enterobactin, aerobactin,
and salmochelin, which are all synthesized by enteric bacteria (43, 273, 303).
Iron acquisition is tightly regulated since excess iron can promote Haber-WeissFenton chemistry, creating highly reactive, toxic hydroxyl radicals within the cell (115).
In many bacteria including N. gonorrhoeae, the ferric uptake regulator (94) acts as a
transcriptional regulator for iron acquisition genes. Under iron-replete (+Fe) conditions,
a dimer of Fur binds to its co-repressor, ferrous iron, and assumes a DNA binding
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conformation. The Fur-Fe2+ complex binds to a specific DNA sequence called the Fur
box found in the promoter regions of iron regulated genes (13). Once Fur is bound to the
Fur box it blocks gene transcription. As intracellular iron stores become depleted, apoFur dissociates from the Fur box allowing RNA polymerase to bind to the promoter and
transcribe the Fur regulated gene (83). Gonococcal Fur not only regulates iron
acquisition genes but also impacts the expression of a broad range of genes including
those that encode Opa proteins, NADH dehydrogenase, sodium pumps and other
transcriptional regulators (139). The regulation of genes involved in iron acquisition,
adhesion and metabolism establishes Fur as a global regulator (139, 264).
Fur may not be the sole transcriptional regulator of iron acquisition systems in N.
gonorrhoeae. AraC-like regulators operate as both positive and negative regulators of
iron acquisition systems in other microorganisms including Pseudomonas aeruginosa,
Yersinia pestis, and Bordetella (16, 87, 127, 227). In these microorganisms, the AraClike regulator functions as a transcriptional regulator of siderophore biosynthesis and
acquisition genes. The mechanism of AraC-like regulation of siderophore genes involves
the cognate siderophore functioning as a co-inducer. The AraC-like regulator is under the
transcriptional control of Fur and therefore AraC-like regulation occurs under iron
deplete conditions. The gonococcal genome encodes multiple AraC-like regulators and it
has been recently demonstrated that one of these regulators, MpeR (92) is Fur regulated
(139).
In this study, we demonstrate that MpeR, an iron-regulated AraC-like regulator is
required for up-regulated expression of the outer membrane transporter, FetA, in
gonococcal strain FA1090. We also establish that fetA is part of an iron regulated operon
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that encodes a periplasmic binding protein and components of a putative ABC transport
system; however, only fetA but not the downstream genes require MpeR for detectable
expression. Additionally, we determined that gonococcal strain FA1090 acquires iron
from enterobactin, enterobactin derivatives and salmochelin S2 in a FetA- and TonBdependent manner and identified genetic differences between strains that could clarify the
Ton-dependent and Ton-independent pathway for xenosiderophore utilization.
Expression of MpeR was necessary to achieve maximal growth on these siderophores,
but none of the utilizable iron sources appear to act as a co-inducer for MpeR-dependent
activation of fetA.
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II. Results
A. The mpeR mutant displays differential protein expression under iron-deplete
conditions The mpeR gene was originally identified by Folster et al. as encoding an
AraC-like regulator that plays a role in the coordinate expression of hydrophobic agent
efflux pumps (92). We began investigating whether MpeR plays other regulatory roles in
gonococci due to its proximity to a gene that encodes an uncharacterized TonBdependent transporter, TdfF(113). We initially determined that mpeR was iron regulated,
which was recently confirmed by Jackson et al. via microarray, FURTA assays, and the
presence of a Fur box in its promoter (139). We hypothesized that since MpeR is iron
regulated, it could also regulate iron acquisition systems in gonococci, particularly the
one putatively encoded by the tdfF locus. To test this hypothesis, the wild type (FA1090)
and mpeR mutant (MCV304) were grown under iron-deplete (-Fe) and iron-replete (+Fe)
conditions and total membrane protein fractions were isolated. Using SDS-PAGE
analysis, we determined that an 80 kDa protein was expressed by the wild-type strain
only under iron-deplete conditions, but this protein was not detectable in the mpeR
mutant strain (Figure 16A). The 80 kDa band was excised from the gel and analyzed by
mass spectrometry, which unambiguously identified the protein as FetA. Western blot
analysis of total membrane proteins isolated from the wild type (FA1090), mpeR mutant
(MCV304), fetA mutant (FA6959), and mpeRC (MCV305) grown under iron-deplete (-)
and iron-replete (+) conditions were used to confirm the mass spectrometry results. The
wild-type and complemented strains grown under iron-deplete conditions expressed
detectable levels of FetA, whereas neither the fetA mutant nor the mpeR mutant expressed

136
this protein (Figure 16B). From this analysis, we concluded that the iron-regulated AraClike regulator, MpeR, controls the expression of FetA in gonococcal strain FA1090.
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Figure 16. FetA expression is regulated by MpeR
A) SDS-PAGE analysis of protein expression. Total membrane proteins were isolated
from WT (FA1090) and mpeR mutant (MCV304) strains grown under iron-deplete (-)
and iron-replete (+) conditions for 4 hours. Proteins were separated on a 7.5%
acrylamide gel. The arrow on the left indicates the band that was excised and identified
as FetA by mass spectrometry analysis. The position of molecular weight markers is
indicated on the right.
B) Western blot analysis of FetA expression. The WT (FA1090), mpeR mutant
(MCV304), fetA mutant (FA6959) and the complemented mpeRC strain (MCV305) were
grown under iron-deplete (-) and iron-replete (+) conditions. Total membrane proteins
from each strain were isolated and standardized before being separated by SDS-PAGE
and then transferred to nitrocellulose. Blots were probed with an anti-FetA monoclonal
antibody.
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B. fetA transcription requires MpeR expression and iron-deplete growth conditions
fetA, previously called frpB, encodes a TonB-dependent outer membrane transporter
(FetA) that is immunogenic, and subject to Fur regulation (20, 43, 219, 283). FetA was
renamed by Carson et al. when they discovered that this transporter was necessary for
efficient ferric-enterobactin transport (43). To determine whether MpeR transcriptionally
regulates fetA, end-point relative RT-PCR was utilized to detect fetA and mpeR
transcripts. RNA was isolated from gonococcal strains grown under iron-deplete (-) and
iron-replete (+) conditions. Transcripts from fetA and mpeR were detected in the wildtype strain preferentially under iron-deplete conditions (Figure 17), consistent with
previous published studies (44, 139). The fetA transcript was not detected in the mpeR
mutant (MCV304). In the mpeRC strain (MCV305), both mpeR and fetA transcripts were
detected (Figure 17) indicating that the MpeR effect on fetA expression was restored by
complementation. Expression of mpeR in the mpeRC strain (MCV305) was iron
regulated (Figure 17), consistent with the presence of iron-sensitive regulatory signals in
the sequence upstream of the MpeR start codon, which were included in the
complementation construct. Overall, these data allow us to conclude that MpeR is
necessary for fetA expression under iron-deplete conditions.
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Figure 17. MpeR activates fetA transcription under iron-deplete conditions The WT
(FA1090), fetA mutant (FA6959), mpeR mutant (MCV304), and the complemented
mpeRC strain (MCV305) were grown under iron-deplete (-) and iron-replete (+)
conditions. RNA samples isolated from each gonococcal strain were analyzed for
expression of fetA and mpeR by RT-PCR. 16S rRNA (16S) was used as a positive control
because it was constitutively expressed under all growth conditions. Expression of 16S
rRNA in the absence of reverse transcriptase, (16S (-)) was used as a negative control.
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Real time RT-PCR was employed to confirm the end-point RT-PCR results and to
quantify the level of gene expression. All CT values were normalized to rmpM gene
expression and then fold change was determined using the relative CT method (179). The
rmpM gene encodes an outer membrane protein that is constitutively expressed under all
growth conditions tested in this study. In Table 4, the average fold change is shown,
representing the comparison between expression under iron-deplete and iron-replete
conditions or expression by wild-type and mutant under iron deplete conditions. As
expected, the fold change in expression under iron deplete vs. iron replete conditions was
large for both fetA and mpeR (97-fold for fetA and 198-fold for mpeR; Table4). When the
wild type and its isogenic fetA mutant were compared, there was 194-fold more fetA
expression in the wild type (Figure 18A). mpeR expression was unaffected in the fetA
mutantm (Figure 18). When the wild type and the mpeR mutant were compared, there
was a 117-fold change in fetA expression (Table 4), which is consistent with the inability
to detect fetA transcripts in the mpeR mutant as observed by qualitative RT-PCR (Figure
17). As shown in Table 4 and Figure 18B, the restoration of the mpeR gene in the mpeRC
strain resulted in mpeR expression levels that approached that of the wild-type (1.9 fold
difference between wild-type and the mpeRC strain). Commensurate with the return of
mpeR expression, we detected an increase in FetA expression in the mpeRC strain relative
to the mpeR mutant (Table 4), again supporting the relative RT-PCR data (Figure 17).
Together, the expression data support the previous observations that both fetA and mpeR
are iron regulated (20, 139) and furthermore demonstrate that mpeR expression was not
impacted by the fetA mutation. Results from the relative and real-time expression studies
establish that when mpeR was absent, fetA expression decreased and when mpeR
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expression was restored by complementation with a wild-type copy, fetA levels returned
to near wild-type levels under iron-deplete conditions. Cumulatively, these data indicate
that MpeR is necessary for fetA transcription under iron-deplete conditions.
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Figure 18. Real time RT-PCR analysis for MpeR activation of fetA expression under
iron-deplete conditions
A. Normalized fetA gene expression ratio. Average fold change of fetA expression for
each comparison is shown. Bars represent the median fold change for the following
comparisons: WT-Fe/WT+Fe (gray bars) WT-Fe/ FA6959-Fe (checkered bars), WTFe/MCV304-Fe (horizontal striped bar), WT-Fe/MCV305-Fe (vertical striped bar) and
WT-Fe/MCV306-Fe (white bar). The median fold change is detected from three
independently-conducted real time RT-PCR assays. Numerical values from all three
assays indicated in Table 4.
B. Normalized mpeR gene expression ratio. Average fold change of mpeR expression for
each comparison is shown. Bars represent the median fold change for the following
comparisons: WT-Fe/WT+Fe (gray bars) WT-Fe/ FA6959-Fe (checkered bars), WTFe/MCV304-Fe (horizontal striped bar), WT-Fe/MCV305-Fe (vertical striped bar) and
WT-Fe/MCV306-Fe (white bar). The median fold change is detected from three
independently-conducted real time RT-PCR assays. Numerical values from all three
assays indicated in Table 4.
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TABLE 4. Effects on fetA and mpeR expression measured by real time RT-PCR.
Comparison
WT-Fe / WT+Fe
WT-Fe / FA6959-Fe
WT-Fe / MCV304-Fe
WT-Fe / MCV305-Fe
WT-Fe / MCV306-Fe
1

Normalized target gene expression ratio
fetA
mpeR
97 (103-83)1
198 (301-106)
194 (209-167)
2.2 (3.1-.6)
117 (185-33)
62 (123-46)
9.6 (15-5)
1.9 (2.4-1.3)
108 (154-70)
37 (45-26)

Average fold change for each comparison is shown, with the range detected among
three independently-conducted real time RT-PCR assays shown in parentheses.
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C. Specific binding of MpeR to DNA upstream of fetA
In order to determine whether MpeR-dependent fetA regulation occurred as a
result of direct interaction, we used EMSA to test whether MpeR bound to target DNA
sequences upstream of the FetA start codon. Results from preliminary EMSA
experiments using increasing amounts of MBP-MpeR (1-10 µg) incubated with the
radiolabeled fetA probe showed shifting of a DNA fragment of 500 bp in length (data not
shown). This upstream region was further divided into two smaller DNA fragments of
250 bp in length (Figure 18A), both of which were tested for MpeR interaction by
EMSA. The probe fragment corresponding to the most upstream portion of the intergenic
region (fetA1, Figure 19A) was shifted by addition of MpeR protein (Figure 19B).
However, the probe fragment corresponding to the sequence immediately preceding the
fetA start codon (fetA2; Figure 19B) was not shifted in the presence of MpeR (data not
shown). In order to determine whether MpeR binding upstream of fetA was specific, a
competitive EMSA experiment was performed in which increasing amounts (2-20X) of
excess unlabeled specific (fetA) or non-specific (rnpB) DNA fragments were added to the
binding reaction. The results demonstrate that the specific competitor, but not the nonspecific competitor, reduced binding of MpeR to the labeled fetA probe (Figure 19B).
The unlabeled fetA2 sequence modestly competed with the binding of MpeR to the fetA1
probe, suggesting that MpeR may bind preferentially to fetA1 sequence and with a lower
affinity to the fetA2 sequence. Cumulatively, these results allow us to conclude that
binding of MpeR to the DNA sequence upstream of fetA is specific and that its capacity
to activate fetA expression is likely by a direct mechanism.
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Figure 19. MpeR binds upstream of fetA in a specific manner
A) Sequence of the 500-base pair, intergenic region immediately upstream of fetA. The
sequence highlighted in teal is contained within the fetA1 probe employed for the EMSA
shown in panel B. The sequence highlighted in yellow is contained within the fetA2
competitor DNA. The sequence highlighted in blue is contained in both fetA1 and fetA2
amplicons. The Fur-binding site (139) is highlighted in gray. The previously-mapped
(14) promoter elements (underlined) and transcriptional start site (asterisk below
nucleotide) are identified. The start codon for FetA is shown in red.
B) 5 nanograms of the 250-base pair, labeled fetA1 probe (lane 1) was incubated with 10
µg of MBP-MpeR in the absence of unlabeled competitor (lane 2) or in the presence of 2,
10 or 20X excess unlabeled competitor DNA. Lanes 3-5 contain reactions including
increasing concentrations of the specific competitor (fetA1); lanes 6-8 contain reactions
including increasing concentrations of fetA2; and lanes 9-11 contain reactions including
increasing concentrations of the non-specific competitor, rnpB.
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D. fetA is part of an iron responsive operon that is differentially affected by MpeR
expression
The DNA region downstream of fetA encodes putative xenosiderophore
acquisition genes (Figure 20A). The genes downstream of fetA include: fetB, which
encodes a putative periplasmic binding protein; ng2091 and ng2090, which encode two
predicted permease proteins; and ng2088, encoding an ATP binding protein. The latter
three genes are therefore predicted to form an ABC transport complex. ng2089 encodes
an uncharacterized protein. Most siderophore acquisition systems are co-transcribed and
all genes involved in the system are coordinately regulated. Therefore, end point RTPCR was utilized to determine if fetA and the downstream genes were co-transcribed and
also activated by MpeR. Primers were designed to amplify the intergenic regions
between each gene in the hypothetical operon (Figure 20A). RNA was isolated from
gonococcal strains grown under iron-deplete (-) and iron-replete (+) conditions. In the
wild-type strain (FA1090) all amplicons were detected under iron-deplete conditions
(Fig. 19B) indicating that fetA and downstream genes are part of an iron regulated
operon. Interestingly, the fetA mutant, which contains a polar Ω (228) insertion in the
fetA gene, maintained the ability to express all of the downstream putative genes (Figure
20B). Similar results were observed in the mpeR mutant, in which genes fetB-NG2088
was co-transcribed under iron-deplete conditions (Figure 20B). A fetA mpeR double
mutant strain was also employed to investigate co-transcription of the ABC transport
genes. Again, the downstream putative transport genes, in the absence of both fetA and
mpeR were all transcribed under iron-deplete conditions (Figure 20B). Finally, when the
mpeR mutant was complemented with the wild-type mpeR gene, fetA and the
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downstream co-transcripts were detected under iron-deplete conditions, similar to the
wild-type strain. Based on these RT-PCR results, we propose that the wild-type strain
produces two different transcripts under iron-deplete conditions (Figure 20A). One
transcript encodes fetA-ng2088 whereas the other transcript encodes fetB-ng2088,
expression of which is iron regulated but not qualitatively affected by MpeR (Figure
20A).
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Figure 20. FetA is encoded as part of a multi-gene operon
A) Genetic locus including fetA and downstream genes. Genes are depicted by boxes.
Hatched regions 5’ of fetA and fetB indicate approximate locations of Fur boxes (139).
Below the chromosomal locus are small dark arrows indicating primer locations.
Numbered black bars denote the amplicons generated from each primer set. Long, dark
gray arrows indicate length and start positions of two proposed transcripts.
B) RT-PCR analysis of the fet operon. RNA was isolated from the indicated gonococcal
strains which were grown under iron deplete (-) and iron replete (+) conditions.
Amplicon numbers correspond to the diagram in panel A. 16S rRNA (16S) was used as a
positive control because it is constitutively expressed under all conditions test.
Expression of 16S rRNA in the absence of reverse transcriptase, (16S (-)) was used as a
negative control.
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The fetA transcriptional start site was previously mapped (44) and is identified in Figure
18. To confirm the presence of a second transcriptional start site upstream of fetB, we
employed primer extension analysis. As shown in Figure 21, we identified a
transcriptional start site downstream of several possible -10 sequences, within the
previously-identified Fur binding site (139). The transcript starting with fetB was
modestly iron regulated and the initiation site is located 72 nucleotides upstream of the
FetB start codon.
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Figure 21. Identification of the fetB transcription start site
A) Sequence of the intergenic region immediately upstream of fetB. The ATG at the end
of the sequence represents the FetB start codon. Several overlapping, potential -10
promoter elements are underlined. The Fur-binding site (139) is highlighted in gray. The
transcriptional start site identified in this analysis is identified by the asterisk.
B) Primer extension products generated from RNA samples harvested from wild-type
gonococcal strain FA1090 grown under iron replete (+Fe) and iron deplete (-Fe)
conditions. Equivalency of the amount of RNA template in each sample was confirmed
by ethidium bromide staining of RNA separated on an agarose gel. For comparison, the
sequencing reaction using the same primer as was used for the primer extension reaction,
is shown on the left. The T residue highlighted by the asterisk marks the point of
transcript initiation on the non-coding strand.
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To establish whether mpeR or fetA interruption quantitatively impact expression
of the downstream ABC transport genes, real-time RT-PCR was employed. ng2091 is the
first gene transcribed downstream of the gene encoding the putative periplasmic binding
protein (fetB) (Figure 19A). The same RNA samples isolated for qualitative RT-PCR
(Figure 18B) were used for real-time RT-PCR analysis. All CT values were normalized to
rmpM gene expression. In Table 5 and Figure 22, the average fold change is shown,
representing the comparison between expression under iron-deplete and iron-replete
conditions or expression by wild-type and mutant under iron deplete conditions. As
shown in Table 5, ng2091 gene expression was iron repressed; 16.3 fold more transcript
was detected under iron deplete conditions. When the wild-type and mutant strains were
compared, we observed that ng2091 gene expression levels were 23-fold higher in the
wild type relative to the fetA mutant (Figure 22). Similarly, ng2091 expression was 22.3fold higher in the wild type relative to the mpeR mutant. The wild-type strain expressed
11.5-fold more ng2091 transcript than the fetA mpeR double mutant (Table 5). The
mpeRC strain expressed more ng2091 transcript than did the mpeR mutant, as expected
(Figure 22). Cumulatively, these results indicate that fetA is part of an iron-regulated
operon encoding a putative periplasmic binding protein and ABC transport system. The
quantitative expression studies suggest that the ABC transport system is not as tightly
iron regulated as is either fetA or mpeR, which is consistent with the transcriptional start
site mapping data presented in Figure 21. Furthermore, the real-time RT-PCR data
indicate that expression of ng2091 is activated by MpeR, but that the extent of this
activation is not as great as was detected for fetA.
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Figure 22. Real time RT-PCR of ng2091
Normalized ng2091 gene expression ratio. Average fold change of ng2091 expression for
each comparison is shown. Bars represent the median fold change for the following
comparisons: WT-Fe/WT+Fe (gray bars) WT-Fe/ FA6959-Fe (checkered bars), WTFe/MCV304-Fe (horizontal striped bar), WT-Fe/MCV305-Fe (vertical striped bar) and
WT-Fe/MCV306-Fe (white bar). The median fold change is detected from three
independently-conducted real time RT-PCR assays. Numerical values from all three
assays indicated in Table 5.
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TABLE 5. Effects on gene expression measured by real time RT-PCR.
Comparison
WT-Fe / WT+Fe
WT-Fe / FA6959-Fe
WT-Fe / MCV304-Fe
WT-Fe / MCV305-Fe
WT-Fe / MCV306-Fe
1

Normalized target gene expression ratio
ng2091
16.3 (17-16)
23 (28-16)
22.3 (24.22)
7.1 (9.7-5)
11.5 (16-9)

Average fold change for each comparison is shown, with the range detected among
three independently-conducted real time RT-PCR assays shown in parentheses.
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E. Xenosiderophore-iron acquisition by gonococcal strain FA1090
N. gonorrhoeae does not produce siderophores; however, the pathogen is capable
of utilizing siderophores synthesized by other microorganisms (43, 273, 303). In
gonococcal strain FA1090, Carson et al. demonstrated that FetA functions as a receptor
for the xenosiderophore enterobactin (43). Enterobactin is a cyclic catecholate
siderophore composed of three 2,3-dihydroxybenzoylserine (DHBS) subunits and was
first characterized in E. coli. Enterobactin derivatives including the DHBS monomer
(D1), the DHBS dimer (D2), and the DHBS trimer (D3) have also been identified as
siderophores secreted by E. coli (118, 209). Carson et al. determined that enterobactin is
utilized by gonococcal strain FA1090 in a FetA- and TonB-dependent manner (43). We
tested whether strain FA1090 could also utilize other xenosiderophores in a similar
manner. Since MpeR activates fetA expression, MpeR was predicted to affect catecholate
utilization in gonococcal strain FA1090 as well.
Plate bioassays were employed to measure siderophore-dependent growth of
gonococcal strain FA1090. We tested a variety of siderophores including: ornibactin,
aerobactin, ferrichrysin, ferrirubin, coprogen, neocoprogen, enterobactin, DHBS and
salmochelin for growth support. We found that ferrichrysin, ferrirubin, coprogen and
neocoprogen did not support growth at all. Ornibactin and aerobactin supported growth
but only in a TonB-independent fashion (data not shown). Thus we focused on the
catecholate-type siderophores including: enterobactin, DHBS monomer (D1), DHBS
dimer (D2), DHBS trimer (D3), salmochelin S4 (a cyclic, diglucosylated form of
enterobactin), and the linear derivative of salmochelin (S2) (202). We evaluated
xenosiderophore utilization in the wild type, the tonB mutant, the fetA mutant, the mpeR
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mutant, the mpeRC strain, and the double fetA mpeR mutant. Ferric citrate was used as a
positive control and bovine transferrin was used as a negative control since gonococci
cannot utilize iron bound to non-human transferrin (10, 163). Figure 23 shows the
average growth zone in millimeters detected around each iron source with standard
deviation reflecting the variability within four or five independently-conducted
experiments, each of which was performed in triplicate. As previously shown by Carson
et al. (43), gonococcal strain FA1090 grows in the presence of enterobactin (Figure 23).
Enterobactin-dependent growth by the fetA and tonB mutants was reduced to just above
background levels (dotted line, Figure 23). Enterobactin-dependent growth by the mpeR
mutant was also decreased relative to the wild-type strain, although growth inhibition was
not as great as was observed with the fetA and tonB mutant strains. Enterobactindependent growth in the mpeRC strain was near wild-type amounts, consistent with the
recovery of MpeR regulatory function in this strain. The double fetA mpeR mutant was
severely restricted in enterobactin-dependent growth. These findings are consistent with
those of Carson et al. (43), but further extends our observation that MpeR activates FetA
expression, and leads to an enhanced ability to utilize the xenosiderophore enterobactin.
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Figure 23. Xenosiderophore utilization by gonococcal strain FA1090
CDM plates were supplemented with apo-bovine transferrin and wells within the plates
were inoculated with 10µl of the following siderophores: ENT: enterobactin; D1:
dihydroxybenzoylserine (DHBS); D2: the dimer form of DHBS; D3: the trimer form of
DHBS; S2: the linear derivative of salmochelin; and S4: the cyclized form of
salmochelin. Ferric citrate (+) was used as the positive control and apo-bovine
transferrin (-) was used as the negative control as indicated along the x-axis of the graph.
Each bar indicates the average growth in millimeters around each siderophore source; the
average and standard deviations were determined from seven independent experiments,
each conducted in triplicate. Bars represent average growth zone for the following
strains: wild type FA1090 (black bars), fetA mutant strain FA6959 (checkered bars),
tonB mutant strain MCV656 (gray bars), mpeR mutant strain (white bars), and mpeRC
complement strains (striped bars). The horizontal dotted line indicates the diameter of
the well containing each iron source. Pairwise comparisons between the wild-type and
mutant strains resulted in the following P-values: * < 0.001; # = 0.0124; ^ = 0.0197.
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As shown in Figure 23, our analysis additionally demonstrates that gonococcal
strain FA1090 can employ the enterobactin derivatives D2 and D3 in a FetA- and TonBdependent manner. As was detected with enterobactin, use of these enterobactin
derivatives was also maximized when MpeR was expressed. The mpeR mutant was
capable of less growth around D2 and D3 (Figure 23) relative to the wild-type strain and
complementation of the mpeR mutation led to an increase in D2- and D3-dependent
growth. Interestingly, there was also a significant decrease in salmochelin S2-dependent
growth by both the fetA mutant and tonB mutant, indicating that FA1090 utilized
salmochelin S2 in a FetA-and TonB-dependent manner as well. These results
demonstrate that gonococcal strain FA1090 is capable of employing enterobactin, the
DHBS dimer (D2) and trimer (D3) derivatives and salmochelin S2 as iron sources. FetA,
TonB and MpeR are critical for this process, consistent with the ability of MpeR to
induce expression of FetA. This is the first demonstration that gonococcal strain FA1090
utilizes DHBS dimers and trimers and salmochelin S2 as iron sources and that this uptake
pathway depends upon expression of FetA, TonB, and MpeR activation. While
salmochelin S4 was not utilized by any FA1090 variants tested in this analysis, the
DHBS monomer was employed by all strains, both mutant and wild-type. These results
imply that FA1090 does not have the capacity to internalize salmochelin S4 but can
import DHBS in a TonB- and FetA-independent pathway.
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F. ABC transport genes NG2088 and NG2090 are necessary for xenosiderophore
acquisition
The ABC transporters are ubiquitous membrane proteins that couple adenosine
triphosphate (ATP) hydrolysis to the translocation of diverse substrates across cell
membranes. In a classical transport reaction, two highly conserved ATP-binding domains
or subunits couple the binding/hydrolysis of ATP to the translocation of particular
substrates across the membrane, through interactions with membrane-spanning domains
of the transporter (72). In siderophore acquisition, once the siderophore is bound to the
periplasmic binding protein, it must be transported into the cytoplasm. This is
accomplished by an ABC transporter protein complex. Bacterial ABC transporters
commonly consist of four structural domains: two transmembrane domains that form a
channel through which the ferric-siderophore passes through and two nucleotide binding
domains that hydrolyze ATP. The Fet operon encodes the periplasmic binding protein
fetB as well as a putative ABC transport system encoded by ng2091-ng2088 (Figure
20A). We were interested in the impact these ABC transport genes have on siderophore
acquisition. Employing the plate bioassay we investigated the growth of two ABC
transport mutant strains and compared growth to the wild type strain. A polar omega
cassette was cloned into ng2088 which encodes an ATP binding protein to construct a
mutant ng2088 strain (FA7029). The same omega cassette was also cloned into ng2090
which encoded a transmembrane permease to construct the ng2090 mutant strain
(FA7241). We tested the acquisition of the following catecholate-type siderophores
including: enterobactin, DHBS monomer (D1), DHBS dimer (D2), DHBS trimer (D3),
salmochelin S4 (a cyclic, diglucosylated form of enterobactin), and the linear derivative
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of salmochelin (S2) (202). Growth zones indicated utilization of the iron source tested
with the limit of detection of 8mm indicated by a dotted line (Figure 24). Figure 24
shows the mean and standard deviation from four independent experiments that were
each performed in triplicate. We observed an attenuated growth pattern in the presence of
the catecholates with the exception of DBHS monomer (D1) for both mutants when
comparing growth zones to the wild type strain (FA1090). This is not surprising, since
the omega cassette is polar, the ng2090 mutant is not expected to express any of the
genes downstream including ng2088. Both ABC transport mutants exhibit growth similar
to the tonB and fetA mutants (Figure 23) in which growth was significantly attenuated in
the presence of enterobactin, DHBS dimer (D2), DHBS trimer (D3), and salmochelin S2.
Interestingly, growth in the presence of DHBS monomer (D1) was attenuated but this
difference did not reach a level of statistical significance. Growth above the threshold of
detection was observed in these ABC transport mutants similar to the tonB and fetA
mutant strains implying that an alternative pathway may be utilized for low levels of
xenosiderophore acquisition in these mutant strains. Furthermore, these results indicate
that the entire ABC transport system operon must be expressed for optimal levels of
xenosiderophore utilization and that as in all ABC transport systems, the ATP binding
protein plays a crucial role in transport. When the ATP binding protein encoded by
ng2088 was mutangenized, the mutant strain (FA7021), only supported very low levels of
growth compared to the wild type strain (FA1090). The ATP-binding cassettes power the
transporter by binding and hydrolyzing ATP (71). It is presumed that in the absence of
ng2088, ABC transport through this system cannot occur, due to a lack of energy.
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Figure 24. Xenosiderophore utilization by gonococcal strain FA1090 ABC transport
mutants
CDM plates were supplemented with apo-bovine transferrin and wells within the plates
were inoculated with 10µl of the following siderophores: ENT: enterobactin; D1:
dihydroxybenzoylserine (DHBS); D2: the dimer form of DHBS; D3: the trimer form of
DHBS; S2: the linear derivative of salmochelin; and S4: the cyclized form of
salmochelin. Ferric citrate (+) was used as the positive control and apo-bovine
transferrin (-) was used as the negative control as indicated along the x-axis of the graph.
Each bar indicates the average growth in millimeters around each siderophore source; the
average and standard deviations were determined from four independent experiments,
each conducted in triplicate. Bars represent average growth zone for the following
strains: wild type FA1090 (black bars), ng2088 strain (FA7029) (checkered bars), ng2090
mutant strain (FA7241) (white bars with black dots). The horizontal dotted line indicates
the diameter of the well containing each iron source. Asterisks (*) indicate significant
values from pairwise comparisons between the wild-type and mutant strains at P-values:
< 0.001
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G. Xenosiderophores that support growth do not serve as co-inducers for MpeRdependent fetA activation
AraC-like transcriptional regulators are distinguished by a C-terminal helix-turnhelix motif, which is responsible for DNA binding. These regulators also contain an Nterminal binding site to which activator molecules bind conferring specificity on
regulation (97). MpeR, an AraC-like regulator, enhances fetA transcription (Figures 17
and 18) and MpeR binds to the region upstream of the fetA gene (Figure 19). Gonococcal
strain FA1090 can utilize enterobactin, DHBS, and salmochelin S2 as iron sources
(Figure 22). Given these findings, we tested whether these xenosiderophores could serve
as co-inducers for MpeR-dependent FetA activation. Western blot analysis was utilized
to investigate FetA expression when gonococci were grown in the presence of ferrated
catecholates. The wild-type strain was grown in the presence of the ferrated forms of
enterobactin, DHBS monomer (D1), DHBS dimer (D2), DHBS trimer (D3), salmochelin
S4, and salmochelin (S2). Every two hours, aliquots were removed from the cultures,
and standardized to cell density. FetA expression was analyzed by SDS-PAGE and
western blot analysis. FA1090 grown in the presence of all tested siderophores except
salmochelin S4 exhibited FetA expression levels similar to that detected under ironreplete conditions (Figure 25A). The wild-type strain, grown in the presence of S4,
exhibited similar FetA expression levels to those expressed when grown in iron-deplete
conditions (Figure 25A). To determine whether the decrease in FetA expression was
siderophore specific or due to iron status, we analyzed TbpA expression from the same
cultures. TbpA is a Fur regulated, outer membrane transporter of iron from human
transferrin (64). TbpA expression mirrored that of FetA as a function of growth on
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xenosiderophores (Figure 25A). As observed for FetA, TbpA expression was greatest in
the presence of S4 and when strains were grown under iron-deplete conditions (Figure 24
A). As shown in Figure 23, salmochelin S4 did not support the growth of FA1090. Thus
the increase in FetA expression in the presence of salmochelin S4 is due to iron stress
rather than S4 serving as a co-inducer for MpeR in the activation of FetA. Furthermore,
the other siderophores and derivatives that supported growth resulted in high internal iron
pools and consequently resulted in repression of FetA. We repeated this experiment,
replacing the ferrated siderophores with the iron-free forms during gonococcal growth
(Figure 25B). As seen with the ferrated-xenosiderophores, there was no evidence of
siderophore-dependent induction as all strains expressed FetA at levels similar to those
detected in iron depleted growth conditions. Cumulatively, these results suggest that FetA
expression is sensitive to the iron status of the cell and that the presence of the
xenosiderophores, either in ferrated or iron-free form, did not further influence FetA
expression.
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Figure 25. FetA expression is not induced by the presence of xenosiderophores
A) WT (FA1090) was grown in CDM with the indicated ferrated-xenosiderophores
(final concentration of 10 μM) as the sole iron source. The following ferricxenosiderophores were tested: ENT: enterobactin; D1: dihydroxybenzoylserine (DHBS);
D2: the dimer form of DHBS; D3: the trimer form of DHBS; S2: the linear derivative of
salmochelin; and S4: the cyclized form of salmochelin. As controls the WT strain was
grown in the absence of iron (-) or with ferric nitrate (+) but without the addition of
siderophores. Aliquots collected at 2, 4 and 6 hours (indicated above the blots) were lysed
and subjected to SDS-PAGE. After separation, proteins were transferred to nitrocellulose.
Blots were probed with anti-FetA (top) or anti-TbpA antibodies (bottom).
B) As in panel A, except the WT (FA1090) was grown in CDM with the indicated
xenosiderophores in the iron-free or apo form.
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III. Discussion
MpeR was first identified by Folster and Shafer as a homolog of other AraC-like
regulators (92). MpeR was originally described as a transcriptional regulator of the mtrF
gene, which encodes a protein that modulates antimicrobial efflux pump activity in
gonococcal strain FA19. In the present study, we determined that in contrast to its
repressive action on mtrF, MpeR activates fetA transcription under iron-deplete
conditions. While MpeR clearly plays a role, other regulators or co-factors may also be
involved in controlling fetA expression. Importantly, this is the first example of an AraClike regulator that is involved in the regulation of an outer membrane xenosiderophore
transporter in N. gonorrhoeae. Thus, the transcriptional regulatory activities of MpeR
impact at least two important properties needed for survival of gonococci during
infection: efflux of host-derived antimicrobials by the Mtr system (92) and
xenosiderophore-iron acquisition via FetA. In the context of the present work, we
suggest that MpeR regulation of fetA may aid in gonococcal immune evasion. Anti-FetA
antibodies are present in sera from patients convalescing from meningococcal disease and
these antibodies are cross-reactive against gonococcal strains (3, 27). In addition,
monoclonal antibodies against FetA are bactericidal in the presence of human
complement (219). Therefore, continuous, unregulated FetA expression during the
entirety of an infection is expected to elicit a host response that would inhibit the bacteria
from thriving in vivo. Thus fetA expression is expected to be tightly controlled.
In the current study, we determined that enterobactin and DHBS dimers (D2) and
trimers (D3) were utilized by strain FA1090 in a FetA- and TonB-dependent manner.
MpeR-dependent activation of FetA enhanced the ability of FA1090 to employ these
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xenosiderophores as sole iron sources. We also observed that the ABC transport system
co-transcribed with FetA is important for xenosiderophore utilization as mutations in
ng2090 and ng2088 resulted in reduced growth in the presence of the siderophores. While
the ability of N. gonorrhoeae to utilize enterobactin had been previously recognized (43),
this is the first demonstration that gonococci can use DHBS dimers (D2) and trimers (D3)
as iron sources. Like enterobactin, these enterobactin derivatives were employed by wildtype FA1090 in a FetA-, TonB-, and MpeR-dependent mechanism. This is somewhat
surprising since these siderophores are internalized via distinct TonB-dependent
transporters in other Gram-negative bacteria (98, 316) Moreover, strain FA1090 can also
employ the xenosiderophore salmochelin S2 in the same FetA-dependent pathway. The
broad specificity of FetA for all four xenosiderophores is remarkable, as their import into
E. coli is facilitated by four distinct transporters, including FepA, Cir, FiuA and IroN (98,
316). Carson et al. (43) noted that the sequence of FetA from gonococcal strain FA1090
retained those residues known to be important for enterobactin binding to FepA (51);
however, the spacing between the conserved residues was distinct. In addition, the
binding affinity of FetA for enterobactin was found to be much weaker (43) than that
described for E. coli FepA (42). Thus we propose that FetA and the downstream ABC
transport system has evolved as a gonococcal transporter capable of importing a broad
spectrum of catecholate-type xenosiderophores, perhaps at the expense of high affinity
interactions with any single siderophore.
Salmochelin is known as a "stealth siderophore" and is derived by glucosylation
of enterobactin via the products of the iroA locus (202). Virulent pathogens, including
uropathogenic E. coli, Salmonella enterica, and Shigella dysenteriae harbor the iroA
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locus, sometimes on pathogenicity islands (215). Modification of the enterobactin
molecule by addition of two glucose molecules leads to increased hydrophilicity and to
the ability of salmochelin to evade the host's innate immune response. In the human host,
enterobactin is sequestered and made ineffectual by the innate immunity protein,
siderocalin (also known as lipocalin 2), whereas salmochelin is not (89, 101). Thus,
salmochelin production by pathogens allows for efficient iron acquisition in the presence
of siderocalin (235), which is found in lymphocytes. Salmochelin S4 is a cyclic form of
the siderophore and salmochelin S2 is the linear derivative of S4; both forms coordinate
iron and can be employed as "stealth siderophores". Gonococcal strain FA1090 did not
utilize iron from salmochelin S4 but did obtain iron from S2. As microbial producers of
enterobactin, DHBS and salmochelin inhabit the same niche as the gonococcus (80, 230),
it seems likely that the ability to hijack these siderophores, in the presence of neutrophilderived siderocalin, enhances the survival of N. gonorrhoeae in vivo.
Interestingly, our laboratory has observed differences in xenosiderophore
utilization among gonococcal strains. Strain FA19 utilizes enterobactin, D1, and S2 in a
TonB- and FetA-independent mechanism that requires expression of the FbpABC system
(273). In the current study, we demonstrated that FA1090 utilizes D1 in a TonB- and
FetA-independent mechanism. However, FA1090 utilizes enterobactin, D2, D3, and
salmochelin S2 in a FetA- and TonB-dependent manner. Our hypothesis is that the
differences in xenosiderophore utilization phenotypes between strains are due to two
different pathways by which iron from xenosiderophores can be transported into the
gonococcus. One pathway is TonB- and FetA-dependent while the other pathway is
TonB-independent and requires the FbpABC system. In gonococcal strain FA1090, the
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fetA and tonB mutants were capable of significantly less growth with enterobactin, D2
D3, and S2 relative to the wild-type strain; however, both mutants exhibit
xenosiderophore-dependent growth above background (dotted line in Figure 23). Growth
was diminished but not abolished in the tonB and fetA mutant strains; therefore we
hypothesize that the FbpABC-dependent, Ton-independent pathway is also employed by
these mutants in the FA1090 background. In further support of this hypothesis, Carson et
al. demonstrated that both fetA and fetB mutants of FA1090 exhibited a decrease in
growth in the presence of enterobactin but growth was not abolished(43). Similar results
were also observed with the tonB mutant in the previous study (43). Thus, some iron was
transported into the fet and tonB mutants in an energy- and fet operon-independent
pathway. The difference in xenosiderophore-dependent growth between FA19 and
FA1090 is likely due to differential use of these two distinct pathways. Gonococcal strain
FA19 seems to be limited to use of the TonB-independent pathway that employs the
FbpABC system for iron transit through the periplasm and cytoplasmic membrane. A
possible explanation for the exclusive use of Ton-independent pathway in strain FA19
could be related to the observation that the genome sequence of gonococcal strain FA19
contains a frame-shift mutation within ng2090. We have confirmed by direct sequencing
of a PCR product amplified from FA19 chromosomal DNA that this lesion represents a
genuine mutation and is not a genome sequencing error (Figure 26). This mutation would
result in a truncated Ng2090 protein and may prevent expression of downstream genes as
well (65). Similar to the attenuated growth we observed in gonococcal mutant ng2090
strain (FA7041) we detect attenuated growth of FA19 on the xenosiderophores.
Therefore, we hypothesize that this genetic difference between strains FA1090 and FA19
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results in a defective Fet system and a reliance on the TonB-independent uptake pathway
for uptake of iron from xenosiderophores in strain FA19 (65).
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Figure 26. Amino Acid Sequence alignment of Ng2090
Amino acid sequence alignment of Ng2090 from gonococcal strain FA1090 and FA19.
Amino acid position indicated above each line, gray shading with black font indicates
100% identical sequence. Black font with white background indicates not identical and
dash marks indicate lack of sequence in strain FA19.
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50
FA1090 MPSEKNIGFMAGSSRPLRVAFALLLVSCILFMTLNVKGDWDFVLHLRLTK
FA19 MPSEKNIGFMAGSSRPLRVAFALLLVSCILFMTLNVKGDWDFVLHLRLTK
100
FA1090 LAALLMVAYAVGVSTQLFQTLTNNPILTPSILGFDSLYVFLQTLLVFTFG
FA19
LAALLMVAYAVGVSTQLFQTLTNNPILTPSILGFDSLYVFLQTLLVFTFG
101
150
FA1090 GVGYTSLPLTGKFGFELVVMMGGSLLLFYTLIRQGGRDLPHMILIGVIFG
FA19
GVGYTSLPLTGKFGFELVVMMGGSLLLFYTLIRQGGRDLPHMILIGVIFG
151
200
FA1090 ILFRSLSSLLSRMIDPEEFTAAQANMFAGFNTVRSELLGIGALVLLVSAA
FA19 ILFRSLSSLLSRMIDPEEFTAAQANMFAGFNTVRSELLGIGALVLLVSAA
201
250
FA1090 VVWHERYRSDVHLLGRDQAVNLGISYTRNTLWILLWIAALVATATAVVGP
FA19
VVWRERYRSDVHLLGRDQAVNLGISYTRNTLWILLWIAALVATATAVVGP
251
300
FA1090 VSFFGLLAASLANHFSPSVRHSVRLPMTVCVGGILLVGGQTVFEHFLGMK
FA19
VSFFGLLAASLANHFSRPCAIPSACR-----------------------------------------------301
324
FA1090 AVLSVVVEFAGGLVFLYLVLKHKK
FA19
----------------------------------------------
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In N. gonorrhoeae, the fetA gene is the only TonB-dependent transport system
that is also encoded with a periplasmic binding protein and a complete set of ABC
transport genes (fetB-ng2088). Data presented in the current study suggest that the
putative periplasmic binding protein and ABC transport system are co-transcribed with
fetA, but also independent of FetA and MpeR. Expression of the shorter transcript
encoding fetB-ng2088 was detected only in gonococci grown in iron-deplete conditions.
A Fur box upstream of fetB was identified by FURTA and EMSA assays (139),
consistent with our finding of a separate iron-regulated transcript including the fetBng2088 genes. The FetA-independent but iron regulated transcription of the ABC
transport genes suggests that the ABC transport system could be utilized by other TonBdependent transporters, in addition to FetA.
Enterobactin, D2, D3, and salmochelin S2 were acquired by gonococcal strain
FA1090, which led us to consider the possibility that one or all of these xenosiderophores
could serve as a co-inducer of MpeR for the activation of fetA expression. However,
contrary to our hypothesis, FetA expression was not altered by the presence of any of the
siderophores tested, regardless of their iron status. We are currently entertaining three
possible mechanisms to explain these results. First, MpeR may not require a co-inducing
molecule in order to activate FetA expression. Second, because MpeR is involved in
modulating the expression of proteins involved in antimicrobial efflux, the co-inducing
agent for MpeR-dependent regulation could be related to efflux. In this context, since the
Mtr system is necessary for efflux of host-derived antimicrobials, MpeR might sense an
efflux substrate as a signal of location within the host. And third, other catechols might
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serve as co-inducers with MpeR. Given the broad specificity of FetA, it is possible that
an as yet unrecognized catecholate molecule could serve as an inducer and also provide
iron in a FetA-dependent manner.
The mpeR gene has only been identified in the genomes of the pathogenic
Neisseria and is absent from the genomes of commensal Neisseria (184, 266). The MpeR
proteins are highly conserved, sharing 97-100% sequence identity among the pathogenic
Neisseria species (data not shown). This conserved, pathogen-specific regulator controls
the expression of FetA, which is a pan-Neisseria transporter (184). In Staphylococcus
aureus, different community-acquired strains vary in their virulence. The difference
amongst strains in pathogenic potential is linked to increased expression of core genomeencoded virulence genes (176). It was hypothesized by Li et al. (176) that global
regulators of virulence genes are responsible for variable virulence amongst strains.
Similarly, commensal Neisseria have an extensive repertoire of virulence alleles that are
also expressed by pathogenic Neisseria and other bacterial genera (184). Thus differential
regulation of these alleles, rather than their presence or absence, may contribute to
increased virulence in the pathogenic Neisseria. Perhaps MpeR-dependent activation of
fetA and other potential transporters enhances virulence in pathogenic Neisseriae relative
to the commensals.
In conclusion, in this study we demonstrated that MpeR, a pathogen-specific regulator in
N. gonorrhoeae enhances expression of the siderophore receptor FetA under iron-deplete
conditions. Up-regulation of fetA by MpeR was by a direct mechanism. A second,
internal transcriptional start site was identified upstream of fetB, positioned near several
potential -10 promoter elements, overlapped by the Fur-binding site. Additional studies
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will be required, however, to fully define the mechanisms that control fetB transcription
and whether other regulatory proteins are involved. We also determined that enterobactin,
D2, D3 as well as salmochelin S2 were utilized in a FetA- and TonB-dependent
mechanism in strain FA1090. Expression of MpeR enhanced the ability of strain FA1090
to utilize enterobactin and salmochelin, consistent with MpeR-dependent activation of
FetA. Gonococcal strain FA1090 was also capable of utilization of the DHBS monomer,
but did so in a TonB- FetA-independent manner. We identified one possible mechanism
that may elucidate why gonococcal strain FA19 exhibits Ton-independent
xenosiderophore acquisition. None of the catecholates that supported growth in this
study appeared to act as a co-inducer for MpeR-dependent activation of fetA. To our
knowledge, this study represents the first description of a pathogen-specific regulator in
N. gonorrhoeae that activates expression of a pan-Neisseria TonB-dependent transporter.
In addition, the current study is the first to link regulation of iron transport and
antimicrobial efflux systems through the action of a pathogenic Neisseria-specific
regulator.
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CHAPTER 6 DISCUSSION

Neisseria gonorrhoeae is a well adapted human pathogen. Multiple TonBdependent and TonB-independent iron acquisition systems have been characterized
including those involved in iron acquisition from transferrin (63, 64), lactoferrin (22, 25),
hemoglobin (53), xenosiderophores (43, 273) and intracellular iron (113, 317). All of the
TonB-dependent receptors are regulated by the ferric uptake regulator Fur to prevent iron
overload within the bacteria.
The overall goal of this study was to identify additional iron sources utilized by
Neisseria gonorrhoeae and characterize the regulation of the receptors specific to these
iron sources. This would provide valuable insight into the pathogenesis of the
microorganism and could also lead to new therapeutic targets. Understanding the
mechanism of iron acquisition within the intracellular environment gives us insight into
gonococcal intracellular survival. Currently, the precise intracellular localization of
Neisseria gonorrhoeae is unknown. Investigating potential intracellular iron sources
such as iron derived from degraded ferritin or a putative mammalian siderophore could
further our understanding of gonococcal localization within the cervical epithelial cells.
Ferritin is an iron binding protein ubiquitous in the human host. It is found intracellular,
in the cytosol, as well as in the nucleus, in endo-lysosomal compartments and in the
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mitochondria (120) of the epithelial cells. Extracellular ferritin is found in fluids such as
serum and synovial and cerebrospinal fluids (120). In our study we determined that the
addition of ascorbate to cells incubated in cell culture media inhibited intracellular
survival. Ascorbate inhibits ferritin degradation which could be the major source of iron
for intracellular gonococci. TdfF, a TonB-dependent transporter is crucial for intracellular
survival, and the tdfF mutant strain was rescued during gentamicin protection assays with
the addition of iron (113). This indicates that TdfF is important for intracellular iron
acquisition (113). One hypothesis is that TdfF is a receptor for an iron carrying molecule
involved in the transport of iron from degraded ferritin to other parts of the epithelial
cells. Ascorbate also binds iron and the attenuated intracellular survival observed could
be due to the ascorbate sequestering any iron that gonococci acquire within the epithelial
cell. We cannot conclude that N. gonorrhoeae utilize iron directly from degraded ferritin
until we investigate ferritin levels within an infected epithelial cell. We also investigated
gonococcal growth in the presence of 2,5-DHBA which is the binding moiety identified
for a putative mammalian siderophore (75). Enterobactin, aerobactin and
dihydroxybenzoylserine are xenosiderophores utilized by N. gonorrhoeae (43, 273, 303).
When we performed plate bioassays in which ferrated 2,5-DHBA was the only iron
source available, we observed intermediate growth of gonococci compared to growth in
the presence of utilizable iron sources. The intermediate growth observed occurred in a
TonB-, TdfF- independent manner. These results do not rule out the structurally complete
mammalian siderophore as a possible iron source for gonococcal strain FA1090 nor that
utilization of this siderophore could be TonB- and/or TdfF-dependent. Once the structure
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of the siderophore is elucidated we could test gonococcal iron utilization from this
mammalian siderophore.
Furthermore, understanding how tdfF expression is induced could lead to an
understanding of the regulation of virulence genes specific to the intracellular
environment. From previous studies we understand that tdfF expression was only
observed in the presence of epithelial cells or within cell culture media in the absence of
additional iron (113). In this study we determined that the heat-inactivated fetal bovine
serum component of cell culture media was an iron-depleted media that could contain an
inducing molecule responsible for tdfF expression. These observations indicate that tdfF
expression only occurs in the presence of a host specific signal under iron-deplete
conditions. We also determined that tdfF is identical in all gonococcal strains sequenced
to date. This leads us to the conclusion that TdfF is either not surface exposed or the
protein is only expressed inside the epithelial cell and away from the pressures of the
immune system. TdfF could also not be very immunogenic which could explain our
difficulty in detecting TdfF expression through western blot analysis. We hypothesize
that MpeR, an AraC-like regulator involved in the regulation of hydrophobic agent efflux
pumps (92) and the xenosiderophore receptor fetA could also play a role in tdfF
expression. The gene encoding mpeR is in very close proximity to tdfF on the
gonococcal chromosome and the locus of the gonococcal chromosome from tdfF to mpeR
is conserved only in pathogenic Neisseria species (184, 266). Additionally, mpeR itself is
iron regulated and directly activates the xenosiderophore acquisition system by FetA as
demonstrated in this study. AraC-like regulators are identified due to their homology to
AraC, which regulates arabinose metabolism and transport in E. coli. In E. coli, AraC
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plays a dual role as both an activator and a repressor in this system based on the
availability of the co-inducing molecule, arabinose. MpeR could also be a dual regulator
which activates or represses based on the availability of a co-inducing molecule. For
example, a specific inducing signal for intracellular invasion could make MpeR, activate
or derepresses tdfF expression. When gonococci are in the extracellular environment,
MpeR might no longer bind to this intracellular environment specific co-inducer and
activates the extracellular iron acquisition system, FetA while repressing TdfF. The
opposite could be true such that in the extracellular environment an unknown co-inducing
molecule could bind to MpeR, activating fetA and repressing tdfF expression. The coinducing molecule for MpeR activation of iron acquisition or efflux pumps has not been
elucidated and we tested various xenosiderophores, as well as human specific molecules
such as norepinephrine, epinephrine and ferritin. Since we have determined that MpeR is
involved in the regulation of xenosiderophore uptake and it has already been
demonstrated to regulate efflux pumps, MpeR could be a global regulator. If MpeR is a
global regulator then the inducing signal for MpeR activation could be anything.
FetA and TdfF could also be connected by the ABC transport system encoded by
the fet operon. The FetA-independent but iron regulated transcription of the ABC
transport genes ng2091-2088 suggests that the ABC transport system could be utilized by
other TonB-dependent transporters, such as TdfF. We defined the transcriptional start site
for the ABC transport operon; however, the -35 region could not be identified. This
suggests that this transport system could also be regulated by a transcriptional regulator
other than Fur. This alternative regulation could be important for the transport of other
iron sources besides xenosiderophores. TdfF does not have an associated ABC transport
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system; however, the iron source utilized by TdfF would need to cross the cytoplasmic
membrane. Perhaps, both TdfF and this ABC transport system are regulated by the same
intracellular regulatory cascade. Both TdfF and FetA have associated periplasmic
binding proteins (PBPs), and it is possible that the ABC transport system encoded by the
fet operon recognizes both PBPs. PBPs play an integral role in mediating the transport of
carbohydrates, amino acids, peptides, metal ions, metal chelate complexes and other
nutrients across the periplasm from the outer to the inner membrane (58). It has been
demonstrated that ABC transport systems are inactive until a holo-PBP interacts with the
transporter (178). We aligned both FetB from the fet operon and the periplasmic binding
protein encoded downstream of tdfF, NG0023 also annotated FetB2 and found that they
were 44% identical. We also used the SWISS-MODEL program (11) which is an
automated protein structure homology-modeling server to determine structural
similarities between FetB and NG0023. We used the amino acid sequence for the PBPs
from gonococcal strain FA1090. The SWISS-MODEL program selected Yclq, a Bacillus
subtilis PBP as the biological template structure for the topology model for both
gonococcal PBPs. Yclq is the PBP responsible for the transport of the siderophore
petrobactin in B. subtilis (313). FetB had a sequence identity of 35.4 % to Yclq and
NG0023 had a sequence identity of 32.5% to Yclq. The results of the models reveal that
the PBP structures were almost identical (Figure 26).

187

Figure 27. PBP topology models Ribbon diagrams of PBPs generated using the
SWISS-MODEL program (11) which is an automated protein structure homologymodeling server. The amino acid sequence from gonococcal strain FA1090 was used to
generate the topology models. Yclq, a B. subtilis PBP was used as the biological template
for both FetB and NG0023. FbpA has been crystallized in Neisseria. Protein secondary
structures are indicated by color: β-sheets in yellow, α-helices in magenta and turns in
blue. Three dimensional models of FetB (A), NG0023 (B) and FbpA (C) were
synthesized.

188

B

A

C

189
FbpA, the PBP associated with the transferrin and lactoferrin iron acquisition system
(54), has a very different structure compared to NG0023 and FetB (Figure 25). FbpA
shuttles iron across the periplasm to the ABC transport system, FbpBC. The interaction
between the PBP and its ABC transporter is mediated by charge-charge interactions
formed by surface exposed acidic residues on the PBP and basic residues found on the
periplasmic face of the transmembrane domains of the ABC transporter (132, 136). Since
FetB and NG0023 are nearly identical in structure, the acidic residues on the surface of
both PBPs could interact with the ABC system coded by the fet operon in a similar
manner. Both FetB and NG0023 have structures that would classify them in the class III
of PBPS. Class III is a large family of proteins with low sequence homology but similar
overall 3D structures. Other PBPS that are in this class include PBPs responsible for
transport of catecholate siderophopres (58). FbpA belongs to Class II which binds to a
large variety of substrates including ferric and ferrous iron. Therefore it is plausible that
both FetB and NG0023 periplasmic binding proteins deliver their specific ligand to the
same ABC transport system. The nearly identical structure amongst PBPs could also
signify that both bind to a similar ligand. The ABC system coded by the fet operon is
responsible for xenosiderophore acquisition from enterobactin, enterobactin derivatives
and salmochelin. If the structural similarity between the PBPs indicates similar ligands,
then NG0023 would be responsible for the transport of a catecholate siderophore-like
molecule like the recently identified mammalian siderophore.
Prevention as well as treatment of gonococcal disease is a critical global health
concern. Antibiotic resistance prevails and gonococcal infection increases the
transmission of HIV. Presented in these studies is the investigation of potential
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intracellular iron sources utilized by N. gonorrhoeae strain FA1090 as well as
extracellular iron sources produced by commensal bacteria in the female genital tract.
Understanding xenosiderophore utilization can lead to alternative therapeutic strategies
for the treatment of gonorrhea. In this study, we determined that gonococcal strain
FA1090 utilizes enterobactin and its breakdown product derivatives as well as
salmochelin in a FetA and Ton-dependent and independent manner. Previous studies
have indicated the xenosiderophore utilization occurs in Ton-independent, Fbp-dependent
manner for strain FA19 (273). We have determined that the difference in
xenosiderophore utilization between these strains is likely due to a mutation in the ABC
transport system encoded by the fet operon. However, despite the mechanism of
xenosiderophore utilization, understanding which xenosiderophores are utilized by
gonococci can allow us to exploit the nutrient acquisition pathway for new therapeutic
strategies.
Siderophores or analogs can be used as iron transport–mediated drug delivery or
“Trojan Horse” antibiotics. Siderophore-mediated drug transport in bacteria and fungi
have been demonstrated in both the laboratory and in nature. Sideromycins are naturally
occurring Fe3+-siderophores that are covalently linked to an antibiotic moiety. Only a few
naturally occurring sideromycins have been found, among them albomycin and salmycin
(121). A wide spectrum of siderophore–antibiotic conjugates has been chemically
synthesized. Although the antibiotic moieties account for a substantial part of the
sideromycins and drastically change the shape of the siderophore from which they are
derived, the sideromycins are nevertheless recognized and transported by the Fe3+siderophore transport proteins (232).
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For many antibiotics, the diffusion rate across the cell membranes into the
cytoplasm is poor. This is frequently a problem in antibiotic therapy for Gram negative
bacteria since the outer membrane reduces permeation to such an extent that the minimal
inhibitory concentration required reaches toxic levels (36). In contrast, for sideromycins,
the outer membranes and the cytoplasmic membranes do not serve as permeability
barriers, but rather actively contribute to the entry of the antibiotics to their targets in the
cytoplasm. Active transport reduces the minimal inhibitory concentrations more than a
100-fold (36). Thus, understanding how xenosiderophores are acquired could help in the
design of siderophore-antibiotic conjugates that could be applied for the specific
gonococcal infection. The challenge with using a siderophore-antibiotic conjugate is that
the siderophore used needs to be specific to the pathogen and not affect commensal
bacteria of the genital tract. We could also use this technology for the ligand specific to
TdfF. If this specific ligand is permeable across the epithelial cells, such as the
mammalian siderophore, then we could specifically target intracellular gonococci.
Therefore, identifying specific iron sources within the host and how they are acquired by
gonococci can lead to innovative therapies and a better understanding of the pathogenesis
of the microorganism.
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